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Introduction and Outline of 
the Thesis
Introduction 
This chapter will provide background information including, definition, 
epidemiology, diagnosis, pathogenesis and treatment. This is followed by rationale 
behind this thesis that will elaborate as to what is missing in the current literature 
and how application of our investigative work will help clinical problems in daily 
practice. 
Background 
A pharyngeal pouch or Zenker’s diverticulum is a mucosal out-pouching in the 
cervical oesophagus. It arises from the posterior oesophageal wall in a structural 
weakness between horizontal and oblique cricopharyngeus fibre known as Killian’s 
dehiscence located between the oblique and horizontal muscle fibre layers of the 
cricopharyngeus (CP) muscle Killian. 
1.2 Epidemiology 
The exact incidence of pharyngeal pouch is unknown but ZD is relatively rare 
condition with annual incidence of 2 cases per 1000, 00 and reported prevalence 
of 0.01-0.11%. (1,2). Pharyngeal pouches are twice as common in men and affect in 
the 7th or 8th decade.
Abraham Ludlow first described Zenker’s diverticulum in 1769 at an autopsy finding 
(3). In 1877 Zenker’s was described as an oesophageal diverticulum occurring as a 
result of force within the lumen acting against restriction and thus defined as a 
pulsion diverticulum. Wheeler carried out the first surgical excision of Zenker’s 
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diverticulum in 1886 (4). Endoscopic treatment of Zenker’s diverticulum was 
introduced in 1917 by Mosher who excised the diverticular septum using a rigid 
endoscope (5). This was subsequently modified in 1960 by Dohlman and Mattsson 
who used diathermy to carry out this procedure (6,7). This technique was further 
evolved to include endoscopic stapling after division of the septum in 1993. The 
first use of minimally invasive flexible endoscopic therapy in Zenker’s diverticulum 
was reported in 1995 by Mulder and Ishioka (8,9). (Figure 1)
Figure 1: A historical overview of Zenker’s diverticulum
1.3. Clinical presentation
The majority of patients present with dysphagia which is initially to solids but as 
they may progress to semi-solids and liquids with time and in severe stages the 
patients are unable to swallow their own saliva. Regurgitation of food is present 
in about 80% and because of undigested food in the pouch, halitosis may also be 
present. Weight loss is a common finding. Pharyngeal pouches are less commonly 
associated with pulmonary complications such as aspirational pneumonia and 
pneumonitis. There is a 0.04% risk of squamous cell cancer within the pouch which 
has been reported. Other relatively common symptoms include cough, dysphonia, 
and voice hoarseness  (Boutou, 2009). Although rarely, a palpable or visible lump 
with cervical borborygmus (Boyce’s sign) has been described. 
Historically, a Dakkak and Bennett score was used to score dysphagia (10).
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1.4 Diagnosis
Currently, barium swallow remains the mainstay imaging modality for patients 
with suspected ZD. Multi-frame fluoroscopic imaging is typically performed with 
at least lateral and anteroposterior projections of the hypopharynx and cervical 
oesophagus, although oblique views may also be helpful to adequately image 
the cricopharyngeus muscle (CP). (Figure 1) In addition to the initial diagnosis, 
this technique differentiates ZD seen on the posterior wall, with the neck of the 
diverticulum seen above the level of the cricopharyngeus muscle, from the less 
common, smaller and less symptomatic Killian-Jamieson diverticulum that arises 
from the lateral wall below the level of the CP. Following on from the diagnosis, 
the typical radiological barium swallow assessment of ZD usually involves 
anatomical and functional elements with the lateral projection being most useful. 
The anatomical assessment traditionally consists of an estimate of pouch size and 
neck width. Functional assessment includes evaluating for pooling of contrast, 
regurgitation and aspiration, with exploration of the effects of the diverticulum 
on the adjacent oesophagus which may contribute to symptomatic dysphagia (11). 
Studies on the clinical value of manometry in ZD are lacking. The routine use of 
oesophageal manometry in the work-up of patients with (suspected) ZD is not 
recommended. In individual cases, e.g. in small ZD, oesophageal manometry can 
be used to rule out other causes of similar symptoms. 
Figure 2: Barium swallow demonstrating 
Zenker’s diverticulum (ZD), cricopharyngeus 




Over a century ago Von Zenker hypothesized, Zenker’s diverticulum as posterior 
pulsion herniation of pharyngeal mucosa due to increased intraluminal pressure 
in pharynx and hypopharynx. Since then there is very little progress on this hence 
the pathophysiology of ZD is not fully understood. The most widely proposed 
hypothesis is that a motor abnormity of CPM create a high pressure zone that 
facilitate pulsion herniation of hypopharyngeal mucosa through the weak zone, 
the Killian triangle, resulting in diverticulum development (12,13). 
The CP is a striated skeletal muscle that lies between inferior pharyngeal constrictor 
and superior aspect of oesophagus that constitutes upper oesophageal sphincter 
(UES). The dysfunction of the UES which lead to formation of a ZD include 
excessive contraction (elevated resting tone) incomplete relaxation opening of the 
UES (14,15).
The CP muscle consists of oblique (CP
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lateral sides of and joins together with insertion into median pharyngeal raphe. 
CP
H
 d muscle fibre lay inferior to CP
o
 fibres and form a sling around pharynx by 
attaching to arch of cricoid cartilage.
 
(Figure 2).
Figure 3 shows Pouch anatomy in relation with close proximity to buccopharyngeal 
fascia (BPF) - BPH, EO- esophageal opening, CPM (cricopharyngeus muscle).
Figure 4 illustrate that CPM is circular muscle and not supported posteriorly by 
ELM as is the case in the esophagus. CPM- Cricopharyngeus muscle, KT- Killian 
triangle, ECM- esophageal circular muscle, ELM- esophageal longitudinal muscle. 
ICM: Inferior constrictor muscle. Manometric studies support the hypothesis that 
ZD arises as a result of spasm and poor relaxation of the cricopharyngeus muscle 
that leads to increased intraluminal pressure, hence development of pouch. Studies 
have suggested that acid reflux indirectly can predispose to ZD by increasing Upper 
oesophageal sphincter pressure. Histological analysis has revealed fibrosis of CP 
muscle which can be associated with older age and neuromuscular disorder (16).
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Figure 3: lateral view and posterolateral view of inferior pharynx and superior oesophagus.
Figure 4: Pouch anatomy in relation with close proximity to buccopharyngeal fascia (BPF) - BPH, EO- esophageal 
opening, CPM (cricopharyngeus muscle).
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Figure 5: illustrate that CPM is circular muscle and not supported posteriorly by ELM as is the case in the 
oesophagus.
Video legend (Video 1-FESD Knife)
1.6 Treatment
The aim of the treatment is to provide symptom relief and improve quality of 
life. The end point is to divide the septum (CP muscle). This not only improves 
muscle dysfunction, but also creates a corridor and overflow between the pouch 
and the oesophagus. The majority of patients with ZD are elderly and frail; hence 
it’s paramount to consider the overall health and fitness of patient before consider 
any treatment options and its impact on individual quality of life. Current 
treatment options include: open surgery (i.e. trans-cervical diverticulectomy, 
diverticuloplexy with myotomy of the cricopharyngeus muscle or diverticular 
inversion), rigid endoscopy (i.e. endoscopic stapling or CO2 laser treatment) and 
flexible endoscopy. There is lack of randomized clinical trials hence surgeons 
favour rigid endoscopic stapling technique and gastroenterologists prefer flexible 
endoscopic option.
Success rates of therapy appear comparable between modalities (surgery: 80–
100%, rigid endoscopy: 90–100%, flexible endoscopy: 43–100%), but symptomatic 
recurrence can be as high as 19% for surgery, 12.8% for rigid endoscopy and 20% for 
flexible endoscopy. As most ZD patients are elderly with co-morbidities, surgery 
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is associated with significant morbidity and mortality, with rates of 30 % (vs 3% for 
rigid endoscopy and 1.5% for flexible endoscopy) and 3%, respectively. In addition 
approach using rigid endoscopy requires GA and hyperextension of neck and does 
carry high risk of intraoperative abandonment (7.7%) (17-20). 
Flexible endoscopic septum division (FESD) involves the use of a flexible endoscope 
to carry out dissection of CP muscle (septal myotomy). The goal of treatment is to 
improve pharyngeal motor function, thus improving the symptoms of dysphagia 
along with reduction of the size of the diverticulum and improve food passage 
from Zenker pouch into the oesophagus to improve symptoms of regurgitation.
1.7 FESD Procedure
A transparent hood (Olympus, Tokyo, Japan) is attached to tip of gastroscope. 
Patients either received deep sedation using propofol +/- remifentanil or GA 
depending on experts’ practice. A gastric tube was placed after emptying the 
pouch and gastric fluid was aspirated to protect the anterior oesophageal wall. 
In our unit Procedures were performed using a 9.8 mm endoscope (EG-2990i; 
Pentax, Tokyo, Japan) with a transparent cap attachment. Upon identification of 
the CP muscle and pouch, a single incision along the midline of the septum (CP 
muscle) was carried out to dissect the mucosa and muscle fibres using the any of 
the knife (usually used from Endoscopic submucosal dissection e.g. SB knife, hook 
knife, needle knife). One to three clips (HX-610-090L; Olympus, Tokyo, Japan) 
were then placed at the bottom of the incision to prevent mucosal dissection from 
the underlying muscle and perforation (Figure 3, Video). Patients were discharged 
home on the same day unless they were from outside the region. They were allowed 
to have liquids on day two and a soft diet from day three.
Recent Meta-analysis of FSSD from Ishaq et al report pooled success, adverse 
events and recurrence rates were 92% [95% CI: 86-95%, I2=72%], 13% [95% CI: 9-19%, 
I2=61.4%], and 14% (95% CI: 9-21%, I2=69.6%) respectively. 
Figure 6: FSSD using SB knife to dissect the CP muscle (septum)
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Short term results with rigid endoscopic or flexible endoscopic remain acceptable 
but outcome particularly recurrence is variable in the published literature. To 
overcome this new, alternative strategies for treating ZD by means of flexible 
endoscopy are emerging. Tunnelling techniques for instance, used in patients 
with achalasia (POEM- per oral endoscopic myotomy) have recently used to 
treat ZD as well. Yang et al reported international study on 75 patients treated by 
Z-POEM across 10 centres with technical success rate of 97%, 6.7% complication 
rates (1 bleed and 4 perforations- all managed conservatively), a clinical success 
rate of 92%. They observed only one recurrence after a median 10-month follow-
up treated endoscopically (21). 
1.8 Lack of knowledge about treatment of Zenker’s diverticulum 
and set-up for a PhD project 2013-2020
Flexible endoscopic treatment of ZD in UK was started in our endoscopy unit in 
2013. At that time literature consisted of small series, retrospective studies. There 
was wide variation in the procedure, and it was carried out with different cutting 
devices. Some experts would use general anaesthesia, some use Propofol, some 
use midazolam. There was variation in use of clips, antibiotics to be used. 
We discussed the deficiencies in the knowledge 2013-2020 that provided the 
justification to start our research on treatment of Zenker’s diverticulum.
What was known about the Zenker’s Diverticulum?
The pharyngeal pouch was first discovered in 1769 during an autopsy by a Bristol 
surgeon named Abraham Ludlow. Von Zenker correlated symptoms of dysphagia, 
regurgitation in 1878 and Wheeler in 1886 performed the first successful excision 
of a pharyngeal pouch. Dohlman using a modified diverticuloscope successfully 
divided the cricopharyngeal bar in the late 90’s. 
Mulder and Ishioka carried out a flexible endoscopic treatment of dividing the 
cricopharyngeal bar. Since the inception of the flexible endoscopic treatment in 
1995, there was a surge in new techniques and new cutting devices available to use 
in the treatment of Zenker’s diverticulum. Published data in flexible endoscopic 
treatment is available in the form of small case series and retrospective studies. 
There was a lack of standardisation of the technique and great deal of heterogeneity 
among the studies with variable definition of success, recurrence and failure. 
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In a systematic review Verdonck et al compared rates of failure, revision and 
morbidity from rigid endoscopic and open approach as treatment for ZD. 
Interesting he also presented report on 8 studies with total of 251 patients where 
ZD treated with flexible endoscopic treatment under sedation with failure rate of 
26%. Unfortunately, most of the studies on flexible endoscopic treatment of ZD 
until 2015 were not captured in this review. 
Deficiencies in literature 2013-2020
Collective outcome due to small studies with regards to success, recurrence and 
complication of FSSD was unknown.
There was no fit for purpose assessment tool to assess ZD symptoms.
No data were available on intubation failure with regards to pharyngeal disorders.
Historically general anaesthesia was used; knowledge about the concept of 2 
stage safe deep sedation was not available. In the two stage sedation the pouch is 
emptied of food residue under light sedation, once emptied subsequent dissection 
is carried out in deep sedation with Remifentanil and propofol sedation using TCI 
pump. This might reduce the risk of aspiration.
Nothing was known on uses of newer devices such as Stag Beetle scissor knife (SB 
knife) in FESD. SB knife was developed for use in FSSD.
Long-term outcome of ZD flexible endoscopic treatment was not well known.
There was paucity of literature on predictors of recurrent ZD and its management. 
No knowledge was available how to achieve complete myotomy to prevent 
recurrence of ZD.
No guidelines were available on management of ZD, not by ENT or 
Endoscopy Societies.
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Work-up of Zenker’s Diverticulum studies
To set the scene, we carried out the first systematic review and meta-analysis 
(MA) of the literature focusing on Flexible Endoscopic Septum Division (FESD) 
for Zenker’s diverticulum including in-depth evaluation of its efficacy safety 
and limitation (Chapter 1) Historically, only dysphagia was used as a symptom 
score using the Dakkak and Bennett score (table 1) that was developed to assess 
oesophageal stricture. In the absence of any specific score to assess ZD symptoms 
researchers started to use this score for ZD. This scoring tool has got limitations 
as it only could assess dysphagia but now we know that 80% of the patients with 
Zenker’s will have significant frustrating symptoms of regurgitation and some will 
have weight loss and recurrent chest infections. Dakkak and Bennett score is not 
comprehensive to assess all aspects of Zenker’s symptoms and presentations. 
Table 1: Dakkak and Bennett Dysphagia Score
Description Score
No dysphagia 0
Dysphagia with solid foods 1
Dysphagia with semi-solid foods 2
Dysphagia with liquid foods 3
Total dysphagia/unable to eat 4
Trying to improve the ZD related symptoms score we introduced the DRC scoring 
symptom to encompass other symptoms such as regurgitation and complications. 
In DRC scoring tool in which D stands for dysphagia, R for regurgitation and C 
for complications such as weight loss or recurrent chest infections. This score has 
been prospectively used in our recent study ({chapter 7}; but we have used this 
score in our previously published work (Chapter 5 and 6). In a prospective study 
(chapter 7), we aimed to test the hypothesis that our recently proposed Dysphagia, 
Regurgitation and Complications (DRC) score would be superior to the frequently 
used Dakkak score (which measures dysphagia) for evaluating ZD symptom 
severity.
Endoscopy in Zenker’s diverticulum could pose a significant challenge and that can 
lead to an intubation failure. Little was known on predictors of intubation failure 
with reference to pharyngeal causes. In a recent original study (chapter 3), we 
explored the incidence and aetiology of intubation failure in endoscopy to assess 
the predictors of intubation failure and predictors of pathology in patients with 
intubation failure. 
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Deep sedation in patients with Zenker’s diverticulum poses another challenge as 
most of these patients are elderly with high ASA score with multiple cardiorespiratory 
comorbidities. Many of them are not suitable for a general anaesthetic. Deep 
sedation with Propofol is easy to use and effective; however, it comes with its own 
risks of hypoxia, hypertension and bradycardia. The advent of High Flow Nasal 
Oxygen Therapy (HFNOT) has enabled the procedure requiring deep sedation to 
be performed without the need for endotracheal intubation. However, there is a 
paucity of evidence documenting its use in endoscopic procedures; particularly, 
for endoscopic procedures such as Zenker’s. Zenker’s pouch with food residue 
poses risk of aspiration. We introduced the concept of two stage sedation, in first 
stage under light sedation pouch is emptied and subsequent dissection carried 
out in deep sedation. We conducted first prospective observational study (chapter 
4), designed to assess the efficacy and safety of HFNOT in patients undergoing 
pharyngeal and upper oesophageal procedures using a flexible endoscope and 
introducing two stage sedation
In the last 10 years there has been a change and shift using devices that allows 
the septum to be pulled upwards and cut. Our group remained a dominant 
force with published data (Chapter 1, 2, 3, 4, 5, 6, 7,8, 10) and the use of newer 
devices such as SB scissor knife that allowed the precise and safe cutting of the 
cricopharyngeus muscle (Chapter 5,6,7,10). Historically, the endoscopist have 
divided the cricopharyngeus muscle with a single midline incision but our group 
was the first to publish a double incision technique, in which two incisions are 
placed on the septum 1cm apart and a snare is used to resect the septum in between 
(Chapter 5, 6). This physical removal of the barrier we hypothesize reduces long 
term recurrence. 
Despite the evolution of new techniques and devices, data on the long-term efficacy 
of FESD, particularly in recurrent ZD, are lacking. We reported the first study 
(Chapter 5) with the largest number of patients to evaluate flexible endoscopic 
treatment of Zenker’s diverticulum with recurrence after surgery and endoscopic 
stapling that also compared the outcome with naïve patients (patients that did 
not have previous symptoms of Zenker’s diverticulum). Predictors of recurrence 
remain an enigma as various factors including length of pouch and length muscle 
dissection have been reported. 
In another prospective study we aimed to prospectively evaluate the durability 
of symptom improvement after FESD and identify predictors of post-FESD 
recurrence. (Chapter 7) 
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In view lacking long-term follow up data and with strong publication bias and 
possible underestimation of complication rates in Z-poem, search continues for 
alternative techniques to offer complete myotomy in ZD to reduce recurrence. To 
address issue of safe and minimally invasive complete myotomy we carried out 
an animal pilot experiment on modifying the tunnel approach in such a way to 
prevent need of dissection posterior to CPM (Zenker- anterior tunnel myotomy- 
(Z-ATM), {Chapter 9}. We modified conventional myotomy to make anterior 
tunnelling towards oesophageal lumen. This allowed to complete dissection of the 
CPM without the need to dissect {Chapter 10} posterior to CPM. Due to the Corona 
pandemic we could not present this work at the ESGE days 23-25 April 2020 in 
Dublin. 
We recognised that there was no comprehensive review paper on all aspects of 
ZD treatment including various approaches, techniques and devices with 
supporting evidence. This led us to write this state of the art review published in 
DEN (Chapter 2). 
Published literature on ZD was limited to heterogeneous studies and personal 
series and there were no guidelines from any Endoscopy or ENT societies. In 2018 
we did submit a proposal to ESGE GL chair highlighting the need for guideline to 
standardise treatment of ZD. This subsequently was included in the ESGE GL on 
endoscopic management of GI motility disorders and published in June 2020. 
Conclusion 
In this chapter we discussed deficiencies in current knowledge and studies our 
group conducted on all aspects of ZD to address these gaps in literature. These, 
studies formed the basis of PhD-project since 2013. In 2019 ZD Guidelines with 
other motility disorders were commissioned by ESGE GL chair. I led the Zenker 
Guideline sub-group. A great deal of data and evidence to support these Zenker GL 
came from investigative work that we carried out as part of this thesis. 
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Outline of the thesis
This thesis commences with the review of endoscopic treatment options for 
Zenker’s diverticulum in real life. 
Chapter 1 
It consists of a first systematic review and meta-analysis. The aim of this systematic 
review is to pool the results of endoscopic treatment of ZD in terms of efficacy and 
safety, also addressing relevant clinical, pathophysiological and technical issues 
where this information was available.
Chapter 2 
It Consist of a synopsis of the established and emerging therapeutic methods of 
Zenker’s diverticulum with particular focus on their latest evidence. In this review 
current and emerging treatment option and evolution of devices were reported. 
Chapter 3
In this chapter we describe original study to assess incidence and etiology of 
Intubation failurere (IF) and predictors of structural pharyngeal abnormalities in 
patients with IF.
Chapter 4
It consists of study of Feasibility of High Flow Nasal Oxygen Therapy (HFNOT) and 
two-stage sedation during endoscopic hypopharyngeal therapy. We concluded 
that HFNOT is a useful adjunct to two-stage sedation, which can enable high- 
risk patients (ASA 2-3) to safely undergo deep sedation during hypopharyngeal 
endoscopic procedures.
Chapter 5 
In chapter 5 we reported original studies describing the role of newer devices; SB 
knife in ZD and reported double incision techniques for the first time. We also 
reported a study on flexible endoscopic treatment of recurrent ZD after surgery 
and endoscopic stapling. This study is the first and the largest from our research 
group to evaluate the flexible endoscopic treatment of ZD with recurrence after 
surgery and endoscopic stapling. 
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Chapter 6
In chapter 6 we present original study in which we looked at medium term outcome 
of Stag Beetle Knife treatment in ZD. In addition, we looked at outcome in Naïve 
(with no previous treatment) Vs recurrent (previous stapling surgery) patient 
outcome and superiority of recently proposed Dysphagia, Regurgitation and 
Complications (DRC) score to the frequently used Dakkak score (which measures 
dysphagia) for measuring ZD symptom severity. 
Chapter 7 
In this chapter we present original study describing Long-term Success of Flexible 
Endoscopic Septal Division with the Stag Beetle Knife for Zenker’s Diverticulum 
both in treatment naieve and recurrent ZD.
Chapter 8
In chapter 8 we looked whether in ZD, a protocolised measurements with barium 
Radiology predict severity and treatment outcomes?– A “Zen-Rad” study. We 
looked into Specific parameters and its correlation with severity and post-FESD 
outcomes. 
Chapter 9.1/9.2
In chapter 9.1 and 9.2 describe we describe 2 experiments and demonstrated 
minimally invasive flexible endoscopic treatment for Cricopharyngeal hypertrophy: 
“Experimental treatment of per-oral endoscopic myotomy of cricopharyngeus 
muscle with using SB knife junior- swine model – CP-POEM” and anterior tunnel 
approach in treating ZD in a swine model.
Chapter 10
In this section we described a new concept of minimally invasive anterior tunnel 
approach to complete cricopharyngeus (CP) myotomy: Zenker- Anterior tunnel 
myotomy Z-ATM. 
Chapter 11 
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ABSTRACT
BACKGROUND: Flexible endoscopic septum division (FESD) is a rapidly evolving 
technique for the treatment of Zenker’s diverticulum (ZD). Rates of efficacy and 
adverse events are limited to small number of patients. OBJECTIVE: To perform 
a systematic review and meta-analysis of literature focusing on FESD for ZD, 
including an in-depth evaluation of its efficacy, safety and limitations. DESIGN: A 
comprehensive literature search was completed, identifying papers that examined 
the efficacy and safety of FESD for ZD. Demographic, clinical and technical 
information was retrieved. Main outcomes were extracted, pooled and analyzed. 
Heterogeneity amongst studies was assessed using the I2 statistic. A random effect 
model was used as the pooling method in case of high heterogeneity; otherwise 
the fixed effect model was applied. Meta-regression was also performed. RESULTS: 
The pooled success, adverse events and recurrence rates were 92% [95% CI: 86-
95%, I2=72%], 13% [95% CI: 9-19%, I2=61.4%], and 14% (95% CI:9-21%, I2=69.6%) 
respectively. Substantial heterogeneity across studies was found. However, for 
success rates, excluding one study reduced heterogeneity to non-significant rate 
[I2 =25.3%; P=0.175]. Studies including a larger number of patients showed a more 
beneficial outcome: success rate estimates increased as sample size increased 
(coefficient: 0.007; 95% CI: 0.003-0.014; P=0.042), while both adverse events 
(coefficient, -0.02; 95% CI: -0.03; -0.004; P=0.007) and (coefficient, -0.01; 95% CI; 
-0.02;-0.004; P=0.001) recurrences rates (coefficient, -0.01; 95% CI; -0.02;-0.004; 
P=0.001) decreased. CONCLUSIONS: FESD is a feasible, safe and effective treatment 
of symptomatic ZD, with low recurrence rates. 
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1INTRODUCTION
Zenker’s diverticulum (ZD) is a pulsion diverticulum that develops in an area 
of weakness of the posterior hypopharynx known as the Killian’s triangle. It is 
a relatively uncommon condition, with an overall prevalence estimated to be 
between 0.01 and 0.11% in the American population, and occurs most frequently 
in males between the 7th and 8th decades (1,2).
The pathophysiology of ZD is not completely understood. The most widely accepted 
hypothesis is that motor abnormalities of the upper esophageal sphincter (UES) 
facilitate the herniation of the esophageal mucosa through the Killians triangle, 
resulting in diverticulum development (3-5).
ZD can be clinically silent, or can be responsible for a range of symptoms including 
dysphagia, regurgitation, cough, aspiration, foreign body sensation and body 
weight loss 4. The mechanisms by which symptoms develop are related to both UES 
motor dysfunction and the accumulation of ingested material in the diverticular 
pouch, and are dependent on the size of the diverticulum (6). For these reasons 
the rationale of ZD treatment is to address the motor abnormalities underlying the 
herniation of the mucosa through myotomy of the UES muscles, with or without 
concurrent suspension or resection of the diverticular pouch. 
ZD treatment can be accomplished with open surgery, a rigid endoscope or with 
a flexible endoscope. The latter option has significant advantages over the two 
former techniques: neither general anesthesia (necessary in the surgical approach) 
nor neck hyperextension (necessary for the rigid endoscopic procedure) are 
required (7,8). Flexible endoscopic septum division (FESD) involves an incision of 
the mucosa and the muscular fibers that form the diverticular septum. The goal 
of this treatment is to achieve a partial myotomy of the cricopharyngeal muscle 
and to create a passage through which ingested materials can be cleared from the 
diverticular pouch.
Results of this new approach were published independently for the first time in 
1995 (8,9). Since then many variations of the technique have been reported and a 
wide array of cutting devices have been used. The aim of this systematic review is 
to pool the results of endoscopic treatment of ZD in terms of efficacy and safety, 
also addressing relevant clinical, pathophysiological and technical issues where 
this information was available.
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METHODS
Protocol and eligibility criteria
The Preferred Reporting System for Systematic Reviews and Meta-analyses 
(PRISMA) was used as a guideline for this systematic review (10).
Papers describing the use of flexible endoscopy for the treatment of ZD in 
symptomatic patients were included, irrespective of the technique used. Use of 
flexible endoscopic treatment for ZD was the only inclusion criteria used in the 
study. There were no predetermined limits of design type or language. Papers 
in which flexible endoscopic treatment for ZD was discussed alongside other 
treatment options were included only if data on flexible endoscopic treatment was 
extractable. The exclusion criteria are listed in Table 1.
Literature search, study selection and data extraction
A comprehensive literature search was carried out to identify peer reviewed papers 
that examined the efficacy and safety of flexible endoscopic treatment for ZD.
PUBMED, EMBASE and Cochrane database were systematically searched using 
the following terms: “Zenker’s diverticulum, pharyngeal pouch, endoscopy, 
endoscopic” from January 1995 to May 2015. Additional papers were searched by 
cross-checking the bibliographies of papers retrieved in full text. After removal of 
duplicates, two reviewers (SI, AA) independently screened titles and abstracts to 
identify papers potentially pertinent to the systematic review. In the title review 
stage, any paper with a title not related to flexible endoscopic treatment for ZD 
was excluded. During the abstract review stage, any paper that was a comment to 
previous papers, a review, or in which the use of non-flexible devices was evident 
was excluded. The remaining papers were retrieved in full text and independently 
screened for eligibility. During study selection, any difference of opinion between 
the aforementioned reviewers was resolved by referral to the co-authors (AR, CH).
Once eligibility was confirmed, data was extracted from each of the selected studies 
by three reviewers independently (SI, AA, KT) using a standard form. The retrieved 
parameters were: study design, number of patients and their demographics and 
clinical features (i.e. previous treatments for ZD and size of diverticula), symptom 
evaluation criteria used, FESD technique features (i.e. single or multiple sessions, 
cutting tool, additional tools, use of clips, choice of sedation, drugs administered 
peri-operatively, post-procedural esophagrams and/or endoscopies), adverse 
events, first treatment(s) success, follow-up duration, recurrences and their 
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1management. Any difference was resolved through referral to the co-authors 
(AR, CH). The main clinical outcomes noted were: rate of success (i.e. symptom 
resolution), rate of adverse events and rate of recurrences. 
Assessment of the susceptibility to bias
The methodological quality and the susceptibility to bias was assessed by two 
reviewers independently using the MINORS quality score (SI, AA), from which 
items were adapted to the scope of the review (Table 2) (11). Any differences of 
opinion between the two authors regarding quality assessment were settled 
through referral to the co-authors (AR, CH).
Statistical Analysis
Data on success rates, adverse events and recurrences was extracted, pooled and 
analyzed. Heterogeneity among studies was assessed by using the I2 statistic, 
which describes the percentage of total variation attributable to between-study 
heterogeneity as opposed to random error or chance. In the presence of substantial 
heterogeneity (I2>50%), a random effect model was used as the pooling method; 
otherwise, the fixed effect model was adopted as the pooling method. Meta-
regression was performed to assess the potentially important covariates: socio-
demographic attributes e.g. geographic origin of the studies, and sex, as well as 
methodology-related attributes e.g., study design, year of publication (categorized 
as before 2005 vs. after 2005), and study sample size, in addition to clinical and 
technical parameters. The leave-one-out sensitivity analysis was completed to 
evaluate the key studies with substantial impact on between-study heterogeneity 
(13). If the main estimate of an individual study omitted analysis lay outside the 
95% CI of the combined analysis, it is suspected of excessive influence. Publication 
bias was estimated using the Begg’s test.
Table 1: inclusion and exclusion criteria
Inclusion criteria: Flexible endoscopic treatment for Zenker’s diverticulum as one of the main focuses of the article
Exclusion criteria:
Comments or review articles
Lack of data on outcome and/or follow-up
Exclusive use of animal models
Use of non-flexible devices during the procedure
Less than 10 patients included in the study
Expansion of a previously published series *

























































































































































































































































































































































































































































































































































































































































































































































































































































































After the removal of duplicates, a total of 433 records were initially identified in 
the literature search. From these, 403 were excluded after title and abstract 
screening due to irrelevance. Overall, 31 full text articles were retrieved for more 
detailed examination. Fulfillment of inclusion and exclusion criteria was assessed 
for each of these studies. Sixteen studies met these criteria and hence were 
included in the review (7,9,14-27). The three reviewers agreed completely on 
inclusion of studies (Figure 1).












1Study characteristics and methodological quality
No randomized or non-randomized clinical trials were identified. Five studies 
were prospective cohort studies (20,21,24,25,27) whilst the others were either 
retrospective (7,17-19,22,23,26) or failed to mention study design (9,14-16). The 
number of patients included in the studies ranged from 10 to 150. Study review 
with the MINORS scale revealed that two studies were of low quality (9,14) whilst 
the others were of moderate to good quality (Table 3). Dysphagia was the only 
symptom taken into account in six studies (7,9,15,19,24,27) regurgitation alongside 
dysphagia was recorded in two (17,22) and in six studies additional symptoms 
were recorded as well (14,16,18,20,23,25). Moreover, an objective evaluation of all 
recorded symptoms was carried out in three studies (18, 22,25) only dysphagia was 
graded in five (15,16,20,21,27) and in the remaining seven no objective grading of 
symptoms was carried out (7,9,14,17,19,23,24).
Techniques and devices
A brief description of FESD technique is illustrated in Appendix 1. Regarding 
inter-study technical differences, in 3 studies moderate sedation alone (i.e. 
combination of midazolam, meperidine and topical lidocaine) was used (9, 14, 
15) while in 3 deep sedation (i.e. with a continuous infusion of propofol, without 
intubation) was chosen (15, 23, 26). In 7 studies the type of sedation was tailored 
on the patient status: moderate sedation, deep sedation or general anesthesia 
(i.e. with endotracheal intubation) were used interchangeably (7, 16, 18, 19, 21-
23, 27). In 2 studies general anesthesia was routinely used (20, 25). In 7 studies 
antibiotic prophylaxis was employed (14, 15, 18-20, 23, 24). In all but one study 
the technique used consisted of a single incision alongside the midline of the 
diverticular septum (7,9,14-25,46) while in one two parallel incisions on the 
septum were performed and the septum in between was removed with the aid of 
a polypectomy snare (26). In 5 studies clips were deployed prophylactically at the 
site of the incision (16,18,21,23). Cutting devices and additional tools used in the 
procedure are reported in Table 5.
Patient cohort and results of individual studies
The demographic and clinical characteristics of the patients included in the studies 
and their outcomes are summarized in Table 4. The selected studies provided 
data on 634 patients (238 females - 38%) who underwent FESD for treatment of 
symptomatic ZD. The number of patients enrolled per study ranged from 10 to 150, 
with a median of 32 (IQR: 26.5-42.0). The minimum average age was 54.0 (range: 











Seven studies, involving a total of 393 patients (62% of total patients) provided 
information regarding prior treatments. Of these, 45 patients (7.1% of total patients) 
received prior treatments, while the majority received FESD as the first treatment. 
In 4 studies a multiple treatment approach (i.e. repeat procedures until complete 
septum division was achieved) was carried out (9.17.19,26) whilst in the other 11 a 
single treatment protocol was adopted, and further treatments were undertaken 
on a need-to treat basis (13-15,17,19-24,27). 
Results
The overall initial treatment success rate ranged from 56.4% to 100%, with a 
median of 91.2%, whilst the success rate of studies where a comprehensive evaluation 
of ZD symptoms was carried out ranged from 56.4% to 96.6% with a median of 95.1%. 
Adverse event rates ranged from 0% to 36.4%, with a median of 14.1%. The most 
frequently reported complication was perforation (either directly diagnosed or 
indirectly due to the presence of subcutaneous, cervical or mediastinal emphysema), 
which occurred in 41 patients overall (6.5%) with a range from 0% to 27.3% (median 
3.3%). The follow-up duration ranged from 1 day to 48 months. Relapse rates ranged 



















Random-effects meta-analysis of the proportion of adverse events
A total of 82 adverse events were reported. Adverse events included hemorrhage 
(n=2), pneumonia (n=4), fever (n=15), perforation (n=24), emphysema (n=17), 
bleeding (n=21). Figure 3 shows individual and pooled estimation of adverse 
events. The random effects pooled rate was 13.0% [95% CIs: 9%-19%] (see Figure 2). 
Estimates ranged from 0% to 36% with a substantial heterogeneity among the 
studies (I2=61.4%, 95% CI: 33.4-77.6%; P=0.001). Restricting to the studies published 
before 2006 resulted in a declined I2 measure of 0% (p=0.42) and an adverse events 
rate of 12.00% (95% CI:7-19%) (see Supplementary Fig 3). Results of univariate 
analysis are shown in Supplementary Table 3). At multivariate analysis including 
additional device; year of publication, previous treatments and study sample size 
as covariates, there was evidence that studies using larger numbers of subjects 
showed lower adverse events rates (coefficient, -0.02; 95% CI:-0.03; -0.004; 
P=0.007). Publication bias was statistically significant (Egger’s regression: bias=-
2.9; Standard Error (SE)=1.0; P=0.014). 
Figure 3: Results of random-effects meta-analysis of the proportion of adverse events. The squares represent 
individual studies, and the size of the square represents the weight given to each study in the meta-analysis. Error 
bars represent 95% confidence intervals. The diamond represents the combined results. List of studies shows 
name of first author and year of publication.
Random-effects meta-analysis of the proportion of technical 
success 
The initial treatment success rate ranged from 56.4% to 100% (Figure 2). The random-
effect pooled rate across all studies was 92% (95% CIs: 86-95%). Significant statistical 
heterogeneity was observed for this outcome (I2=72%, 95% CI: 53.8-83.3%; P<0.001). 
To determine the degree of influence of any study on the pooled rate estimate, we 
conducted a sensitivity analysis in which the pooled success rate was assessed after 
dropping each study in turn. In this analysis, low heterogeneity (I2=25.3%; p=0.175) 
was found, when one study18 was dropped from analysis (Supplementary table 1). 
After excluding this article, the pooled success rate was 91.8% [95% CI: 88.9-93.9%]. 
Univariate meta-regression showed that time period of publication (categorized as 
before 2005 vs. after 2005), sample size and minimum age of the patients had a 
significant impact on the outcome (Supplementary table 2, Supplementary Figure 
1; Supplementary Figure 2). At multivariate analysis including all these explanatory 
variables there was evidence that the time period of publication (coefficient: 
-1.2; 95% CI: -2.3; 0.01; P=0.028) and sample size of trial (coefficient: 0.007; 95% 
CI: 0.003-0.014; P=0.042) affected the outcome. Publication bias was statistically 
significant (Egger’s regression: bias=1.5; Standard Error (SE)=0.6; P=0.032).
Figure 2 Results of random-effects meta-analysis of the proportion of successes. The squares represent 
individual studies, and the size of the square represents the weight given to each study in the meta-analysis. Error 
bars represent 95% confidence intervals. The diamond represents the combined results. List of studies shows 
name of first author and year of publication. 
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1Random-effects meta-analysis of the proportion of adverse events
A total of 82 adverse events were reported. Adverse events included hemorrhage 
(n=2), pneumonia (n=4), fever (n=15), perforation (n=24), emphysema (n=17), 
bleeding (n=21). Figure 3 shows individual and pooled estimation of adverse 
events. The random effects pooled rate was 13.0% [95% CIs: 9%-19%] (see Figure 2). 
Estimates ranged from 0% to 36% with a substantial heterogeneity among the 
studies (I2=61.4%, 95% CI: 33.4-77.6%; P=0.001). Restricting to the studies published 
before 2006 resulted in a declined I2 measure of 0% (p=0.42) and an adverse events 
rate of 12.00% (95% CI:7-19%) (see Supplementary Fig 3). Results of univariate 
analysis are shown in Supplementary Table 3). At multivariate analysis including 
additional device; year of publication, previous treatments and study sample size 
as covariates, there was evidence that studies using larger numbers of subjects 
showed lower adverse events rates (coefficient, -0.02; 95% CI:-0.03; -0.004; 
P=0.007). Publication bias was statistically significant (Egger’s regression: bias=-
2.9; Standard Error (SE)=1.0; P=0.014). 
Figure 3: Results of random-effects meta-analysis of the proportion of adverse events. The squares represent 
individual studies, and the size of the square represents the weight given to each study in the meta-analysis. Error 
bars represent 95% confidence intervals. The diamond represents the combined results. List of studies shows 
name of first author and year of publication.
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Random-effects meta-analysis of the proportion of recurrences
Across studies, the follow-up duration ranged from 1 day to 48 months. A forest plot 
of relapse rate is shown in Figure 4. Rates ranged from 0% to 50%, with a random 
effects pooled rate estimate of 14% (95% CI: 9%; 21%). Substantial heterogeneity 
was found for this outcome (I2=69.6%, 95% CI: 49-82%; P<0.001). At multivariate 
analysis there was evidence that rates were associated with sample size of study 
(coefficient; -0.01; 95% CI: -0.02-0.001; P=0.03) and the cutting mode of the device 
(categorized as “Cap guidewire” vs “other cutting devices” (coefficient; 0.86; 95% CI: 
-0.1; 1.9; P=0.08). Publication bias was statistically significant (Egger’s regression: 
bias=-2.9; Standard Error (SE) =1.0; P=0.014). 
Studies not meeting the inclusion and exclusion criteria
Among the 31 publications retrieved in full text, 15 did not fulfil our inclusion and 
exclusion criteria. Further details of these studies are outlined in Appendix 2. 
Figure 4: Results of random-effects meta-analysis of the proportion of recurrences. The squares represent 
individual studies, and the size of the square represents the weight given to each study in the meta-analysis. Error 
bars represent 95% confidence intervals. The diamond represents the combined results. List of studies shows 
name of first author and year of publication.
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1DISCUSSION 
According to this meta-analysis, FESD treatment for ZD is effective and safe. Our 
results showed that this treatment option is associated with a pooled success 
estimate of 92%, a pooled adverse event rate estimate of 13% and a pooled recurrence 
rate estimate of 14%. Observing heterogeneity effect across multiple independent 
trials is important, since it could reflect heterogeneity that would occur in clinical 
practice (45). However, the high heterogeneity in the main outcome of our meta-
analysis – i.e. the success rate – was exclusively observed in one paper18, which 
yielded the lowest rate of success (approximately 56%). Moreover, the relatively 
low success rate was related only with the cap-assisted FESD that was replaced 
with diverticuloscope-assisted technique.18 
Regression analyses revealed that the rate of success appeared to be influenced 
by the date of publication and by the sample size of study. In addition, lower rates 
of adverse events and recurrences were associated with higher sample size. The 
time trend observed for success rate was in a negative direction, studies published 
after 2005 tending to report a less beneficial effect of the treatment than those 
published before 2005. This result was opposite to what we expected: increased 
experience over time – both with the technique in general and for single operator 
– should have led to improved procedure outcome, both in terms of efficacy and 
safety. However, there was a significant increase in success rate estimate as sample 
size of these studies increased. 
We found larger estimated rates of success in large trials with at least 40 patients 
(on average 94%) compared with smaller trials (on average, 89%). The fact that 
small studies with less favorable findings were mostly recently published (of the 12 
studies in the group “published after 2005” (16-27), 7 trials included less than 40 
patients (17-22,25,26) and 4 trials included less than 29 patients (17,19,20,24 ) offers 
the most plausible explanation for the “time effect” found in our meta-analysis. 
Such finding underlines the need of large, prospective and multicenter studies to 
validate new technologies applied to ZD. Moreover, there may be a study design 
bias that may have influenced the time trend with older studies being mostly 
retrospective and less accurate in reporting clinical outcome and later studies 
paying more attention to real efficacy of the technique.
The strengths of this review include: (1) A rigorous literature search with well-
defined inclusion and exclusion criteria and careful exclusion of redundant 
studies; (2) Exclusion of papers in which non-rigid devices (such as harmonic 
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scalpels) were used since they negate one of the main advantages of this technique, 
that is not requiring neck hyperextension; (3) A rigorous and thorough analysis 
of study quality. The main limitations of this review are: (1) A limited number 
of studies included; (2) the limited sample size in many studies. However, when 
meta-analyses included at least two adequately powered studies, the contribution 
from smaller studies becomes less significant, (3) the presence of retrospective 
series; (4) the presence of heterogeneity issues that limit the generalizability of our 
findings 45 and (5) variable definitions of success used in different studies. 
Based on the findings of this meta-analysis, the results suggest that flexible 
endoscopic cricopharyngeal myotomy is a feasible, safe and effective treatment 
of symptomatic ZD, with low recurrence rates. Success and adverse event rates are 
comparable to surgery (success rate of 90%, over all perforation rate of 4.8% and 
7.7% of procedures abandoned intraoperatively) and the rigid endoscopic approach 
(42). In routine practice flexible endoscopic approach may have additional 
advantages such as avoiding the need of general anesthesia and shorter procedure 
and recovery time 25 It may be the treatment of choice in patients who are high 
risk for surgery or who failed surgical treatment. However, further endoscopic 
improvement in ZD treatment need to be tested in rigorous and well-designed 
RCT studies.
Implications for future research
Our systematic review indicated a high degree of heterogeneity among studies. 
This appeared to be mainly related to the small sample size of the selected studies. 
Thus, large, prospective, multi-center studies are needed to validate further 
endoscopic advances. There is also the need for improved standardization in 
terms of symptom evaluation and objective scoring, as well as clear definitions of 
success, relapse and adverse events.
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The technique for FESD involves the careful insertion of a flexible endoscope to 
visualize the diverticulum. A nasogastric (NG) tube is placed into the oesophagus 
over an endoscopically placed guidewire to separate the oesophageal lumen from 
the diverticulum to improve visualization of septum. Some centers place a soft 
duck bill diverticuloscope (ZD overtube, ZDO-22-30; Cook Medical, Winston-
Salem, North Carolina) to expose and straddle the septum (longer flap of 
diverticuloscope is in the oesophageal lumen and shorter one in the diverticulum). 
This diverticuloscope is available in Europe and Canada (CE mark 0123), but not 
FDA approved hence not available in USA. Some centers apply a soft cap at the 
tip of scope instead of diverticuluscope for better exposure of CP septum and 
muscle. Once CP muscle is exposed, a cutting device is used (needle knife, hook 
knife, SB knife) to divide the septum. The needle knife technique involves cutting 
from the top of the CP bridge downward across the transverse fibres of the CP 
until the muscle fibres are completely cut. With Hook knife although CP muscle 
is cut, but transverse fibres of CP muscle are hooked and pulled upward and then 
cut. Recently an SB knife has been used that acts like scissors, blades of knife are 
insulated from outside, and allow the CP muscle to be gripped and pulled upwards 
and before it is cut, thus permitting precise and controlled cutting. Standard 
diathermy is used to cut the CP muscle. 
Once the CP muscle is cut many centers place 1-3 clips to prevent perforation and 
bleeding. Few centers use CO2 laser to cut the CP muscle. Division of the septum 
reconnects the pouch with the normal oesophagus and also divides the CP muscle 
that is implicated in the pouch development. More than onetreatment session 
may be needed. In 3 studies conscious sedation alone (i.e. with a combination of 
midazolam, meperidine and topical lidocaine) was used to during the procedure 
9,14,17 whilst in 3 deep sedation (i.e. with a continuous infusion of propofol, 
without intubation) was used 15,23,26. In 7 studies the type of sedation was tailored 
on the patient status: conscious sedation, deep sedation or general anesthesia 
(i.e. with intubation) were used interchangeably 7, 16, 18, 19, 21-23. In 2 studies 
general anesthesia was routinely used 20, 25. In 7 studies antibiotic prophylaxis 
was employed 14, 15, 18-20, 23, 24, 27. In all but one paper the technique employed 
consisted of a single incision alongside the midline of diverticular septum 7,9,14-
25,27, whilst in one two parallel incisions on the septum were performed and 
the septum in between was removed with the aid of a polypectomy snare 26. In 5 
studies clips were deployed prophylactically at the site of the incision 16,18,21,23.
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1Appendix 2
Among the 31 papers retrieved in full text, 15 did not fulfill our inclusion and 
exclusion criteria. 
In three papers animal models of pharyngeal/esophageal pseudodiverticula 
were used. In the experience of Tang et al a needle knife and a custom made 
“septotome” consisting of a modified EMR cap with an indentation mimicking the 
Van Overbeek diverticuloscope and a cutting wire fixed to the cap perpendicular 
to the indentation was used to dissect pharyngeal diverticula in a porcine model. 
Incision carried out with the septotome proved to be effective and required 
limited dexterity to be accomplished, thus the author suggested how it could be 
employed in clinical practice more readily than the standard ZD diverticulotomy 
techniques 28. Seaman et al experimented with a similar device: a WEMR cap fitted 
with a cutting wire, with comparably good results 29. In the study by Rieder et al a 
bipolar forceps was used to treat pharyngeal diverticula on a porcine model, and 
the technique was compared with the needle knife: the author emphasized how 
forceps shaped devices exhibit an improved control of the incision in comparison 
to needle shaped ones 30.
The 1999 study by Mulder, in which septum division in 125 patients was performed 
with APC, hot biopsy forceps and needle knife was not included in this systematic 
review due to lack of data on follow-up 31.
Seven papers did not meet the inclusion criteria due to an excessively limited 
number of patients (i.e. less than 10). In the experience of Ramchandrani et al 
the SB knife by Sumitomo Bakelite was used to treat 3 patients with ZD 32. The 
treatment was carried out without complications. In the experience of Wahab et 
al argon plasma was used to dissect diverticula in a limited number of patients 
33. Efthymiou et al reported two cases of flexible endoscopic septum division 
respectively in a bi-lobed ZD and in a nonagenarian 34,35. Heinrich et al reported 
their positive experience with the use of the Hook Knife to treat ZD, Pech et al 
theirs with the use of APC and Tang et al their results with the treatment of a 
bilateral ZD 36-38. In four experiences rigid cutting devices were used to achieve 
ZD septum division: Hondo et al used a harmonic scalpel, Christiaens used a 
monopolar forceps and Tang et al as well as Altman et al used a rigid stapler 39-42.
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Supplementary Table 1: leave-one-out meta-analysis of first treatment success rate
Study Pooled rate (FEl) if 
corresponding study 
left out








Ishioka et al 87.2 [83-90[ 91.2 [83.5-94.6] I2 = 72.2% [52.5%; 83.8%] <0.001
Hashiba et al 86.9 [82.6-89.7] 91.4 [83.5-94.9[ I2 = 72.4% [52.9%; 83.9%] <0.001
Sakai et al 87.5 [83.9-90.0] 91.8 [85.7-95.4] I2 = 72.1% [53.8%; 83.1%] <0.001
Evrard et al 87.1 [83.0-90.1] 91.4 [84.8-95.3] I2 = 72.9% [54.7%; 84.0%] <0.001
Rabenstein et al 87.0 [83.2-90.4]] 91.5 [84.8-95.3] I2 = 72.9% [54.6%; 84.0%] <0.001
Costamagna et al 91.8 [88.9-93.9] 91.7 [88.6-94.6] I2 = 25.3% [0%; 59%] 0.175
Vogelsang et al 87.5 [83.7-90.5] 91.8 [84.9-95.7] I2 = 73.8% [55.6%; 84.6%] < 0.001
Al-Khadi et al 87.9 [84.0-90.6] 92.4 [86-96] I2 = 73.7% [54.4%; 84.3%] < 0.001
Case et al 86.9 [83.2-90.0] 90.6 [83.7-94.8] I2 = 73.1% [54.3%; 84.2%] < 0.001
Repici-R et al 86.8 [82.9-90.0] 91.3 [84.0-95.1] I2 = 73.6% [55.1%; 84.4%] < 0.001
Repici et al 87.1 [83.3-90.2] 91.5 [84.5-95.5] I2 = 74% [56%; 84.7%] < 0.001
Huberty et al 84.7 [80.0-88.5] 90.6 [83.4-94.8] I2 = 68.7% [45%; 82%] < 0.001
Manno et al 86.9 [83.1-90.0] 90.7 [83.8-94.9] I2 = 73.2% [54.4%; 84.3%] < 0.001
Laquiere et al 87.1 [83.1-90.0] 91.5 [84.4-95.2] I2 = 74% [56%; 84.7%] < 0.001
Halland et al 87.1 [83.1-90.0] 0.91 [85.0-95] I^2 = 72% [52.9%; 83.3%] < 0.001
Battaglia et al 87.0 [83.0-90.0] 91.3 [84.3-95.4] I2 = 74% [56%; 84.6%] < 0.001
Data in parentheses are 95% confidence intervals.
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1Supplementary Table 2: Meta-regression with a random effects model (after excluding the article by 
Castomagna et al) of the logit of prevalence of first treatment success according to socio-demographic, 
methodological and clinical characteristic 
Variable Coefficient (β) 95% CI P -Value
# of pts with previous treatments 0.04 (-0.05; 0.13) 0.396
time period of the study 
   before 2005 
   after 2005 
-1.1 (-2.1;- 0.07) 0.066
sample size of the study
   <40
   >39
0.7 (-0.02; 1.43) 0.057
ratio of female pts -2.1 (-5.8; 1.6) 0.260
Evaluation of symptom
   Generic ZD symptom
   Dysphagia 
-0.2 (-1.1; 0.7) 0.644
Minimum Age
   >49
   <50
0.98 (0.16; 1.8) 0.019
# of Session
   Multiple
   Single 
-0.1 (-1.0; 0.78) 0.828
Follow up duration 0.01 (-0.4; 0.5) 0.967
Antibiotic use
   no
   yes
-0.2 (-1.1; 0.7) 0.698
Other Drugs
   no
   yes
-0.7 (-2.3; 3.6) 0.668
Additional Device
Cap_guidewire
   other types
-0.4 (-0.7; 1.5) 0.508
Sedation
Mild or general
   Deep
-0.3 (-0.6; 1.1) 0.539
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Supplementary Table 3. Meta-regression with random effects model (for all selected studies) of the logit of 
prevalence of adverse events to socio-demographic, methodological and clinical characteristic 
Variable Coefficient (β) 95% CI P -Value
# of pts with previous treatments -0.05 (-0.16; 0.06) 0.330
time period of the study
   before 2006 
   2005 and later
-
-0.2. (-1.3;-0.95) 0.705
sample size of the study -0.02 (-0.03;-0.009) 0.01
ratio of female pts 4.3 (-5.8; 1.6) 0.260
Evaluation of symptom
   Two or more ZD symptom
   Dysphagia 
-
-0.32 (-1.3; 0.68) 0.52
Minimum Age 0.03 (-0.02;0.07) 0.232
# of Session
   Multiple
   Single 
-
0.13 (-0.9; 1.23) 0.801
Follow up duration -0.3 (-0.9; 0.25) 0.265
Antibiotic use
   no
   yes
-
0.6 (-0.5; 1..7) 0.276
Additional Device
   Cap guidewire
   other types
-1.2 (-2.3; 0.4) 0.04
Sedation
   Mild or general
   Deep
-
0.3 (-0.6; 1.1) 0.407
Intubation
   Yes
   No 
-
0.4 (-0.8; 1.5) 0.529
Data in parentheses are 95% confidence intervals. 
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1
Supplementary Fig 1: Forest plot of treatment success rate stratified by year of publication (categorized as 
Before 2005 vs. 2005 and later) with fixed-effects
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Supplementary Fig 2: Forest plot of success event rate with fixed effects stratified by study sample size 
(>39 vs. <40); TRUE, NPts>39; FALSE, NPts<40.
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Abstract
Zenker’s diverticulum (ZD), or pharyngeal pouch, is an anatomical defect 
characterised by herniation of the posterior pharyngeal wall through Killian’s 
dehiscence, and may result in dysphagia and regurgitation. Multiple therapeutic 
modalities including surgery, rigid and flexible endoscopy have been developed 
to manage ZD. Although surgical management with open and endoscopically-
assisted techniques have historically been the mainstay of ZD treatment, minimally 
invasive flexible endoscopic techniques, performed under conscious sedation, are 
increasingly favoured. Over the last two decades, the advent of new accessories 
and techniques have changed the landscape of endotherapy for ZD, with the 
current armamentarium including, but not limited to: endoscopic stapling, CO2 
laser, APC, needle knife, bipolar forceps, hook knife, clutch cutter, stag beetle (SB) 
knife, and submucosal tunneling endoscopic septum division (STESD). We hereby 




Zenker’s diverticulum (ZD), also known as pharyngeal pouch, is a condition 
characterised by herniation of the posterior pharyngeal wall. Specifically, this 
occurs in an area located between the thyropharyngeus and the cricopharyngeal 
muscle fibres of the inferior constrictor, known as Killian’s triangle (1). ZD is a 
relatively rare disorder with a prevalence ranging between 0.01%-0.11%. (2). There 
is a male preponderance and it is most common in the 7th-8th decades of life (3). 
Clinically, ZD may manifest with symptoms such as dysphagia, regurgitation, and 
its associated complications. 
Historically, ZD was first described in 1769 by Ludlow, (4) an English surgeon, as an 
autopsy finding. In 1886, Zenker described an oesophageal diverticulum occurring 
due to ‘forces with the lumen acting against restriction’ and the condition has since 
been eponymized (5). In 1856, Wheeler performed the first surgical excision of ZD 
(6). Endoscopic treatment for ZD was introduced by Mosher in 1917 (7) who excised 
the diverticular septum using a rigid endoscope. This was modified by Dohlman 
in 1960, who incorporated the use of diathermy (8). In 1993, the technique further 
evolved to include endoscopic stapling after septal division (9). As ZD commonly 
affects the elderly, there has been increasing demand for minimally-invasive 
methods for the population who may otherwise have been unsuitable for general 
anaesthesia. The first use of minimally-invasive flexible endoscopic therapy in 
ZD was reported in 1995 by Mulder and Ishioka (10,11). Ever since, endoscopic 
techniques have been adapted over the last two decades with increasing operative 
success and safety profile, and are beginning to replace conventional surgery as 
the mainstay of treatment for ZD. 
This review article aims to provide a synopsis of the established and emerging 
therapeutic methods for ZD, with particular focus on the therapeutic accessories 
and latest evidence.
Anatomy and Pathophysiology
The pharynx comprises two groups of pharyngeal deglutition muscles. The 
longitudinal group elevate and shorten the pharynx. The circular muscles 
include the superior, middle and inferior constrictors, which serve to clear 
the trailing portion of bolus into the oesophagus (12) The inferior pharyngeal 
constrictor is formed of the thyropharyngeus and the cricopharyngeus (CP). 
The CP muscle wraps posteriorly around the cricoid cartilage and has superior 
and inferior components. ZD forms in the area between the two components of 
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the CP muscle. Manometric studies support the hypothesis that ZD arises due to 
increased intraluminal pressure in the oesophagus, in conjunction with impaired 
relaxation of the upper oesophageal sphincter (UOS) (12,13)<whereby the maximal 
pressure coincides with the location of ZD. Studies have suggested that acid reflux 
can indirectly predispose to ZD by increasing UOS pressure (14,15). Moreover, 
the development of ZD may also be preceded by the radiological finding of a 
cricopharyngeal bar, characterised by hypertrophy and fibrosis of the CP muscle, 
which is also associated with older age and neuromuscular disorders (16). 
Assessment of Zenker’s Diverticulum
Dysphagia is the predominant symptom in ZD. Several assessment tools have been 
validated to quantify dysphagia severity. These include the Dakkak and Bennett 
scale, (17) EAT-10 (18), MDADI (19), and SWAL-QOL (20) SWAL-QOL is a 44 item scale 
which measures dysphagia-related quality of life, and has been used to measure 
response to treatment after endoscopic therapy (21) However, regurgitation and 
aspiration are commonly associated with ZD, but may be under-represented by 
these dysphagia-specific scoring scales. There is thus a need for a novel symptom 
assessment tool specific for ZD, which may be better suited for assessing response 
to treatment.
Fluoroscopic assessment, e.g. contrast swallow, remains the gold standard modality 
for diagnosing ZD (Figure 1) (22). Although diagnosis may be made by endoscopy 
and cross-sectional imaging, fluoroscopy allows for dynamic visualization at 
various stages of deglutition, with the additional advantage of enabling assessment 
of diverticular sac dimensions. 
Established Treatments
Treatment for ZD should be limited to symptomatic patients. The aims of ZD 
management are to provide symptomatic relief and improve quality of life. The 
endpoint of therapy is to dissect the septum of the cricopharyngeal muscle, i.e. 
myotomy, in order to create a common cavity between the diverticulum and 
oesophageal lumen. 
Currently, there are three main treatment options for ZD: open surgery 
(i.e. transcervical diverticulectomy, diverticuloplexy with myotomy of the 
cricopharyngeal muscle, or diverticular inversion), rigid endoscopy (i.e. 
endoscopic stapling or CO2 laser treatment) and flexible endoscopy. Success 
rates of therapy appear comparable between modalities (surgery: 80-100%, rigid 
endoscopy: 90-100%, flexible endoscopy: 43-100%), but symptomatic recurrence 
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can be as high as 19% for surgery (23,24), 12.8% for rigid endoscopy and 20% for 
flexible endoscopy (25). Surgery is associated with significant morbidity and 
mortality, which rates of 30% (vs 3% for rigid endoscopy and 1.5% for flexible 
endoscopy) and 3% respectively (26,27). Approaches using rigid endoscopy has its 
limitations, including the need for general anaesthesia and high rates of intra-
operatively abandonment (7.7%), mainly in cases of small diverticular size (<3cm), 
and restricted neck mobility.24 Although the open approach may be feasible for 
smaller pouch sizes (24), it is an invasive procedure which merits careful patient 
selection (28). The limitations of surgery and rigid endoscopy have therefore led to 
a demand for a flexible endoscopic approach to manage ZD (29). 
Flexible Endoscopic Septum Division 
Flexible endoscopic septum division (FESD) involves the use of a flexible 
endoscope to perform septal myotomy. The goal of treatment is to reduce the 
size of diverticulum and improve pharyngeal motor function, thus improving 
the symptoms of dysphagia and regurgitation. The technique is often used in 
conjunction with several pre-endoscopic measures. A transparent cap (Figure 2A) 
may be attached to the end of the endoscope to improve operating space, and may 
also aid cases of difficult intubation arising from ZD. The technique is often used 
in conjunction with a diverticuloscope, a specific overtube designed to straddle 
Figure 1: A) Barium swallow demonstrating contrast within a Zenker’s diverticulum measuring 8cm in diameter. 
B) Anteroposterior views of residual diverticulum after endoscopic treatment. 
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the CP between two flaps (Figure 2B). Nasogastric tube placement (Figure 2C) is 
favoured by some endoscopists to delineate the oesophagus, and allows for enteral 
feeding in the event of perforation.
The safety and efficacy of FESD has been confirmed in a meta-analysis by Ishaq et al 
(30) with a pooled success rate of 91%, adverse event rate of 11.3%, and recurrence 
rate of 10.5%. In a meta-analysis of 596 patients comparing endoscopic and surgical 
approaches, Albers et al31 reported improved symptom reduction (standardized 
mean difference [SMD] 0.08, 95% CI 0.03-1.13) with surgery, but increased rates of 
complications (SMD 0.09, 95% CI 0.03-0.43). Notably, differences in diverticular 
size between groups were not subjected to heterogeneity assessment.
Complications of FESD mainly include cervical emphysema (5.7%), perforation 
(4.0%) and bleeding (3.1%).26 Perforation and haemorrhage are typically amenable 
to endotherapy. These are outweighed by the advantages of FESD, which precludes 
the need for general anaesthesia and cervical hyperextension, which confers 
clear benefits to the elderly population base. Other advantages include: shorter 
procedural duration, lower complication rates, shorter inpatient stay (32), and 
reduced fasting period (31). The appeal for flexible endoscopic management has 
brought forth the evolution of new incision techniques and devices, with the aim 
of safe and efficient CP myotomy. 
Evolution of Devices 
The first cutting device used in FESD in 1995 was the needle knife papillotome 
(Wilson Cook, USA), which applied diathermy to dissect the septum.11 Advantages 
of the needle knife include low cost, easy availability, but disadvantages include 
difficulty in precise knife tip control, and the procedure involving a downward 
cutting motion of the septum (32). Further, the monopolar energy may lead to 
muscle contractions and tension, hindering precise myotomy. This which may risk 
perforation and mediastinitis, which occurs in up to 23% of cases (29,33). 
The role of argon plasma coagulation (APC) [Figure 3A] and carbon dioxide (CO2) 
laser are not confined to rigid endoscopy and may be used for FESD. The CO2 laser 
has advantages such as low cost and wide availability. However, disadvantages 
included the relative difficulty in delivering targeted treatment and the potential 
for thermal injury (32) which may precipitate surgical emphysema and delayed 
perforation (34). Similarly, complications of APC remain high, with one series 
reporting complications in 25%, comprising: fever (17%), haemorrhage (6%) and 
surgical emphysema (2%) (35). 
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Figure 2: (A) Transparent cap; (B) Diverticuloscope (ZDO-22-30, CookEndoscopy, Winston-Salem, USA); 
(C) Nasogastric tube which delineates the diverticular septum from the oesophagus.
Figure 3: Established devices for septal myotomy: (A) Needle knife; (B) argon plasma coagulation catheter; 
(C) Harmonic scalpel; (D) Hook knife; (E) Stag Beetle knife.
The Harmonic Scalpel (Ethicon Endo-Surgery, Cincinnati, USA) [Figure 3B] is used 
in conjunction with a diverticuloscope. As another dissecting device, the blades 
operate ultrasonically and have the ability to simultaneously cut and coagulate 
tissue, causing vessel tamponade (2). Other potential advantages include better 
exposure of the septum (36-38), improved procedural accuracy and safety, and 
wall protection offered by the diverticuloscope. Success rates from small series 
have been reported at 80-100%.37,38 In the largest cohort studied (N=25), Fama 
et al (36) presented one case of subcutaneous emphysema (4%) and two cases of 
chest pain (8%), without haemorrhage or mediastinitis. However, this technique 
requires neck extension to position the diverticuloscope, and is deemed safer 
under general anaesthesia (32), which limits the pool of suitable patients. 
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The Hook Knife (Olympus Co., Tokyo, Japan) [Figure 3C] is another cutting device 
which was originally designed for endoscopic submucosal dissection (ESD) (39,40). The 
tip of the knife is bent at a right angle, with the rotatable ‘hook’ measuring 1.3mm and 
the arm measuring 4.5mm. This design enables CP muscle fibres to be grasped, pulled 
upwards, and then cut, leading to a complete myotomy. Theoretically, the upwards 
pull of septal fibres minimises perforation risk. Repici et al (41) (N=32) reported a 
complication rate of 6.3% and overall success rate of 90.6% with Hook Knife myotomy. 
Similar findings were presented by Rouquette et al (N=24), who demonstrated overall 
success rates of 91.7%, complication rates of 8.4% and recurrence in 12.5% (42). 
The Stag Beetle (SB) knife (Sumitomo Bakelite Co., Japan) [Figure 3D] is a scissor-
shaped cutting tool which can be used to divide the septum and is often used with 
a diverticuloscope or cap (43). Both blades of the SB knife are insulated externally. It 
has two significant advantages over other cutting devices. First, the SB knife allows the 
incision from the apex to the base of the septum but with a scissor-like movement, 
which pulls the muscle fibres towards the endoscope whilst cutting. In addition, 
the 360-degree rotational ability increases therapeutic precision and prevents 
unwanted deep incisions that may lead to perforation. In a retrospective study of 31 
patients undergoing SB knife septal myotomy Battaglia et al (43) described a median 
procedure time of only 14 minutes, with 83.9% of patients in symptom remission after 
a median follow-up of 7 months. Efficacy and safety data were replicated by Goelder 
et al44 (N=52), who reported a low recurrence rate of 9.6% over 6 months, without 
complications of perforation or mediastinitis. 
Emerging Devices
The Clutch Cutter knife (DP2618DT-35, Fujifilm, Tokyo, Japan) [Figure 4A] is a novel 
device with a rotatable serrated cutting edge measuring 0.4mm in width and 3.5mm 
in length (45), and has an insulated outer coating. Its rigid blades allows selective 
grasping and cutting of the CP muscle, increasing its precision.46 However, the 
efficacy of the Clutch Cutter are currently confined to case reports (45,46)
Modern stapling devices (MicroCutter 30 Xchange, Cardica Inc., Redwood City, 
USA) [Figure 4B] have been modified for use with flexible endoscopes (47). This 
confers advantages over a rigid endoscope by improving visualization and accessory 
positioning, and enables therapy under conscious sedation (47). This new device 
involves a thin 5mm surgical stapler which rotates to 80 degrees in each direction. 
However, in their series of 17 patients, Wilmsen et al reported a success rate of only 
64.7%,47 with procedural failure in patients with insufficient head reclination and 
those with thick CP muscle.
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Figure 4: Emerging devices for septal myotomy: (A) Clutch Cutter; (B) Microcutter 30; (C) Flexible rotatable 
bipolar forceps; (D) Ligasure device.
Flexible rotatable bipolar forceps (“BELA” prototype instrument; Ethicon, Endo-
Surgery, Cincinnati, USA) are currently in development and are a novel devices 
for CP myotomy (48). A study on porcine models has shown advantages over 
needle knife cautery. Due to its jaw-like shape, the forceps fix the tissue to prevent 
unwanted movement, and allows precise therapy. In one small series (N=5), precise 
dissection of the CP septum was demonstrated in all patients. Instead of relying on 
precise endoscope positioning, the maneuverability of the bipolar forceps allows 
easier targeting of the intended dissection plane.
Recently, the role of Ligasure (LS1500, Covidien, Medtronic) has been evaluated 
for endoscopic diverticulotomy (49). The Ligasure vessel sealer is used to dissect 
the tissue and simultaneously provide haemostasis at the site. In this small study 
(N=8), the technical success rate was 100% on a range of diverticular sizes, with 
one case of bleeding reported as the only complication. Thus, further studies are 
required to assess its role in ZD.
Novel computer-assisted flexible endoscope systems are also being developed 
(50). The Flex System (Medrobotics, Raynham, USA) [Figure 5] features a surgeon 
operated-controlled unit, touchscreen monitor and a base for the attachment of 
the flexible endoscope which can be maneuvered with a 3-dimensional joystick. 
This confers advantages including: better visualization and laryngeal access 
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compared to open surgery, and allows for suturing of the mucosa and closure of 
small perforations. A wide range of accessories and devices are compatible with 
this system, which may accommodate patients with restricted neck mobility. 
Disadvantages include the requirement for general anaesthesia, setup costs, and 
potential learning curve. 
Incision Techniques
The single incision technique involves a midline incision to the cricopharyngeal 
septum with the option of clipping the base (51). This is usually used with needle 
knife, APC and the Hook knife. The double incision technique allows a wider area 
of the septum to be dissected (52). It involves creating two, 1cm incisions, which 
are made 1cm apart from each other. The septum in between the incisions is then 
resected using a snare and the base is clipped (53). One study reported complete 
remission rate in 71.4% after one session, with the remainder reporting symptom 
improvement after therapy was repeated (52). 
A novel technique involving wedge-shaped volumetric excision of the septum has 
also been described which similarly aims to reduce recurrence rate of ZD (54). It 
involves fixing the cricopharyngeal septum with a suture, which is then secured 
with a clamp, followed by dissection inferomedially on either side of the suture 
creating a wedge shaped incision, allowing a larger section of tissue to be removed. 
A snare then resects this incision. Data from a small series (N=6) has demonstrated 
complete resolution, with no significant complications (54). 
Submucosal tunnelling endoscopic septum division (STESD) is a technique that has 
most recently been inspired by peroral endoscopic myotomy (POEM) (55-57). This 
cutting-edge technique obviates direct dissection of the CP septum, and instead 
involves dissecting a submucosal tunnel around the septum to achieve a complete 
myotomy. This is important as longer septostomy is a prognostic marker of procedural 
success (58). Theoretically, STESD is associated with reduced risk of perforation and 
mediastinitis as the oesophageal mucosa is sealed with clips, and reduced recurrence 
rates. Efficacy for STESD is still confined to case reports (55-57). Its mainstream 
application is restricted by the lack of evidence, and expertise in POEM.
Endoscopic Management of Recurrent Zenker’s Diverticulum
Regardless of treatment modality, ZD recurrence is common (30,51,59) Predictors 
of symptom relapse within 48 months of endoscopic therapy include: pre-
treatment ZD size (³50mm), post-treatment ZD size (³10mm), and length of 
septostomy (£25mm).58 The effectiveness of redo myotomy has been demonstrated 
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in recurrent ZD (41,42,51,60). In their retrospective study (N=134), Huberty et al51 
reported recurrence rates of 23.1%; of those who underwent repeat treatment 
(N=23), 78.3% achieved symptom remission after re-do myotomy.
Figure 5: Flex system setup. A joystick is used by the surgeon as a control unit. The endoscope is driven with 
computer-assistance and has a distal tip diameter of 15mm x 17mm. Flexible instruments are manipulated 
independently by the hand of the surgeon. Reproduced with permission from Elsevier.50
Endoscopic management of recurrence after surgery or endoscopic stapling can 
be particularly challenging. Staples within small residual pouches can result in an 
adequate grasp of the common wall between the diverticulum and the oesophagus, 
and a higher risk of perforation is encountered when small pouches are stapled 
(61). Moreover, the staple-over-staple effect may lead to unpredictable scarring and 
fibrosis that can lead to persisting dysphagia despite apparent procedural success 
(62). In their series of 25 patients with post-surgical recurrence, Antonello et al59 
described symptom remission in 84%, with partial improvement in the remainder. 




High-flow intranasal devices,63 such as Optiflow™ (Fisher & Paykel Helathcare 
Ltd., Auckland, New Zealand), deliver low-level positive airway pressure with up to 
70L/min of oxygen, and prevents hypoxaemia. As endoscopic treatment for ZD is 
often a relatively short procedure performed under conscious propofol sedation, 
Optiflow is thought to be an effective method in stabilising oxygen saturations, 
whilst avoiding the need for intubation and ventilation (64). Thus, it is particularly 
useful in the setting of elderly, higher-risk ZD patients. 
The risks associated with general anaesthesia, particularly in the patient-base 
with ZD are well-recognised. Deep sedation with a continuous propofol infusion 
has been used in flexible endoscopic procedures (64), and can be used alongside 
analgesics such as fentanyl (64). Benefits of propofol sedation over benzodiazepines 
include the rapid onset of action, short half-life of 4 minutes, improved patient 
co-operation,65 and favourable safety profile (65,66).
Figure 6: Submucosal tunneling endoscopic septum division. (A) Zenker’s diverticulum (black arrow). 
(B) Submucosal injection and mucosal incision toward the submucosal space. (C) Creation of the submucosal 
tunnel and clear exposure of muscle fibres of septum inside the tunnel. (D) Septum division started inside the 
tunnel. (E) Complete myotomy beyond the bottom of the diverticulum. (F) Closure of mucosal entry. Reproduced 




Established and emerging treatment strategies for ZD may be summarised in 
Figure 7. Flexible endoscopy is a safe, effective and minimally-invasive option for 
treating ZD. The popularity of FESD has catalysed the research and development 
of available accessories, technologies, and operative approaches to maximise the 
safety and efficacy profile. 
Based on meta-analysis data,30 pooled rates of complications (11.3%) and 
recurrence (11.0%) remain high. Studies performed pre-2005 were associated with 
increased clinical success, but with higher recurrence rates (30). This observation 
is interesting, particularly when quality of training and practice has improved 
considerably over this time. One possible explanation could be the lack of a single 
standardized technique. As technology for ZD therapy evolves without the real-
world patient volume to develop endoscopist expertise, the optimal combination 
of technique and device to achieve favourable safety, efficacy and long-term 
outcome remains unclear. 
Due to the relative infrequency of the condition, studies for ZD therapy are at 
best, limited to small prospective studies, without randomised-controlled trial 
data. There is a clear need for larger, well-designed, comparative prospective 
studies to assess the optimum method and treatment device, in order to allowing 
standardization of training and practice. Additionally, universal definitions of 
outcomes, such as treatment success, relapse and complication rates are needed 
to allow better comparisons between studies, and to quality assure practice. There 
may be a role for specialist tertiary units to manage ZD, where there is sufficient 
volume to preserve the competence of endoscopists. There is also a case for 
multidisciplinary interaction with otolaryngologists and anaesthesiologists to 
determine the optimum treatment modality for each affected patient, and for 
outcomes in both specialties to be monitored. 
Since the inception of FESD, there has been no consensus on the training and 
technical aspects of how therapy should be performed. Due to ZD being a rare 
disorder, training in therapeutic endoscopy can be challenging, with an unknown 
learning curve. There is a clear need to ensure that training for such a high-risk 
procedure has been of sufficient quality, and that necessary technical and non-
technical competencies have been attained before allowing unsupervised practice. 
For this, a standardised framework for defining competence in FESD is required, 
supported by mentorship and methods of competence assessments. Beginners in 
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FESD may benefit from training outside the endoscopy room. As most domestic 
pigs possess pharyngeal diverticulae resembling human ZD (67), porcine models 
may be a useful tool in training and assessment. Also, in development is a surgical 
simulator which demonstrates content and construct validity in allowing trainees 
to acquire the skills within a controlled environment to develop competence in ZD 
therapy (68). 
Figure 7: Summary of current approaches available for Zenker’s diverticulum which are presented in this review.
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Currently, there is a notable lack of clinical guidelines or auditable performance 
metrics in the endoscopic management of ZD. Establishing these are fundamental 
to the process of quality assurance, which has seen significant strides in the quality 
and outcomes of diagnostic and therapeutic endoscopic modalities in the last two 
decades. Incorporating quality assurance into the ZD arena may be the upcoming 
strategy to improve operator proficiency and patient outcomes in the future.
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Abstract 
Background: Intubation failure (IF) occurs when an endoscopist is unable to 
progress via the oropharynx into the upper oesophagus. Objective: To assess 
incidence and etiology of IF and predictors of structural pharyngeal abnormalities 
in patients with IF. Methods: All gastroscopies performed our centre between 
August 2010-2016 were retrospectively reviewed. Barium radiology and repeat 
gastroscopy findings were evaluated for structural causes of IF. Patients were 
categorised into ‘failure to tolerate’ and ‘failure to progress’ based on endoscopy 
reports. Results: The incidence of IF was 0.95% (248/26130). Among cases of IF, 
structural pharyngeal abnormalities were detected in 28.9% of cases, consisting of 
cricopharyngeal hypertrophy and/or Zenker’s diverticulum in most cases. Rates 
of IF varied between endoscopist specialty (p=0.021), but not with patient age, 
sex and sedation dose. ‘Failure to progress’ predicted pharyngeal pathology in 
55.6%. Predictors of structural causes on barium radiology following IF included: 
age ≥65 (OR 4.0, 95% CI: 1.8-8.9, p<0.001); dysphagia indication for gastroscopy 
(OR 5.5, 95% CI: 2.5-11.8, p<0.001), and failure of endoscopic progression (OR 5.2, 
95% CI: 2.3-12.0, p<0.001). Conclusion: Patients with IF should be investigated 
owing to high risk of underlying pathology, particularly if associated with age ≥65, 




In gastroscopy, intubation failure (IF) may be defined as a situation when a trained 
endoscopist is unable to progress into the upper oesophagus via the oropharynx. 
Although this is a relatively common problem during endoscopy training, the 
incidence is relatively unknown. The Joint Accreditation Group in Gastrointestinal 
Endoscopy (JAG) mandate the auditing of intubation success across endoscopy 
units in the UK as a performance indicator in gastroscopy (1). Despite this, neither 
the incidence nor the aetiologies of IF have been reported in large cohort studies. 
Limited data arise from randomised trials which have compared conventional 
gastroscopy with transnasal routes, with rates of IF ranging from 0% to 1.8% (2,3). 
In contrast, airway intubation failure has been well-studied in anaesthetics. Here, 
the reported incidence range from 0.05% electively to 1-2% in the emergency 
setting (4) with causes of failure summarised in an aide-memoire (Figure 1) (5). 
Moreover, the Mallampati classification is routinely used to assess variations in 
oropharyngeal anatomy to gauge the difficulty of airway intubation (6). However, 
for gastroscopy, little emphasis is placed on variations in oropharyngeal anatomy 
which may pose challenges in intubation. In clinical practice, patients are often 
deemed to not tolerate intubation due to factors such as anxiety, when these may 
be due to variations in oropharyngeal anatomy. So far, no published studies have 
explored whether patients fail intubation due to anxiety, or anatomical causes.
Aims
1. Explore the incidence and aetiology of IF 
2. Assess predictors of IF 
3. Assess predictors of pathology in patients with IF
4. Perform a formal literature review into IF
Methods
Study Design
We performed a single-centre retrospective cohort study of all gastroscopies 
performed between August 2010–2016 at a district general hospital. All procedures 
were performed using Pentax gastroscopes (EG-2990i, EG29-i10; insertion tube 
diameter of 9.8mm). Patients were routinely offered the choice of pharyngeal 
anaesthesia (lidocaine 100mg) and/or midazolam (usual dose <2mg). Data were 
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retrieved from a prospectively collected endoscopy database (Unisoft), and all 
procedures where endoscopy failed to progress beyond the oropharynx were 
identified as intubation failure. We analysed all patients >18 years who had failed 
intubation, including patients who had attempted to pull out the gastroscope. 
Exclusion criteria included withdrawal of consent prior to the procedure and 
inability to enter the oral cavity. 
For all endoscopy reports, data were collected on the specialty of endoscopist 
(gastroenterologist, surgeon or non-medical (nurse) endoscopist (NME)), patient 
age, sex, use of pharyngeal anaesthesia and sedation. For patients with IF, procedural 
data, sedation use, subsequent barium radiology, computed tomography (CT), and 
repeat gastroscopy findings were reviewed to assess for structural causes of IF. 
Barium radiology was reported by a dedicated gastrointestinal radiologist. 
Concordant pathology was defined as upper gastrointestinal pathology which related 
to the indication(s) of the endoscopy, e.g. carcinoma for dyspepsia, and dysmotility 
for reflux. Based on the procedural comments from endoscopy reports, each case of 
failed intubation was categorised by two reviewers into groups of ‘failure to tolerate’, 
based on patient’s intolerance of the procedure, e.g. pulling out scope, anxiety, 
excessive gag, or ‘failure to progress’ (i.e. physically unable to progress, structural 
abnormality, or endoscopist’s decision to abandon intubation). 





This study was carried out according to the principles of the Declaration of Helsinki 
of good clinical practice. Data were collected as part of JAG Global Rating Scale 
(GRS) audit requirement, hence ethics committee approval was not required, 
according to local regulations.
Literature Review
We performed a literature search on EMBASE, MEDLINE, PubMed for relevant 
studies on intubation failure using a combination of the following search headings: 
1) MeSH Major topics: Gastroscopy OR endoscopy OR esophagogastroduodenoscopy 
OR oesophagogastroduodenoscopy OR OGD; 2) MeSH terms: Intubation AND 
difficult OR difficulty OR fail OR failure OR failed; 3) MeSH terms: NOT tracheal; 
4) Limit to English language. We expanded our search to all studies including 
published conference abstracts. We also included a google scholar search with: 1) 
FAIL or FAILED or FAILURE or DIFFICULT in title; 2) gastroscopy OR endoscopy OR 
esophagogastroduodenoscopy OR oesophagogastroduodenoscopy in title. 
Statistical Analysis
Statistical analyses were performed using IBM SPSS 23 (IBM Corp. Armonk, 
NY). Pearson’s chi2 was used for univariable analyses of categorical data, and 
Wilcoxon’s signed rank test for paired continuous data. The student t-test was used 
to compare normally distributed variables and the Mann-Whitney U-test used 




In the six-year study period, 248 failed procedures for 238 patients were identified 
from 26,130 gastroscopies, providing an estimated incidence of 0.95% (248/26130). 
In the IF group, patients had a mean age of 63.2 years (SD 16.1) and were female in 
126 (52.9%). Of the 238 patients, primary indications consisted of: pain/dyspepsia 
(74; 31.1%), dysphagia (63; 26.5%), anaemia (28; 11.8%), bleeding (17; 7.1%), reflux (14; 
5.9%), duodenal biopsy (10; 4.2%), follow-up gastroscopy (10; 4.2%), weight loss (8; 
3.3%) and other (14; 5.9%). ‘Failure to progress’ occurred in 41 (17.2%) and ‘failure 
to tolerate’ in 197 (82.8%). 
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Based on comments from the endoscopy report, the failure to tolerate group 
consisted of: patient unable to tolerate – not otherwise specified (109; 55.3%), 
pulled scope (34; 17.3%), anxiety/agitation (30; 15.2%), non-compliance (17; 8.6%), 
and excessive gag (7; 3.6%). Based on endoscopist’s comments, reasons for failure to 
progress consisted of: suspected Zenker’s (23; 56.1%), tight/acute upper oesophageal 
sphincter (5; 12.2%), unable to pass cricopharyngeal not otherwise specified 
(5; 12.2%), pharyngeal stricture (4; 9.8%), cricopharyngeal spasm (2; 4.9%), 
prominent CP (1; 2.4%) and possible web (1; 2.4%). 
Causes
Subsequent investigations were requested for 190 patients (79.8%). As a proportion 
of the total IF cohort, investigations consisted of barium radiology (142; 59.7%), CT 
(50; 21%), repeat gastroscopy (70; 29.4%) and no further investigations (48; 20.2%). 
Of patients undertaking further investigations, structural pharyngeal abnormalities 
were detected in 41 (28.9%), comprising of cricopharyngeal hypertrophy (CPH) 
(49%), Zenker’s diverticulum (ZD) (14.6%), pharyngeal web (12.2%), ZD with CPH 
(9.8%), cervical spondylosis (7.3%) and other (7.3%) (Figure 2). 
Figure 2: Barium swallow demonstrating incipient 





The incidence of IF varied between groups (p=0.021), with lowest pooled rates 
in gastroenterologists (0.74%) compared with surgeons (1.07%) and NME (1.05%). 
Between the IF and successful intubation (SI) groups, there were no significant 
differences in mean age (63.2 for IF vs. 63.6 for SI, p=0.77), gender (47% male for 
IF vs. 49.5% male for SI, p=0.46) or mean midazolam dosage where administered 
(1.31mg for IF vs. 1.19mg for SI, p=0.28). Overall, 61.4% of procedures were 
performed with pharyngeal lidocaine (without sedation). Patients with IF were 
more likely to receive only pharyngeal lidocaine (65.0% vs. 61.3%, p=0.05) and dual 
premedication with pharyngeal anaesthesia and midazolam (11.9% vs. 3.7%, OR 
3.56, 95% CI 2.36-5.36, p<0.001). 
‘Failure to tolerate’ vs. ‘Failure to progress’
Within the IF cohort, the median age of the failure to tolerate group was 64 (IQR 
24) vs. 73 (IQR 22) for failure to progress (p<0.001). 86.5% of females had failure to 
tolerate compared to 78.6% of males (p=0.12). There were no significant differences 
in use of dual premedication (p=0.77), midazolam dose (p=0.22) or pharyngeal 
lidocaine (p=0.55) between groups. Gastroenterologists (27.3%) were more likely to 
report ‘failure to progress’ over ‘failure to tolerate’ than NME (12.1%) or surgeons 
(0%) (p=0.002). Additional predictors of ‘failure to progress’ vs. ‘failure to tolerate’ 
included dysphagia (33.3% vs. 11.4% without dysphagia, OR 3.88, 95% CI 1.92-7.81, 
p<0.001) and pharyngeal abnormality on barium radiology (36.1% vs. 2.0%, OR 
27.70, 95% CI 3.41-224.7, p<0.001). 
Predictors of abnormal radiology in patients with IF
The diagnostic yield for barium radiology, CT and repeat gastroscopy were 69.0%, 
54.0% and 64.3% respectively. The diagnostic yield of pathology concordant with 
symptoms on further investigation for IF was 110/192 (57.3%). In patients undergoing 
barium radiology and repeat gastroscopy, the false negative rate for endoscopy 
was 17/30 (56.7%), comprising of missed cases of pharyngeal pathology (n=9), 
dysmotility (n=4) and significant reflux (n=4). Within the IF cohort, predictors of 
structural causes on barium radiology included: dysphagia (OR 5.5, 95% CI: 2.5-
11.8, p<0.001), failure to progress (OR 5.2, 95% CI: 2.3-12.0, p<0.001) and age ≥65 
(OR 4.0, 95% CI: 1.8-8.9, p<0.001). Repeat gastroscopy was successful in 63/70 (2 
using nasogastroscope) after increasing midazolam dosage (mean increase=1.5mg, 
95% CI: 1.0-2.0mg, p<0.001). Overall, the positive predictive value for concordant 
pathology in the ‘failure to progress’ group was 55.6% compared to 20.3% in ‘failure 
to tolerate’ group. 
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Discussion
In this largest study of IF to date, our incidence of approximately 1% is comparable 
to the estimated 0-1.8% from small cases reported in the gastroscopy arm of 
clinical trials(2,3) Despite our literature search, we found no published studies 
which have correlated oesophageal intubation failure with follow-up findings. 
The limited data relating to gastroscopy failure have largely approached the 
issue from the angle of patient intolerance and discomfort. Data from Reed 
et al (7) involving 3525 gastroscopies performed by surgeons, demonstrated a 
0.3% rate of incomplete examinations to the stomach, but does not report rates 
of IF. Qualitative research investigating the psychological aspects of failure to 
tolerate endoscopy have identified patient apprehensions arising from feelings of 
vulnerability, embarrassment, fear of physical discomfort, as well as anxiety over 
the outcome of the investigation(8,9). 
Pre-procedural psychological anxiety is not the only predictor of intubation 
intolerance. A study by Campo et al involving 509 patients undergoing unsedated 
gastroscopy identified factors for poor tolerance including: first-time experience, 
presence of gag reflex, anxiety, young age, and female gender(10). The authors 
concluded that patients with such predictive factors may benefit more from 
sedation during gastroscopy. However, techniques in intubation may also affect 
tolerance. In a randomised trial conducted by the same group (2) nasogastric 
intubation using a thinner endoscope reduced the need for sedation compared 
with conventional gastroscopy, but routine use was restricted by the size of the 
working channel and image quality. 
The efficacy of the nasogastric scope for diagnostic and therapeutic procedures 
have been demonstrated in a large case series (11), with demonstrated advantages 
of improved patient comfort, and successful negotiation of high-grade strictures. 
As a high proportion of our patients were unsedated (61.4% overall) and median 
midazolam dosage appears to be lower than that used in European centres, 
nasogastroscopy may be more tolerable option for our patient group, particularly 
in the setting of outpatient clinics, or in patients with IF who have declined or 
are unsuitable for sedation, e.g. critically-ill patients. However, the literature on 
patients with IF due to anatomical causes remain confined to case reports which 
showcase techniques for overcoming difficult intubation, especially in cases of 
Zenker’s diverticulum. These include the use of an overtube (12), guidewire (13), 
or catheter to facilitate passage through the upper oesophageal sphincter (14). 
3
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In our study, CPH was the most common abnormality found on subsequent 
evaluation of patients with failed intubation. CPH is a poorly recognised entity 
in gastrointestinal endoscopy, with diagnosis of CPH based on visualisation of 
a hypertrophied CP muscle during the swallowing phase on videofluoroscopy 
(Figure 3) (15), which may be more familiar to radiologists as “cricopharyngeal 
bar”. In an early case series of 618 patients (16), CPH was observed in 10.8%, 
increased with age, and was associated with obstruction of a pharyngeal bolus 
or cricopharyngeal indentation of the oesophagus during different phases of 
swallowing. On manometry, CPH has been correlated with reduced maximal 
diameters (compliance) and raised intrabolus pressures at the upper oesophageal 
sphincter (17,18). 
It is thus feasible how CPH can contribute to dysphagia and impede intubation. 
In addition to age, CPH has been found in association with neurological disorders 
(16) myositis (17), and, as with our study, with structural pharyngeal abnormalities 
such as ZD (16). It has been proposed that ZD could be a consequence of CPH(15) 
ZD, which occurs due to herniation of the posterior pharyngeal wall through 
Killian’s dehiscence (20), is thought to arise from longstanding elevations 
in hypopharyngeal intrabolus pressures during swallowing which occurs in 
conjunction with CPH (15), However, the relationship between CPH and dysphagia 
has been controversial, as dysphagia is found in only 15% of patients with CPH(16) 
Nevertheless, a variety of therapeutic strategies have been effective in managing 
oropharyngeal dysphagia secondary to CPH, including balloon dilatation (21,22), 
myotomy (21,22), botulinum toxin (22,23), and flexible endoscopic septum 
division (FESD) in the context of ZD (24). Hence, barium assessment of patients 
with oropharyngeal dysphagia and IF is necessary to facilitate treatment and 
reduce dysphagia-related morbidity. 
Our study does have its limitations. First, due to its retrospective nature, we 
had not collected data on patient-reported outcomes such as anxiety or comfort 
scores. Not all patients with IF underwent subsequent investigations; those who 
did may have had investigations to evaluate the primary endoscopic indication 
rather than for IF, which may affect the validity of our findings. This would have 
been especially the case for CT scans, and repeat gastroscopies, which would be 
less reliable for detecting functional pharyngeal pathology such as CPH. Second, 
the arbitrary groupings of IF into ‘failure to tolerate’ and ‘failure to progress’ may 
also be deemed as subjective and a source of bias, although we have subsequently 
correlated this distinction with significantly increased likelihood of structural 
pharyngeal abnormalities. 
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We acknowledge that patients may have a combination of both factors, which may 
be impossible to separate, even with the presence of a neutral study investigator in 
the context of a prospective study. Third, the study was meant to be an exploratory 
analysis of the IF cohort. As such, the data collection variables for the successful 
intubation group was limited to demographics and premedication use. Our study 
does not address endoscopist expertise, variations between sites, nor mental or 
physical co-morbidities of patients, which we suspect may also influence successful 
intubation. Although we have reported on some univariate predictors of IF, this 
was not a dedicated case-control analysis. Larger numbers of IF may have allowed 
for multivariate regression analysis.
Despite limitation of this study to our knowledge, our analysis of 26,130 
gastroscopies over 6 years is the largest studied real-world IF dataset. Our results 
do have practical implications, as patients with IF have high rates of underlying 
structural pharyngeal pathology, with 73.2% comprising of ZD and/or CPH on 
subsequent investigation, which may be amenable to treatment. Our data suggest 
that barium swallow is effective at detecting non-structural pathology in cases 
of IF, such as dysmotility and reflux. Furthermore, the high rates of intubation 
success on subsequent attempts, albeit with higher doses of sedation, is reassuring. 
For future research, we believe there may be a role for a prospective study 
involving the pre-endoscopic assessment of the oropharyngeal cavity using the 
Mallampati score, and correlating this with intubation failure or discomfort 
scores. In anaesthetics, a Mallampati score of III or IV were associated with 
difficult tracheal intubation (OR 5.89, 95% CI 4.74-7.32) (25) but this has not 
been validated in endoscopy. We hypothesise that higher Mallampati scores, in 
addition to factors outlined in the aide memoire (Figure 1), may predispose to IF, 
and in these circumstances, nasogastroscopy may be preferred over conventional 
gastroscopy in the first instance. However, more data are required before these 
recommendations can be made.
For future practice, our data may have relevance for the quality assurance of 
gastroscopy. Although the JAG states that intubation success is an auditable 
outcome, no current key performance indicator exists. The Association for 
Gastrointestinal Endoscopy (ASGE) does not specifically mention IF, but states that 
complete examinations should be achieved in >98% of gastroscopies. Based on our 
data, and that from Reed et al (7) we propose that an IF rate of <1% is a realistic and 
auditable quality metric in gastroscopy.
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Additionally, we recommend for endoscopists to carefully document reasons for 
IF and into groupings of “failure to tolerate” and “failure to progress”, as this can 
affect subsequent management and pathological yield. Failure to tolerate may 
be overcome by addressing patient factors such as allaying anxieties, increasing 
sedation, use of general anaesthesia, and use of nasogastroscopy, whereas failure 
to progress may benefit from nasogastroscopy, or endoscopic adjuncts such 
as cap-assisted intubation or catheter guidance. Our study also suggests that 
endoscopist factors may influence intubation success. There should be a low 
threshold to offer intubation at the same sitting with a nasogastric scope which 
can improve patient comfort. If intubation failure persists, the patient should 
undergo barium assessment and/or further attempts with greater sedation under 
the most experienced endoscopist available. 
Conclusion
In the largest study of IF to date, we report an incidence of ≈1%, with structural 
pharyngeal abnormalities found in 28.9% of patients undergoing further 
investigation. Older age, dysphagia and abnormality on barium radiology 
correlated with failure to progress compared to failure to tolerate intubation. 
This association of IF and pharyngeal abnormality does not appear casual. Hence 
patients with IF should be investigated further owing to the high risk of underlying 
pathology, particularly if associated with age ≥65, dysphagia, and failure of 
endoscopic progression. Barium radiology is comparable to repeat gastroscopy in 
terms of diagnostic yield, and may be more helpful in evaluating pharyngeal and 
functional pathology. IF rates of <1% may be considered as an auditable metric for 
the quality assurance of gastroscopy.
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ABSTRACT
BACKGROUND: Structural disorders of the hypopharynx can lead to dysphagia-
related morbidity. Endoscopic therapy in this area, e.g. myotomy for Zenker’s 
diverticulum (ZD), has traditionally been performed under general anaesthesia 
(GA). We have developed a two-stage sedation process, which is used along with 
High Flow Nasal Oxygen Therapy (HFNOT) to facilitate endoscopic hypopharyngeal 
procedures. METHODS: In this prospective, single-centre study, patients 
undergoing endoscopic procedures between June 2016 and March 2018 were 
included. All endoscopies were performed with propofol and/or remifentanil 
and supported with HFNOT. In patients with ZD, the diverticulum and stomach 
were cleared of debris under conscious sedation to reduce the risk of aspiration, 
before sedation was deepened to facilitate myotomy. Sedation-related adverse 
events were recorded. RESULTS: A total of 50 patients were included for analysis 
(mean age of 71.1, range 31-93; 58% male). 48% were categorized as American 
Society of Anesthesiologists (ASA) Grade III and 6% as Grade IV. The median 
procedure time was 20 minutes. 83% of patients were sedated with both propofol 
and remifentanil using a target-controlled infusion under specialist anaesthetic 
supervision. Sedation-related adverse events included transient hypotension 
(38%), bradycardia (8%) and hypoxia (8%). No procedures were abandoned due 
to complications and no patients required conversion to general anaesthesia. 
Patients achieved full post-procedure recovery from sedation after a median 
duration of 5 minutes.
CONCLUSIONS: HFNOT is a useful adjunct to two-stage sedation, which can 
enable high-risk patients to safely undergo deep sedation during hypopharyngeal 
endoscopic procedures. 
What is already known on this 
topic?
• Deep sedation with or without intubation poses 
a real challenge in patients with ZD who have 
significant co-morbidities and risk of aspiration 
of gastric or pouch contents
What this study adds • A novel technique combining two-stage 
sedation and HFNOT allows these procedures 
to be performed without the need for a general 
anaesthetic.
• The first (conscious) stage of sedation facilitates 
suctioning of pouch contents, whilst minimising 
the risk of pulmonary aspiration.
• The use of HFNOT reduces the risk of hypoxaemia 




Structural disorders of the hypopharynx and upper oesophagus are associated 
with significant patient morbidity owing to complications of dysphagia, 
regurgitation malnutrition and recurrent aspiration. Therapy in this area remains 
challenging due to its rich nervous innervation and confined working space. Over 
the last two decades, endoscopic techniques have been developed and refined for 
hypopharyngeal conditions such as Zenker’s diverticulum (ZD) (1) cricopharyngeal 
hypertrophy and upper oesophageal disorders including strictures and webs (2). 
With its favourable efficacy and safety profiles, endoscopic therapy has largely 
superseded surgical alternatives, particularly in the case of ZD (1). Such cases are 
generally performed under general anaesthesia (GA) or deep sedation and may 
require invasive ventilation. However, the incidence of hypopharyngeal and 
upper oesophageal disorders increases with age, with a peak preponderance in 
the 70s and 80s age groups, where patients are particularly susceptible to medical 
co-morbidities which may be an unacceptably high risk for GA. Thus it is desirable 
to develop a safe approach, that avoids general anaesthsia, to facilitate endoscopic 
therapy in this group of potentially frail patients. 
In most centres, deep sedation is used to minimise patient discomfort and keep 
the patient still to enable endoscopic therapy (3). This patient group is at risk of 
aspiration of gastric and pouch contents due to the combination of sedation and the 
pathology of the condition (4). Therefore, to improve patient safety, we developed 
a novel two-stage approach to sedation, with an initial conscious phase, followed 
by a deep phase. The conscious phase enabled suctioning of the pharyngeal pouch 
and stomach, whilst the deep phase facilitated the myotomy. The sedative drugs are 
associated with the risk of hypoxia, hypotension and bradycardia (5). We therefore 
introduced an approach to further improve patient safety, especially during the 
deep phase of sedation.
The advent of High Flow Nasal Oxygen Therapy (HFNOT) has enabled procedures 
requiring deep sedation to be performed without the need for endotracheal 
intubation (6,7) and reduces the risk of hypoxia during the deep phase. However, 
there is paucity of evidence documenting its use, particularly for endoscopic 
interventional procedures of the hypopharynx.
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In this study, we aimed to assess the efficacy and safety of HFNOT during a two-
stage approach to sedation, as an adjunct to endoscopic pharyngeal and upper 
oesophageal procedures with regards to safety and successful completion of 
procedures and limiting sedation-related adverse events. 
METHODS
Study Design
This was a prospective observational single-centre study which assessed the 
efficacy and safety of HFNOT in patients undergoing flexible endoscopic therapy 
for hypopharyngeal and upper oesophageal disorders. The study was conducted 
at Russells Hall Hospital, Dudley, a national referral centre for patients with ZD, 
including patients who had been deemed unsuitable for surgery under a general 
anaesthetic due to it being too high risk, or those with recurring ZD following 
previous therapy. 
Study Approval
This study was carried out according to the principles of the Declaration of Helsinki 
of Good Clinical Practice. Study approval was formally granted by the Research 
and Development department of the Dudley Group of Hospitals Foundation Trust. 
All patients provided written informed consent to participate.
Patients
Participants included any patient scheduled for a hypopharyngeal procedure 
(endoscopic treatment of ZD, Botox injection for cricopharyngeal hypertrophy) or 
oesophageal dilatation between June 2016 and March 2018. There were no exclusion 
criteria. 
Procedures
Patients were instructed to have fasted for 12 hours prior to their procedure and were 
assessed by an anaesthetist prior to entering the endoscopy suite. An intravenous cannula 
was inserted, and monitoring was applied. This included a pulse oximeter, three-lead 
ECG, non-invasive blood pressure and respiratory rate monitoring. Capnography 
monitoring could not be used alongside HFNOT. Blood pressure readings were 
taken every five minutes. HFNOT (Optiflowä, Fisher and Paykel Healthcare Limited, 
Auckland, New Zealand) was applied to all patients, and the throat was sprayed with 
lidocaine 1%. All patients were placed in the left lateral position. All patients received 
intravenous paracetamol. A clinical assistant collected the data intraoperatively.
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An experienced consultant anaesthetist administered the sedation and monitored 
the patients. Patients with ZD who were deemed at high risk of aspiration underwent 
conscious sedation with a remifentanil Target Controlled Infusion (TCI) in order 
to allow the endoscopist to suction both the pharyngeal pouch and the stomach. 
Once the aspiration risk was optimised, deeper sedation was commenced either 
with higher doses of remifentanil or the addition of a propofol TCI. In accordance 
with American Society of Anaesthesiologists (ASA) guidance,8 deep sedation was 
defined as “a drug-induced depression of consciousness during which patients 
cannot be easily aroused but respond purposefully following repeated or painful 
stimulation”. All patients were spontaneously breathing.
All procedures were performed by an experienced interventional endoscopist. For 
Zenker’s diverticulotomy, a nasogastric tube was placed after emptying the pouch 
and aspiration of gastric fluid. This helped to protect the anterior oesophageal 
wall. The ZD repair was performed using a 9.8mm endoscope (Pentax EG-2990i, 
Pentax, Tokyo, Japan), using a transparent cap at the tip. The scope was carefully 
introduced to identify the CP muscle and pouch. A single incision along the 
midline of the septum (cricopharyngeus muscle [CP]) was carried out to dissect 
mucosa and fibres of the CP muscle using SB knife junior scissor knife (Sumitomo 
Bakelite, Japan). One to three clips (HX-610-090L; Olympus, Tokyo, Japan) were 
then placed at the bottom of the incision to prevent mucosal dissection from 
underlying muscle and perforation (Figure 1). The patients were discharged home 
the same day unless they were from outside the region. Patients were allowed to 
have liquids on day two and soft diet from day three onwards. At least two litres 
of intravenous fluids were administered prior to discharge. For cricopharyngeal 
hypertrophy, Botulinum toxin (Botox) injections of the cricopharyngeal (CP) 
muscle consisted of identifying the CP muscle, injecting it with diluted Botox 100 
IU in two to three sites followed by dilatation over a guidewire if required. For 
oesophageal dilatations alone, a guidewire was placed over the stricture and then 
dilated with bouginage. 
Outcomes
The primary outcome studied was the incidence of sedation related adverse 
events. These comprised hypotension (mean arterial pressure <70mmHg), hypoxia 
(saturation <90% for more than 10 seconds) and bradycardia (heart rate <50 
beats per minute). Episodes of bradycardia and hypotension were treated with 
glycopyrrolate, vasopressors and intravenous fluids. Hypoxia was treated at the 
discretion of the anaesthetist according to the cause, such as airway support or 
removal of the endoscope temporarily. 
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Secondary outcomes included the total doses of propofol and remifentanil, and 
the total time taken for completion of the procedure. Time to recovery was also 
recorded (defined as recovery of protective airway reflexes) every 5 minutes from 
the time of endoscope extubation. 
Study covariates
For each patient, the ASA score and co-morbidities were systematically recorded. 
At the end of the procedure, the endoscopist graded the difficulty of the procedure 
on the following scale: I- satisfactory, II- difficult or III- extremely difficult.
Statistical analyses
All continuous variables were subjected to normality testing. Data were expressed 
as frequency (percent) for categorical variables and mean (± standard deviation 
[SD]) for parametric data and median (interquartile range) for non-parametric 
data. Patients were classified into binary categories of those who experienced 
complications (hypoxia, bradycardia, or MAP<70 mmHg) and those who did not. 
Comparisons were made between the two groups using chi-square or Fisher’s exact 
test for categorical data, and student t-test or Mann–WhitneyU test for parametric 
or non-parametric continuous variables.P<0.05 was considered statistically 
significant. Data were analysed using SPSS Statistics V21.0. 
RESULTS
A total of 50 consecutive patients underwent hypopharyngeal or upper oesophageal 
endoscopic therapy between June 2016 and March 2018. Mean age was 71.1 years 
(range 31-93). 58% of patients were male. ASA status comprised: Grade 1 - 8%, 
Grade 2 – 42%, Grade 3 – 38%, Grade 4 – 6%. Endotherapy comprised: Zenker’s 
diverticulotomy (70%), upper oesophageal dilatation (20%) and Botulinum toxin 
injection (10%). 
85.4% of patients were sedated with both propofol and remifentanil TCI, 8.3% 
with propofol only and 6.3% with remifentanil only. The mean (±SD) total dose of 
propofol and remifentanil used was 126.7±93.35mg (median[interquartile range 
25%–75%]:103[57-192]) and 188.5±115.81mcg (median[interquartile range 25%–




Table 1: Univariate analyses of patient and procedural factors associated with sedation-related complications. *Data 
presented as mean± standard deviation.
Hypoxic events Bradycardic events Hypotensive events
















0.63 1 0.521(5%)† 19(95%) 2(10%) 18(90%) 9(45%) 11(55%)















0(0) 4(100) 0(0) 4(100) 25) 3(75)
2(10) 18(90) 1(5) 19(95) 7(35) 13(65)
1(5.3) 18(94.7) 2(10.5) 17(89.5) 9(47.4) 10(52.6)
0(0) 2(100) 0(0) 2(100) 1(50) 1(50)
0.66 0.59 0.47
4(11.4%) 31(88.6%) 2(5.7%) 33(94.3%) 15(42.9%) 20(57.1%)
0(0%) 6(100%) 1(16.7%) 5(83.3%) 3(50%) 3(50%)
0(0%) 5(100%) 1(20%) 4(80%) 20%) 4(80%)



























































0(0%) 3(100%) 0(0%) 3(100%) 0(0%) 3(100%)
0(0%) 15(100%) 1(6.7%) 14(93.3%) 9(60% 6(40%)
4(13.8%) 25(86.2%) 3(10.3%) 26(89.7%) 9(31%) 20(69%)
Figure 1: Endoscopic septum division using the SB Knife. From left to right: Septum (cricopharyngeus muscle) is 
identified and nasogastric tube placed to delineate the oesophageal entrance; the SB knife is used to perform 
the midline incision on the septum to dissect the mucosa and muscle fibres to fully divide the septum; two clips 
are positioned at the bottom of the incision.
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HFNOT was used for all patients with flow rates of between 30 and 70 litres per 
minute. Most procedures were classified as difficulty II (32%) or III (58%) whereas 
only 6% were classified as difficulty I. Median (interquartile range 25%–75%) dose of 
propofol for procedures of difficulty I/II and III was 90.5 (59-185.5) mg (mean[±SD]: 
131.2±110.6) and 105 (49.75-187) mg (mean[±SD]: 119.7±83.6) respectively (p=0.79). 
Median (interquartile range 25%–75%) dose of remifentanil for procedures of 
difficulty I/II and III was 130.5 (99.75-213.5) mcg (mean[±SD]: 152.8±78.2) and 175.5 
(118.25-265.25) mcg (mean[±SD]: 200.4±120.1) respectively (p=0.14). 
Table 1 presents patients and procedural factors associated with sedation-related 
complications, including hypotension, bradycardia and hypoxemia. There was 
no significant association found between patient characteristics and sedation 
related adverse events, but rates of hypoxia and bradycardia were associated with 
procedural difficulty.
The commonest sedation-related adverse event was hypotension (Table 2). Just 
over one third of patients experienced at least one episode of hypotension, 
whereas only 8% of patients experienced at least one episode of either bradycardia 
or hypoxia. Boluses of metaraminol were required for one patient to treat 
hypotension. No procedures were abandoned. 
Table 2: Sedation related adverse events, based on definitions described under Methods. 
Adverse event 1 episode 2 episodes 3 episodes 4 episodes 5 episodes Total 
Hypotension 9 (18%) 7 (14%) 2 (4%) 0 1(2%) 19 (38%)
Hypoxia 3 (6%) 0 0 1 (2%) 0 4(8%)
Bradycardia 3 (6%) 1 (2%) 0 0 0 4 (8%)
Post-procedure, the median recovery time was five minutes. 30-day mortality 
was zero. Minor adverse events were noted in four patients (8%), with three 
patients complaining of neck pain and one developing pyrexia. These patients 
were admitted for overnight observation and monitoring, with no radiological 





This single-centre prospective observational study demonstrates that 
supplementary oxygenation with HFNOT is a feasible and safe adjunct to use 
alongside a two-stage sedation technique during therapeutic endoscopy within the 
hypopharynx. Rates of sedation-related complications were low, with no patients 
requiring conversion to endotracheal intubation, despite the age and high rates of 
ASA grade 3/4 patients. These results suggest that our technique is a feasible and 
safe alternative to general anaesthesia and invasive ventilation, which remains the 
mainstay airway modality in other ZD centres.
Patients with ZD are at a high risk of aspiration due to the potential for food 
residue within the diverticulum. Anaesthetic techniques have traditionally relied 
on endotracheal intubation to provide definitive airway protection. In this study, 
the use of HFNOT in combination with suctioning of the pharyngeal pouch and 
stomach prior to deep sedation provided optimal operating conditions, whilst 
minimising the aspiration risk and maintaining oxygenation. The low rate of 
hypoxia is reassuring and may be attributable to the use of HFNOT, which delivers 
100% oxygen up to a rate of 60L/min. 
Optiflowä (Fisher and Paykel Healthcare) is a system which delivers heated (up 
to 37oC), humidified oxygen at flow rates up to 60L/min, via wide bore nasal 
cannulae. It provides up to 100% Fio2 and can deliver low levels of positive 
pressure, preventing alveolar collapse and atelectasis. Using higher gas flow rates, 
higher airway pressures can be generated with the mouth closed.9 It has been 
used to treat respiratory failure in intensive care and emergency departments,10 
and in anaesthesia for preoxygenation and for procedures requiring apnoeic 
oxygenation. It is thought that its ability to flush out the anatomical dead space 
and aid gaseous mixing through continuous gas insufflation and positive airway 
pressures facilitates both oxgyenation but also carbon dioxide clearance.11 These 
effects are particularly beneficial during deep sedation to keep patients still 
for flexible endoscopic septal division (FESD), when ventilatory efforts may be 
somewhat suppressed. It has also been shown to improve Pao2 levels both during 
and after procedures (7). 
Endotherapy within the hypopharynx can be challenging due to the limited 
operating space. Although FESD may be performed without GA, patients suffering 
from ZD are often elderly with multiple comorbidities. Procedures requiring 
FESD require deep sedation, which can pose significant anaesthetic challenges. 
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A meta-analysis on the efficacy and safety of FESD included 20 studies with 
anaesthetic techniques comprising GA, deep sedation without tracheal intubation 
and moderate (conscious) sedation (12). Procedures performed under GA had 
relatively higher complication rates of bleeding, fever and perforation (13-
15), whereas studies involving conscious sedation appeared to report a higher 
incidence of subcutaneous emphysema, bleeding, pneumonia and perforation 
with mediastinitis and sepsis (16-19). It is possible that the observed differences 
in GA complication profiles may be due to endotracheal intubation which may 
limit the view and operating space during hypophayngeal procedures. Conversely, 
under conscious sedation, the patient may move unexpectedly in response to 
noxious stimuli, thus predisposing to procedure-related complications. The 
use of deep sedation, with additional HFNOT combines the advantages of both 
techniques. 
There is ongoing debate on the balance of safety and feasibility of propofol sedation 
and who should administer sedation to these patients (20). In the UK, propofol 
sedation is undertaken by anaesthetists. Sedative agents work synergistically, with 
a narrow therapeutic window. One study of 799 patients investigating sedation 
related complications with propofol for advanced endoscopic procedures, showed 
that rates of hypoxaemia can be as high as 12.8%, with 0.6% of procedures being 
terminated due to adverse effects (5). Another study comparing midazolam to 
propofol sedation in ERCP showed more patients desaturated and one required 
bag mask ventilation in the propofol group.21 Unlike this study, others which 
investigate deep sedation may exclude high risk patients (ASA III or IV), which is 
associated with significantly higher rates of hypoxia and hypotension (22). The Joint 
Royal Colleges of Anaesthetists (RCoA) and British Society of Gastroenterologists 
(BSG) Working Party advocates the involvement of an anaesthetist for complex 
upper GI procedures (20). 
Our study and approach had several limitations, principally the lack of a 
comparison arm. Due to the frailty of some participants, they would not have been 
eligible for randomisation into a GA arm, owing to selection bias. As such, our data 
provides real-world data for a higher risk population. Next, procedural difficulties 
owing to HFNOT should be mentioned. There were difficulties in positioning 
the nasal prongs whilst the patient was in the left lateral position. We were also 
unable to provide capnography to monitor the respiratory rate, airway patency 
and end tidal CO2 measurements. Instead, we had to use transthoracic impedance 
to record the respiratory rate and clinical vigilance to monitor airway patency. 
Finally, this was a single operator study involving a small sample size. However, ZD 
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is rare with prevalence of 0.01-0.11% and at present, our centre is the only centre 
in the UK to use HFNOT with FESD. 
In conclusion, our study demonstrates that a two-stage sedation technique, along 
with the use of HFNOT for ZD repair using a flexible endoscope is both safe and 
effective. Anaesthetic complications were transient, predictable and responded 
to first line treatment. This HFNOT technique allows deep sedation without the 
need for invasive ventilation, which may enable therapy in patients who would 
otherwise be unsuitable for other techniques. Moreover, use of HFNOT can 
preserve the operating space within the hypopharynx, which has the potential to 
mitigate the risk of post-procedural complications as seen in other studies. The key 
to the success of this technique is due to team work of an experienced anaesthetist 




1. Ishaq S, Sultan H, Siau K, Kuwai T, Mulder CJ, Neumann H. New and emerging techniques for 
endoscopic treatment of Zenker’s diverticulum: State-of-the-art review. Dig Endosc 2018; 
30: 449-60
2. Ashman A, Dale OT, Baldwin DL. Management of isolated cricopharyngeal dysfunction: 
systematic review. J Laryngol Otol 2016; 130: 611-5
3. Horiuchi A, Nakayama Y, Hidaka N, Ichise Y, Kajiyama M, Tanaka N. Low-Dose Propofol 
Sedation for Diagnostic Esophagogastroduodenoscopy: Results in 10,662 Adults. Am J 
Gastroenterol 2009; 104: 1650–5
4. Kuwata NY, Gotoda T, Suzuki S, Mukai S, Itoi T, Moriyasu F. Reasonable decision of anesthesia 
methods in patients who underwent endoscopic submucosal dissection for superficial 
esophageal carcinoma: A retrospective analysis in a single Japanese institution. Turkish J 
Gastroenterol 2016; 27: 91–6 
5. Coté GA, Hovis RM, Ansstas MA, et al. Incidence of Sedation-Related Complications With 
Propofol Use During Advanced Endoscopic Procedures. Clin Gastroenterol Hepatol 2010; 8: 
137–42
6. Tam K, Jeffery C, Sung CK. Surgical Management of Supraglottic Stenosis Using Intubationless 
Optiflow. Ann Otol Rhinol Laryngol 2017; 126: 669-72
7. Lucangelo U, Vassallo FG, Marras E, et al. High-Flow Nasal Interface Improves Oxygenation 
in Patients Undergoing Bronchoscopy. Crit Care Res Pract 2012; 2012: 506382
8. Blayney MR. Procedural sedation for adult patients: an overview. Contin Educ Anaesth Crit 
Care Pain; 2012; 12: 176–80
9. Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified high-flow oxygen 
system, using oxygraphy, capnography and measurement of upper airway pressures. 
Anaesth Intensive Care 2011; 39: 1103-1110
10. Parke RL, McGuiness SP, Eccleston ML. A Preliminary Randomized Controlled Trial to Assess 
Effectiveness of Nasal High-Flow Oxygen in Intensive Care Patients. Respiratory Care 2011; 
56: 265-270.
11.  Patel A, Nouraei SAR. Transnasal Humidified Rapid Insufflation Ventilatory Exchange 
(THRIVE): a physiological method of increasing apnoea time in patients with difficult 
airways. Anaesthesia 2015; 70: 323-329
12. Ishaq S, Hassan C, Antonello A, et al. Flexible endoscopic treatment for Zenker’s diverticulum: 
a systematic review and meta-analysis. Gastrointest Endosc 2016; 83: 1076-89.e5
13. Laquiere A, Grandval P, Arpurt JP, et al. Interest of submucosal dissection knife for endoscopic 
treatment of Zenker’s diverticulum. Surg Endosc 2015; 29: 2802-10
14. Costamagna G, Iacopini F, Bizzotto A, et al. Prognostic variables for the clinical success of 
flexible endoscopic septotomy of Zenker’s diverticulum. Gastrointest Endosc 2016; 83: 765-73
15. Pescarus R, Shlomovitz E, Sharata AM, et al. Trans-oral cricomyotomy using a flexible 
endoscope: technique and clinical outcomes. Surg Endosc 2016; 30: 1784-9
16. Ishioka S, Sakai P, Maluf Filho F, Melo JM. Endoscopic incision of Zenker’s Diverticula. 
Endoscopy 1995; 27: 433-7
17. Hashiba K, de Paula AL, da Silva JGN, et al. Endoscopic treatment of Zenker’s diverticulum. 
Gastrointest Endosc 1999; 49: 93-7
18. Christiaens P, De Roock W, Van Olmen A, Moons V, D’Haens G. Treatment of Zenker’s 
diverticulum through a flexible endoscope with a transparent oblique-end hood attached to 
the tip and a monopolar forceps. Endoscopy 2007; 39: 137-40
19. Rabenstein T, May A, Michel J, et al. Argon plasma coagulation for flexible endoscopic 
Zenker’s diverticulotomy. Endoscopy 2007; 39: 141-5
20. Sidhu R, Turnbull D, Newton M, et al. Deep sedation and anaesthesia in complex 
gastrointestinal endoscopy: a joint position statement endorsed by the British Society of 
Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists 
(RCoA). Frontline Gastroenterol 2019; 10: 141-47
4
101
21. Wehrmann T, Kokabpick S, Lembcke B, Caspary WF, Seifert H. Efficacy and safety of 
intravenous propofol sedation during routine ERCP: a prospective, controlled study. 
Gastrointest Endosc 1999; 49: 677-83
22. Schilling D, Rosenbaum A, Schweizer S, Richter H, Rumstadt B. Sedation with propofol 
for interventional endoscopy by trained nurses in high-risk octogenarians: a prospective, 





Flexible endoscopic treatment 
for Zenker’s diverticulum with the 
SB Knife. Preliminary results from 
a single centre experience
Giorgio Battaglia1, Alessandro Antonello1, Stefano Realdon1, Martina Cesarotto Lisa 
Zanatta2, Sauid Ishaq3,4
1.  High Technology Endoscopy Department, Istituto Oncologico Veneto IRCSS, Padova, 
Italy 
2.  Department of Surgery, Santa Maria del Prato Hospital, Feltre, Italy 
3.  Department of Gastroenterology, Dudley Group Hospitals, Birmingham City 
University, Birmingham, United Kingdom 
4.  Department of Medicine, St. George’s University, Grenada, West Indies 
Dig Endosc. 2015 Nov;27(7):728-33. doi: 10.1111/den.12490. Epub 2015 Jun 26.
104
Abstract 
OBJECTIVE: Flexible endoscopic septum division is becoming a prominent 
treatment option for Zenker’s diverticulum (ZD). Over the years, various techniques 
have been developed and many cutting tools have been tested with varying results. 
We report our experience with a recently designed, monopolar, rotating, scissor 
shaped device (SB knife). METHODS: Data on 31 consecutive patients that underwent 
flexible endoscopic treatment for ZD with the employment of the SB knife were 
retrieved. Dysphagia, regurgitation, and respiratory symptom severity before 
the procedure was graded. Procedure duration, rate of complications, symptom 
changes after the procedure and rate of relapsing patients during follow-up were 
recorded. RESULTS: The procedure was carried out successfully in all patients. The 
median procedure time was 14 minutes. One case of late-onset bleeding developed 
one week after the procedure, and was managed endoscopically. A significant 
symptom improvement was achieved (dysphagia: median score before 3, median 
score after 0, p<.001; regurgitation: median score before 2, median score after 0, 
p<.001; respiratory symptom: median score before 2, median score after 0, p=.009). 
Two patients had mild relapsing symptoms respectively after 4 and 9 months 
from the procedure but refused further treatment. CONCLUSIONS: Endoscopic 
treatment of ZD using this new device is safe and efficient at short term follow up. 
No perforations were observed and there was a substantial reduction of symptoms 
after the treatment. Larger studies are needed to fully assess advantages of this 




Flexible endoscopic septum division is emerging as a safe and effective treatment 
option for Zenker’s diverticulum (ZD). The main hazard of this procedure is the 
risk of perforation, which can occur in up to 27% of patients and can lead to 
potentially lethal adverse events such as mediastinitis and cervical or mediastinal 
emphysema (1-5). 
Sumitomo Bakelite Ltd. has recently commercialized the SB Knife: a scissor shaped, 
rotating device with two insulated monopolar blades designed primarily for ESD. 
(Figure 1). This device was proven to be associated with an improved safety profile 
for ESD in comparison to other devices (6-8). 
The SB Knife has already been tested as a cutting tool for flexible endoscopic 
treatment of ZD in a small number of patients with promising results; data on 
follow up and symptoms relief are however lacking (9). The aim of this study is 
to review our experience in order to assess the efficacy, safety and outcome of 
flexible endoscopic treatment of ZD with the SB Knife.
Figure 1: A photograph of the SB-Knife (Sumitomo-Bakelite ltd., Tokio, Japan). The device features two monopolar 
blades insulated both externally and on the tip. The device is capable of effortless 360° rotation, thus enabling 
a quick and precise positioning over the diverticular septum
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Methods
Ethical considerations and patients
This is a retrospective review of the outcome of a routinely performed procedure 
at our Department, with no changes in the standard of treatment and follow-up 
protocol. All patients were informed on the technical aspects of the procedure. 
Informed consent for the procedure and data collection was obtained from all 
patients. Data for this study was collected retrospectively hence ethical Committee 
approval was not required according to local regulations.
Data on 31 patients with ZD consecutively treated at our Department between March 
2013 and November 2014 was collected. Data on type of symptom before treatment 
and on every follow up was routinely recorded as per our protocol, and was collected 
from the electronic medical records of the patients. Dysphagia was graded with the 
Dakkak and Bennett scale, while regurgitation and respiratory symptoms (cough and 
aspiration) with a numeric analogue scales (NAS) (Table 1) (10). All patients underwent 
an esophagram before the procedure (Figure 2). Diverticula were divided in small 
(less than 2 cm of length), medium (between 2 and 4 cm) and large (more than 4 cm) 
using the Morton and Bartley classification (11).
Figure 2: An esophagram taken before (A) and after the procedure (B) in a patient with a large Zenker’s 
diverticulum (8 cm). The amount of contrast medium retained in the diverticular pouch after swallowing is 




The procedures were performed under deep sedation with a continuous infusion of 
Propofol. IV Fentanyl citrate was used for analgesia, no prophylactic antibiotics were 
administered. A 9.9 mm diameter endoscope (GIF-H180J; Olympus, Tokyo, Japan) 
was used. A duck-bill diverticuloscope (ZDO-22-30; Cook Endoscopy, Winston-
Salem, North Carolina) was positioned under direct vision to expose and straddle the 
diverticular septum. Two parallel incisions were performed to dissect mucosa and 
the horizontal fibers of the cricopharyngeal muscle with the SB-Knife (Sumitomo 
Bakelite, Tokyo, Japan), and a monopolar snare was used to remove the portion of 
the septum in between. Endocut currents were employed throughout the procedure 
(VIO 200 D; ERBE Electromedizin, Tübingen, Germany). The depth of the incision 
was variable from patient to patient depending on the size of diverticulum, and was 
balanced to achieve a near complete CP myotomy but without risking perforation. 
Two to three clips (Clip HX-610-090L; Olympus, Tokyo, Japan) were deployed at the 
site of the incision to prevent mucosal dissection and perforation (Figure 3). After the 
procedure patients received IV acetaminophen and PPI. 
Figure 3: Endoscopic septum division using the SB Knife. From left to right: after the diverticuloscope is 
positioned the SB knife is used to perform the first incision on the septum; the second incision is performed; a 
monopolar snare is used to remove the remaining septum between the incisions; fully divided septum; two clips 
are positioned at the bottom of the incision.
Post procedure esophagrams were carried out to rule out perforation and assess 
esophageal transit. If no adverse events occurred, patients were allowed liquids 
and discharged day after the procedure and instructed to have soft diet for the 
first week. All patients were contacted 7 days after the procedure and reviewed in 
our outpatient clinic at 2 months to assess their symptoms. Afterwards patients 
were contacted at 6 months intervals, and were advised to contact us if symptoms 
relapsed as well. Adverse events were graded according to the classification by 
Cotton et al 12).
Outcome parameters and statistics
Outcome was evaluated in terms of rate of adverse events, duration of the 
procedure, symptom improvement and hospital stay. Descriptive statistics was 
expressed as median, interquartile range (IQR) and range for continuous variables, 
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and the scores were considered as continuous variables. The differences between 
the scores before and after the procedure were assessed with a Mann-Whitney 
U-test, and a P value < .05 was considered statistically significant.
Results
Demographic and clinical informations of the patients are summarized in Table 2. 
According to the Morton and Barley classification 7 diverticula were small, 13 were 
medium and 11 were large. 
All procedures were carried out successfully and without adverse events. The median 
duration of the procedure (i.e. the time between overtube positioning and retrieval) 
was 14 minutes (IQR 4, range 11-23). All patients stayed in hospital for 2 days.
One patient had an episode of melena one week after the procedure: endoscopy 
revealed a small ulcer with stigmata of recent bleeding on the remaining 
septum. The patient was admitted, and the lesion was successfully treated with a 
combination of polidocanol injection and a clip. Bleeding was however limited: the 
patient had no systemic symptoms nor required blood transfusions. The patient 




The follow up at 2 months after the procedure revealed that 26 patients (83.9%) 
were symptom-free. There was a significant improvement of dysphagia (median 
score before 3, median score after 0, p<.001), regurgitation (median score before 
2, median score after 0, p<.001), and respiratory symptom score (median score 
before 2, median score after 0, p=.009) (Table 3). Five patients (19.3%) had residual 
symptoms after the procedure. Among them, 3 declined further treatments since 
they were able to eat soft diet with ease, and the remaing 2 underwent an additional 
treatment. The second treatment was carried out without any adverse events, and 
resulted in a complete symptom remission in both patients.
The median follow up was 7 months (IQR 9, range 2-18). Two patients (6.5%) 
reported relapse of symptom respectively at 4 and 9 months from the procedure. 
One reported mild symptoms (occasional bouts of regurgitation graded 1 on the 
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NAS scale) and declined further treatment, while the other reported more 
pronounced symptoms (dysphagia graded 2 on the Dakkak scale and regurgitation 
graded 1 on the NAS scale), albeit still improved from before the first treatment. 
The latter patient underwent a further treatment session that was carried out as 
per protocol, without adverse events, and resulted in complete symptom 
remission. The overall outcome of the procedure is summarized in Figure 4. At the 
end of follow up stable symptom remission was achieved in 27 patients (87.1%) and 
stable symptom improvement in 4 (12.9%).
Figure 4: Flow-chart of the overall outcome of the procedure.
Discussion
Endoscopic treatment of zenker diverticulum is evolving. New devices and 
technique to reduce procedure time and reduce complication are important to 
refine this procedure and make this a safer option. The usefulness of scissor-
shaped devices for the treatment of ZD has undergone a limited evaluation to this 
date. This is the first series reporting the use of a scissor shaped device for such 
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procedure.. The technical advantages of such devices in the treatment of ZD have 
been explored by Rieder et al on an animal model, and the only data on human 
subjects is reported in the preliminary experience by Ramchandrani et al with the 
same device used in our series (9-13). However, data on follow up and symptom 
relief is still lacking.
Ours is the first study that evaluated the feasibility, efficacy and safety of ZD 
endotherapy using the SB knife. Our results are comparable to other published 
series of flexible endotherapy for ZD in terms of efficacy and mid-term results 
(14-19).
The SB-knife used in our study has three significant advantages over other cutting 
devices. First, with the SB knife the incision is carried out with a scissor-like 
movement, and the muscular fibers can be pulled towards the endoscope whilst 
cutting. This allows a precise control on the depth of the incision, thus avoiding 
the risk of unwanted deep incisions that can potentialy lead to a perforation. A 
recent study by Repici et al has outlined the usefulness of pulling muscular fibers 
rather than pushing them away from the endoscope during cutting (14).
Second, the shape of the device and its capability of 360° rotation on its axis allow 
an easy and precise positioning on the septum. This enabled us to perform the 
two incisions required for our innovative technique with ease. Moreover, the ease 
of positioning the device on the septum allowed for a reduced procedure time as 
well. An average procedure time of 10 minutes was reported by Ramchandrani et 
al 9. In our series a median procdeure time was 15 minutes despite the fact that our 
double incision technique increases the duration of the procedure irrespective 
of type of device used. Short procedure time makes it safer in elderly patients 
who frequently have cardiological and pulmonary comorbidities that can make 
prolonged sedation hazardous. Third, its ability to coagulate without the need to 
change device allows for quick cautery of minor bleeding that can occur during 
the procedure. 
There are two available models of the SB-knife. In our study the short-type was 
used since, in our opinion, it has an increased precision while cutting the septum 
and allows a better mobility within the limited space of the diverticuloscope.
In our series one treatment session resulted in complete resolution of symptoms 
in 83.9% of treated patients. There was no perforation. Persisting symptoms were 
observed in 5 patients and 2 had relapsing symptoms. This, in our opinion, is 
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likely to be due to an incomplete division of CP fibers. We believe it is safer to 
carry out additional teatment in patients who relapse or have partial response as 
attempting a complete division of the septum in the first session can run a high 
risk of perforation.
Moreover, persistence/recurrence should not be strictly viewed a failure: at the 
end of follow-up, all patients in our series were either symptom free or satisfied 
with the results and refused additional treatment.
Our study has two limitations: a small number of patients and a limited follow up. 
Our limited sample size, however, did not reveal a high rate of adverse events that 
would have raised concern over the safety of the SB knife for this treatment.
In our series there was one adverse event in 31 patients (3.2%): a case of late onset 
bleeding. Further studies are needed to assess whether this was an accidental 
occurrence or a real risk associated with this technique. Nevertheless, the rate 
of adverse events encountered in our series was low, and comparable with other 
series on flexible endotherapy for ZD.
The limited follow up duration of our series did not allow us to draw conclusions 
over the long term outcome of the procedure. However, flexible endoscopic 
septum division is a well documented procedure and long term outcomes have 
been extensively investigated. Albeit limited, the follow-up duration of our 
experience showed at a favourable outcome in symptoms control and recurrence 
and did not reveal any obvious impairment of the outcome that could be related 
with the use of the SB knife. 
In conclusion flexible endotherapy of ZD using the SB knife is feasible, safe and 
effective. . The unique design of the SB knife allows pulling of the CP whilst 
performing incision, and allows precise cutting of the septum. This enabled us to 
employ the novel technique of double incision and snare with ease. It is minimally 
invasive and has a low rate of adverse events, comparable with most published 
series 1. Larger prospective studies and comparison trials are required to fully 
evaluate and compare the use of SB-Knife in ZD treatment with more established 
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Abstract
BACKGROUND:Currently there are three main treatment options forZenker’s 
diverticulum (ZD): surgery, rigid endoscopy and flexible endoscopy. After primary 
success, recurrence can be as high as 19% for surgery, 12.8% for rigid endoscopy and 
20% for flexible endoscopy. Flexible endoscopy may represent an ideal treatment 
option for recurring ZD. The aims of this paper are to evaluate the efficacy and 
safety of flexible endotherapy for recurring ZD after surgery and/or endoscopic 
stapling and to compare the treatment outcome between naive and recurring 
patients. METHODS:Data on patients that underwent flexible endotherapy for 
ZD between January 2010 and January 2015 were collected. Patients were divided 
into those with recurrences after surgery and/or endoscopic stapling and those 
who did not have previous treatments. Dysphagia, regurgitation, and respiratory 
symptom severity before the procedure were graded. The outcome parameters 
were: complications, symptom improvement after the first treatment, number 
of treatment sessions, rate of complete remission and relapses. These parameters 
were then compared between patients’ groups. RESULTS:Twenty-five recurring 
patients were included. Treatment was carried out successfully in all patients. Two 
adverse events occurred; they were successfully managed conservatively. After 
the first treatment, there was a significant reduction in dysphagia, regurgitation 
and respiratory symptoms scores. The median number of treatments was 1 (IQR 
0.25, range 1-3): symptom remission was achieved in 84% patients and partial 
improvement in 16%. Relapsing symptoms occurred in 20% patients; they were 
successfully managed with an additional treatment session. Results were compared 
with data on 34 consecutive naive patients treated within the same time span; no 
differences of the outcome parameters were revealed. CONCLUSIONS:Flexible 
endotherapy for ZD recurrences after surgery and endoscopic stapling appears to 
be safe and effective, and its efficacy and safety profile seems to be comparable 




Zenker’s diverticulum (ZD) is an outpouching of mucosa and submucosa that 
develops in an area of weakness of the lower posterior hypopharynx known as 
Killian’s triangle. It has an estimated prevalence between 0.01% and 0.11% of the 
general population, and it develops mainly in elderly males (1, 2). Its pathogenesis 
is still poorly defined: it is believed, however, that increased intraluminal pressure 
in conjunction with an impaired relaxation of the upper esophageal sphincter 
play a pivotal role in promoting the herniation of mucosa and submucosa through 
Killian’s triangle (3).
The main symptoms attributable to ZD are dysphagia, regurgitation and cough/
aspiration, although it can be responsible of more severe but rare complications 
such as aspiration pneumonia, weight loss, fistulization, bleeding, and vocal cords 
paralysis (1-3).
Currently there are three main treatment options for ZD: open surgery 
(i.e. transcervical diverticulectomy / diverticulopexy with myotomy of the 
cricopharyngeal muscle), rigid endoscopy (i.e. endoscopic stapling or CO2 laser 
treatment) and flexible endoscopy. All treatment options have a satisfactory 
success rate (80-100% for surgery, 90-100% for rigid endoscopy and 43-100% for 
flexible endoscopy), but symptom recurrence can be as high as 19% for surgery, 
12.8% for rigid endoscopy and 20% for flexible endoscopy (4-8). In addition 
surgery is associated with significant morbidity and mortality rates, which can be 
as high as 30% (vs 3% for rigid endoscopy and 1.5% for flexible endoscopy) and 3% 
respectively (9,-11). 
Treatment of recurrences after surgery or endoscopic stapling can be technically 
challenging. Endoscopic stapling of small residual pouches poses some issues: an 
adequate bite of the common wall between the diverticulum and the esophagus 
cannot be achieved in a significant number of patients, and a higher risk of 
perforation is encountered when small pouches are stapled (12-14). Moreover, 
the staple over staple effect may lead to unpredictable scarring and fibrosis that 
can lead to persisting dysphagia despite an apparent success of the procedure 
(16). Moreover surgery, while being potentially applicable regardless of the size 
of the diverticulum, is an invasive procedure and aging patients may not be fit for 
repeated surgery due to associated comorbidities.
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Flexible endoscopy may represent an optimal treatment option for patients 
relapsing after either surgery or endoscopic stapling. This approach can be 
effectively used to treat small diverticuli and does not require general anesthesia 
or neck hyperextension. In addition, flexible endoscopic treatment allows 
shorter procedure time and a reduced hospital stay. These characteristics make 
this approach ideal for elderly patients with comorbidities or patients with small 
residual pouches that may not always be suitable for surgery or endoscopic 
stapling. Whilst many published series on flexible endoscopic treatment for ZD 
quote successful treatment of relapsing patients after surgery or rigid endoscopic 
treatment, there is actually no data on the outcome of the procedure for this 
specific subset of patients (17-22).
The primary aim of this study is to evaluate our experience with flexible endoscopic 
treatment of ZD in patients with recurrences after surgery or endoscopic stapling. 
The secondary aim is to compare the outcomes of treatment carried out in naïve 
patients (i.e. patients that did not have previous treatments for ZD) and those 
treated for a recurrence.
Material and methods
Patients and ethics considerations
We retrospectively evaluated data on patients that underwent flexible endoscopic 
septum division for a symptomatic ZD at our Department from January 2010 to 
January 2015 and fulfilled inclusion and exclusion criteria (Table 1). Patients 
were thoroughly informed of the aims and nature of the procedure and written 
informed consent for the procedure and data collection was obtained. This study 
was carried out according to the principles of the Declaration of Helsinki and of 
good clinical practice. Data was collected retrospectively hence ethics committee 
approval was not required, according to local regulations.
Table 1: inclusion and exclusion criteria.
Inclusion criteria
Follow-up of at least 6 months
Exclusion criteria
Previous flexible endoscopic treatment for ZD at another Institution
Presence of gastroesophageal reflux 
Presence of psychiatric comorbidities
6
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Demographic and clinical information were collected, and patients were 
subsequently divided in those who underwent previous treatments (either 
surgery or endoscopic stapling) and those who did not. Before the procedure 
and on every follow up dysphagia was measured with the Dakkak and Bennett 
scale and regurgitation and respiratory symptoms with a numeric analogue scale 
(NAS) (Table 2) (24). All patients underwent a barium esophagography prior the 
procedure to characterise the diverticulum. Morton and Bartley classification 
used to measure the size of diverticula 2.
Table 2: symptoms scoring used in the study
Dysphagia score (Dakkak and Bennett) 21
No dysphagia 0
Dysphagia with solid foods 1
Dysphagia with semi-solid foods 2
Dysphagia with liquid foods 3
Total dysphagia/unable to eat 4
Regurgitation score (numeric analogue score)
No regurgitation 0
Less than once a week 1
More than once a week, less than once a day 2
Once a day 3
Multiple times every day 4
Respiratory symptoms score (numeric analogue scale)
No symptoms 0
Less than once a week 1
More than once a week, less than once a day 2
Once a day 3
Multiple times every day 4
Endoscopic procedure
All procedures were performed under deep sedation with a continuous infusion of 
Propofol. Fentanyl citrate was used for analgesia. A 9.9 mm endoscope (GIF-H180J; 
Olympus, Tokyo, Japan) was carefully introduced until the diverticulum was 
visualized. With the guidance of the endoscope a soft duck bill diverticuloscope 
(ZDO-22-30; Cook Medical, Winston-Salem, North Carolina) was introduced to 
expose and straddle the diverticular septum. As per our standard protocol, if the 
horizontal length of septum was 2 cm or less, a single incision along the midline of 
the septum was carried out to dissect mucosa and fibers of cricopharyngeal muscle 
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(CP). In case of larger diverticula (with a septum length > than 2 cm) two parallel 
incisions approximately 1cm deep were performed and a monopolar snare was 
used to remove the part of septum in between. One to three clips were then placed 
at the bottom of the incision to prevent mucosal dissection from underlying muscle 
and perforation. The depth of the incisions was balanced in order to achieve a near 
complete horizontal CP myotomy without excessive risk of perforation. After the 
procedure PPI, analgesics and antiemetics were administered. Routine antibiotic 
prophylaxis was not used.
Post procedure esophagrams were carried out to rule out perforation and to assess 
esophageal transit on the day of the procedure. Inflammation markers (CRP and 
WBC) were measured on blood samples 6, 12 and 24 hours from the procedure. The 
patients were allowed liquids on day 2 and were discharged if no adverse events 
occurred and the esophagrams excluded the perforations. They were instructed 
to have a soft/liquid diet for the first week after the procedure. Patients were then 
contacted via telephone 7 days from the procedure to assess their conditions, and 
were assessed at our Outpatient Clinic 2 months from the procedure.
Afterwards Patients were contacted via telephone at 6 months intervals to assess 
their symptoms and to plan additional treatments in case of relapses.
Outcome parameters and statistics
Descriptive statistics was expressed as median, interquartile range (IQR) and range 
for continuous variables, and the scores were considered as continuous variables. 
The outcome parameters used in this study are: rate of complications, symptom 
improvement after the first treatment, number of treatments required to achieve 
remission, rate of complete symptom remission after a treatment and rate of relapse. 
Complications were graded with the classification by Cotton et al 26. A relapse 
was defined as a symptom recurrence after complete remission or as a symptom 
worsening after partial remission. The Pearson’s Chi square test or Fisher’s exact test, 
if appropriate, were used for categorical variables and the Mann Whitney U-test was 
used for continuous variables. The same test was used to determine score differences 
before and after treatment. A p value <.05 was considered as statistically significant. 




Between January 2010 and January 2015, 69 consecutive patients underwent 
flexible endoscopic septum division. After checking for inclusion and exclusion 
criteria a total of 59 patients were included in the study. Among them, 25 had 
previous treatments at other Institutions (17 endoscopic stapling, 8 surgeries). 
Demographic and clinical information are summarized in Table 3. No significant 
differences in terms of sex, age, diverticulum size and symptoms scores were 
observed between both patient groups.
Table 3: demographic and clinical information of patients included in the study.
Naïve patients (n=34) Patients with recurrences (n=25) P value
Age: median (IQR, range) 71 (12, 48-88) 68 (11, 48-85) .51
Sex: M:F 22:12 20:5
Diverticulum depth (mm): median, IQR, range * 20 (13, 10-54) 22 (19, 10-44) .68











Dysphagia: n (%) 30 (88.2%) 22 (88%) .99
Dysphagia score: median (IQR, range) 2 (1, 0-3) 2 (1, 0-3) .37
Regurgitation: n (%) 31 (91.2%) 19 (76%) .15
Regurgitation score: median (IQR, range) 2 (2, 0-4) 2 (2, 0-4) .92
Respiratory symptoms: n (%) ** 16 (47.1%) 9 (36%) .43
Respiratory symptoms score: median (IQR, range) 0 (1, 0-3) 0 (1,0-4) .51
*The depth of the ZD was measured on radiographic views the distance from the top of the septum to the bottom of the pouch.
**Chronic cough, aspiration, pneumonia.
Outcome of flexible endoscopic treatment of recurring ZD 
Double incision technique was used in 18 patients (72%), while in the remaining 7 
(28%) single incision technique was used. Treatment was carried out successfully in 
all patients. The Needle Knife (Cook Medical, Winston-Salem, North Carolina) was 
used in 6 patients, the Hook Knife (Olympus, Tokyo, Japan) in 9 and the SB Knife 
(Sumitomo-Bakelite, Tokyo, Japan) in 15. Peri-procedural complications developed 
in 2 patients (8%): one micro perforation (i.e. not visible during endoscopy but 
revealed by the post-procedural esophagram) and one case of moderate bleeding. 
The micro perforation was treated conservatively by keeping the patient NPO and 
treated with intravenous broad spectrum antibiotics and parenteral nutrition. An 
esophagram carried out 7 days after the procedure revealed a complete healing of 
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the perforation, and the patient was discharged the day after. The bleeding was 
successfully stopped by using hemostatic forceps (Coagrasper; Olympus, Tokyo, 
Japan). The patient did not require blood transfusions. The patient was kept NPO 
and under observation for 48 hours and then discharged. 
After the first treatment there was a significant reduction of dysphagia (p<.01), 
regurgitation (p<.01) and respiratory symptom scores (p<.01) (Table 4). Eleven 
patients, despite improvement, had residual symptoms. Among them, 7 underwent 
further treatment session resulting in symptom remission in all, and 3 declined 
further treatment. The median number of treatment sessions was 1 (IQR 0.25; 
range 1-3): symptom remission was achieved in 21 patients (84%), while 4 (16%) had 
a substantial symptom improvement: they were able to have an almost free diet 
hence declined further treatment. The median follow-up duration was 18 months 
(IQR 29, range 6-58). Five patients had recurrence of symptoms after flexible 
endoscopic treatment (median time of recurrence 17 months, IQR 12, range 6-42), 
successfully treated with an additional treatment, without any complications.The 
overall outcome of the procedure is summarized in Figure 1.
Table 4: symptom improvement after the first treatment for patients with relapsing ZD.
Score before Score after p
Dysphagia 2 (1, 0-3) 0(0, 0-1) <.01
Regurgitation 2 (2, 0-4) 0(0, 0-1) <.01
Respiratory symptoms 0 (1,0-4) 0(0, 0-2) <.01
Table 5: differences of outcome parameters between patient groups.
Naïve patients (n=34) Patients with recurrences (n=25) P value
Complications: n (%) 3 (8.8%) 2 (8%) .99
Patients requiring >1 treatment: n (%) 6 (17.5%) 7 (28%) .36
Remission: n (%) 28 (82.3%) 21 (84%) .99
Relapses: n (%) 5 (14.7%) 6 (24%) .50
Comparison of outcomes between naïve patient and patients with 
recurring ZD
No differences were found in terms of technique used (p=.99) or devices employed 
(p=.11) between patient groups. No significant differences were found in terms of 
rate of complications (p=.99), patients requiring extra treatments (p=.36), rate of 
remissions (p=.99) and rate of relapses (p=.50) between patient groups (Table 5,6). 
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Figure 1:  Overall outcome of flexible endoscopic septum division in patients relapsing from surgery or 
endoscopic stapling.
Table 6: Differences of outcome parameters between patient groups
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Discussion
There is limited published evidence on the outcome of treatment of ZD relapses 
after surgery and endoscopic stapling. Studies on the outcome of surgery and/or 
rigid endoscopic treatment for ZD relapses have been published in the past (11-15). 
Both treatment options appear to be safe and effective. However, data on either 
follow-up or symptom relief is lacking.
Flexible endoscopic treatment has, however, many significant advantages in 
comparison to surgery and rigid endoscopic treatment. It is minimally invasive, 
does not require general anesthesia in most patients and can be repeated without 
additional risk. In addition, it is effective in treating small diverticular pouch that 
may not be easily accessible with surgical or and endoscopic stapling techniques. 
This is the first series of patients treated with flexible endoscopic septum division 
for relapsing symptoms after ZD surgery or endoscopic stapling. All treated 
patients had a significant symptom improvement. Complete symptom relief was 
achieved in 84% of them. The occurrence of complication was relatively low, and 
no major, life threatening complications occurred. During follow-up, relapses 
occurred in 5 patients after a median of 17 months. All relapsing patients were 
successfully treated with an additional treatment session, and remained symptom-
free throughout the follow up period. 
The efficacy and safety profile of flexible endoscopic septum division appear to be 
comparable between naive and relapsing patients, with no significant differences 
in terms of complications, symptom remission, relapses requiring additional 
treatment (Table 5). An interesting observation was that patients who relapsed 
after surgery/stapling, required more flexible endotherapy sessions in order to 
achieve symptom remission when compared with naive patients, although this did 
not reach statistical significance. This can be partially explained by the relatively 
limited sample size, but another plausible explanation could be that, due to 
fibrosis and scarring from previous treatment, persisting ZD may be more resilient 
to septum division. The overall outcome of the procedure was however good, and 
all relapses were treated successfully. Hence previous surgery and/or endoscopic 
stapling should not be viewed as a contraindication for flexible endoscopic septum 
division in patients with ZD. 
6
125
Our results are comparable with other series of patients treated for ZD relapses 
with surgery and/or stapling in terms of success, efficacy and safety alike (16-21). 
However, flexible endoscopy has significant advantages over other treatment 
options: it is the least invasive option, can be repeated in case of further relapses, 
and does not pose increased technical challenge in patients who underwent 
surgery and/or endoscopic stapling beforehand.
In our series, we encountered no significant differences of the size of the 
diverticular pouch between naive and relapsing patients. This can be explained 
by the limited sample size of our series, and another plausible explanation could 
be the fact that patients previously treated with endoscopic stapling accounted 
for the majority of relapsing patients (68 %). On contrary to surgery, the core 
technique of endoscopic stapling is the transection of the diverticular septum; 
hence, there is no change in the actual size of the diverticular pouch. Hence, 
patients relapsing after endoscopic stapling treatment is likely to have diverticular 
pouches comparable, in terms of size, to naive patients. The main limitations of 
our study are the limited sample size and relatively short follow-up. The relatively 
limited follow-up of our series could potentially have prevented the detection of 
additional relapses after flexible endoscopic treatment and of secondary relapses 
(i.e., further relapses after a first relapse).
Conclusion. This is the first study with the largest number of patients to evaluate 
flexible endoscopic treatment of ZD with recurrence after surgery and endoscopic 
stapling that also compared the outcome with the naive patients (i.e., patients 
that did not have previous treatments for ZD). Our results clearly suggest that 
the flexible endotherapy is a safe, feasible and efficient treatment in patient 
with recurrence after surgery or rigid endoscopic stapling. Based on our result 
and experience, we propose flexible endotherapy should be considered as first 
line treatment in patients with ZD who relapse after surgery. Larger prospective 
studies with longer follow-ups are required to fully evaluate this treatment option 
for patients with relapsing ZD.
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Abstract
Objectives: Flexible endoscopic septum division is an established treatment for 
Zenker’s diverticulum (ZD); however, long-term outcome data are lacking. We 
aimed to evaluate the long-term efficacy of flexible endoscopic septal division 
using the stag beetle knife for Zenker’s diverticulum and identify predictors of 
symptom recurrence. 
Methods: Patients undergoing the procedure between 2013 and 2018 were 
prospectively enrolled. Procedures were performed by a single operator. 
Symptom severity pre- and post-procedure was recorded using the Dysphagia, 
Regurgitation, Complications scale. Symptom recurrence was defined as a total 
score >1 after the index procedure. Time-to-event analyses were performed using 
Kaplan-Meier plots, with multivariable analyses performed using Cox-regression 
models. 
Results:Altogether, 65 patients (mean age 74.0 years, 60% male) were included. 
Previous stapling had been performed in 44.6% of patients. Over the mean post-
treatment follow-up period of 19 months, 5.6% of the treatment naïve group and 
34.5% of the recurrent group underwent repeat FESD (P=0.003), with rates of 
symptom remission and improvement of 75.4% and 92.7% respectively. Recurrence 
at 48 months was higher in patients with recurrent Zenker’s diverticulum (84.7%) 
than in treatment-naïve patients (10.7%). On multivariable analysis, recurrent 
disease (hazard ratio [HR] 20.8, P=0.005) and younger age (HR 0.96 per year, 
P=0.047) were associated with symptom recurrence. 
Conclusions:In patients with treatment-naïve Zenker’s diverticulum, flexible 
endoscopic septal division is safe and provides durable symptom remission. 





Zenker’s diverticulum (ZD) arises from herniation of the mucosa and submucosa 
through the posterior pharyngeal wall in an area known as Killian’s triangle (1). 
The condition affects 0.01-0.11% of the population, and is associated with male 
gender and older age (typically 70+ years).2,3 ZD may lead to symptoms including, 
dysphagia and regurgitation, as well as complications such as aspiration and 
weight loss (1). 
The goal of management of ZD is to perform myotomy of the cricopharyngeus (CP) 
muscle. A variety of treatment options exist including surgery, rigid endoscopy, 
and flexible endoscopic septal division (FESD) (4,5). FESD has been shown to be a 
safe and effective alternative to surgery, and can be performed in frailer patients 
in whom general anesthesia or cervical spine hyperextension are contraindicated. 
Since the introduction of the FESD concept in 1995, the technique has been 
modified and a range of cutting devices have been studied, including the needle 
knife, CO2 laser, harmonic scalpel, and more recently the Stag Beetle (SB) knife 
(6-11). The SB knife has the theoretical advantage of increasing the precision of 
incisions by having a 360-degree rotational ability and by cutting with scissor-like 
movements, pulling the muscle fibers towards the endoscope whilst cutting (11). 
Despite the evolution of new techniques and devices, data on the long-term efficacy 
of FESD, particularly in recurrent ZD, are lacking. We aimed to prospectively 
evaluate the durability of symptom improvement after FESD and identify 
predictors of post-FESD recurrence. Additionally, we aimed to test the hypothesis 
that the recently proposed Dysphagia, Regurgitation and Complications (DRC) 
score(11), would be superior to the frequently used Dakkak score (which measures 
dysphagia) for evaluating ZD symptom severity (12). 
Methods
Study design
This retrospective, single-centre observational study reviewed patients undergoing 
FESD for symptomatic ZD. All data were collected prospectively. Consecutive 
procedures performed over the 5-year period between October 2013 and October 
2018 using the SB knife were identified. All patients had dynamic videofluoroscopy 
assessment of the pouch, with measurements of the CP (septum) length. Patients 
were included if they had new diagnoses of ZD (treatment-naïve) or if they had 
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failed therapy with endoscopic stapling (recurrent ZD). Patients were only 
excluded if FESD was not feasible. 
FESD Procedure
All FESD cases were performed by an experienced interventional endoscopist (SI) 
without endotracheal intubation. A transparent hood (Olympus, Tokyo, Japan) was 
used in all cases and a soft diverticuloscope used in only 2 cases. Under anesthetist 
supervision, all patients received deep sedation using propofol +/- remifentanil, with 
non-invasive ventilatory support using high-flow oxygen delivered via the Optiflowä 
nasal cannulae system (Fisher and Paykel Healthcare Limited, Auckland, New 
Zealand). A nasogastric tube was placed after emptying the pouch and gastric fluid 
was aspirated to protect the anterior oesophageal wall. Procedures were performed 
using a 9.8 mm endoscope (EG-2990i; Pentax, Tokyo, Japan) with a transparent cap 
attachment. Upon identification of the CP muscle and pouch, a single incision along 
the midline of the septum (CP muscle) was carried out to dissect the mucosa and 
muscle fibres using the SB junior scissor knife (Sumitomo Bakelite, Japan), which is 
designed to enable precise cutting whilst pulling theCP fibres upwards. One to three 
clips (HX-610-090L; Olympus, Tokyo, Japan) were then placed at the bottom of the 
incision to prevent mucosal dissection from the underlying muscle and perforation. 
Patients were discharged home on the same day unless they were from outside the 
region. They were allowed to have liquids on day two and a soft diet from day three.
Outcomes
The primary outcome was symptom-free remission. Symptoms were measured 
according to the Dysphagia, Regurgitation and Complications (DRC) scale, a 
composite symptom-severity score specific for ZD that ranges from 0-10 (Table 1) 
(11). Remission was defined as a DRC score of ≤1 post-FESD. Secondary outcomes 
included complication rates and symptom improvement, defined as a reduction in 
DRC score of ≥2, or DRC of ≤1 post-FESD. The procedure time and post-procedural 
complication rate were also studied. Outcomes, including symptom ascertainment 
and of the DRC scale, were assessed in all patients immediately post-FESD, and 
routinely at 3, 6, and 12 months post-FESD. Patients were also able to self-report 
symptoms in the case of symptom recurrence. An additional assessment was 
performed via telephone consultation in March 2019. 
Factors analyzed
Covariates of interest included: patient demographics (age and sex), American 
Society of Anesthesiologists (ASA) grade, treatment naïve or recurrent ZD, DRC 
score, and CP muscle length prior to index FESD.
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Table 1: The Dysphagia, Regurgitation and Complication (DRC) score for the measurement of symptom severity 
in Zenker’s Diverticulum.11
Score Dysphagia (D) Regurgitation (R) Complication (C)
0 No dysphagia No regurgitation No complications
1 Dysphagia with normal/
solid diet
More than once a week, less than once a day Recurrent chest infections OR 
unintentional weight loss >5kg over 
last 3 months
2 Dysphagia with soft diet 
(semi solid)
At least once per day Recurrent chest infections and 
unintentional weight loss
3 Dysphagia with fluids Immediately following all meals/drinks
4 Difficulty swallowing saliva Regurgitation resulting in choking or coughing
Ethics approval
The data collected in this retrospective observational study protocol was approved 
by the local ethics committee and Research and Development department (DFT 
dated 6th June 2018). Written consent was obtained from all study participants. 
The study conformed to the provisions of the Declaration of Helsinki. 
Statistical analyses
All continuous variables were subjected to normality testing using the Shapiro-
Wilk test. Categorical comparisons were performed using Fisher’s exact test. 
Comparison of symptom scores pre- and post-FESD were performed using 
Wilcoxon signed rank tests for the overall DRC score, with subgroup analyses 
performed for each subset of the DRC scale. Bivariate correlation analyses of pre-
treatment DRC scores and each subset of DRC was performed using Spearman’s 
rank test to identify the symptom most associated with ZD severity. In order to 
assess durability of therapy, a time-to-event analysis was performed using Kaplan-
Meier plots, with univariable analyses performed using log-rank tests and Cox 
regression. A P-value of <0.10 on univariable analysis was set as the imputation 
threshold for multivariable analysis, which was performed using Cox regression 
via a backward stepwise approach. Statistical analyses were performed using SPSS 
v25 (IMB Corp., Armonk, NY), with p<0.05 indicative of significance throughout.
Results
Baseline Characteristics
Over the study period, 65 patients undergoing FESD with the SB knife were 
included in the analysis. The mean age of this cohort was 74.0 years [standard 
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deviation (SD) 12.0] and a male preponderance (60.0%) was observed. Among our 
cohort, 43.1% were categorized as ASA grade III or IV and 55.4% were treatment 
naïve, with the remainder being referred for recurrent ZD following failed stapling 
treatment. The median CP muscle length was 24 mm [interquartile range (IQR) 17-
30 mm]. The mean number of FESD sessions per patient was 1.4 (SD 0.6). Baseline 
characteristics and the comparisons between treatment naïve and treatment 
recurrence groups are presented in Table 2.
Table 2: Baseline characteristics and comparisons between treatment naïve and treatment recurrent (post-
surgical recurrence) patients. DRC: Dysphagia, Recurrence, Complications scale; ASA: American Society of 
Anesthesiologists.
Treatment Naive Treatment Recurrent p-value
Age (mean) 75.3 (13) 72.5 (10.6) 0.333
Sex Male 16 10 0.415
Female 20 19
Total DRC score (median) 4.5 (3-6.8) 5.0 (4.0-6.5) 0.244





CP length (median) 20.2mm (16.8 – 29.1) 26.5mm (15.9 – 43.6) 0.200
Table 3: Distribution of Zenker’s diverticulum symptom severity scores measured using the Dysphagia, 
Regurgitation and Complications (DRC) scale.
Score Dysphagia (D) Regurgitation (R) Complication (C) DRC Total
0 2 (3.1%) 11 (16.9%) 34 (52.3%) 2-3 13 (20.0%)
1 16 (24.6%) 10 (15.4%) 23 (35.4%) 4 14 (21.5%)
2 23 (35.4%) 8 (12.3%) 8 (12.3%) 5 14 (21.5%)
3 19 (29.2%) 16 (24.6%) - 6-7 18 (27.7%)
4 5 (7.7%) 20 (30.8%) - 8-10 6 (9.2%)
DRC Scale Assessment
Baseline symptom severity scores, as measured using the DRC scale, are presented 
in Table 3. All but 2 patients (96.9%) reported dysphagic symptoms. Bivariate 
correlation analyses between DRC score and its individual subsets (Table 4) 
found regurgitation to be the symptom with strongest correlation with the 
composite DRC score (rho 0.815, P<0.001), compared to complications (rho 0.558, 
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P<0.001) or dysphagia (rho 0.298, P=0.016). Spearman’s coefficients between 
individual symptoms showed non-significant correlations between dysphagia and 
regurgitation (P=0.152) or complications (P=0.525), but a significant correlation 
between regurgitation and complications (rho 0.271, P=0.029).
Table 4: Spearman rank correlations between subset scores of the Dysphagia, Regurgitation and Complications 
(DRC) scale and the total DRC score
Dysphagia 
(D)
















A total of 67 patients were originally referred for FESD. Of these, FESD was 
undertaken in all but 2 patients, giving a feasibility rate of 97.0%. Both patients had 
recurrent ZD; one had failed esophageal intubation and was referred for external 
myotomy, and the other had pouch deviation with inability to access the CP bridge. 
The median FESD procedure time was 20 minutes (IQR 16-25). 
Complications
Intraprocedural complications occurred in 4 patients, giving an overall 
complication rate of 6.2%. Intraprocedural hypoxia developed in 2 patients 
and minor bleeding amenable to hemostasis occurred in 2. No post-procedural 
complications, such as perforation, were identified.
Symptom Remission
The mean follow-up duration was 19.0 months. In total, 75.4% of patients achieved 
symptom remission post-FESD. Kaplan-Meier estimated rates of symptom 
recurrence at 12, 24, 36 and 48 months were 15.0%, 37.9%, 43.1% and 51.2%, 
respectively (Figure 1). The median time from the final planned FESD procedure 
to symptom recurrence was 37.4 months. 
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On univariable analysis, only previous stapling was significantly associated with 
symptom recurrence [hazard ratio (HR) 8.70; 95% CI: 2.0-38.6, P=0.004], while 
age (HR 0.965 per year, 95% CI 0.93-1.00, P=0.059), gender (HR 1.09 for male 
vs. female, 95% CI 0.66-1.79, P=0.736), CP muscle length (HR 1.04 per mm, 95% 
CI 0.99-1.08, P=0.075), procedural duration (HR 1.03 per min, 95% CI 0.95-1.12, 
P=0.438), combined DRC score (HR 1.27, 95% CI 0.99-1.63, P=0.066) were not. On 
multivariable analysis, recurrent ZD (HR 20.8, 95% CI 2.5-169.2, P=0.005) and 
younger age (HR 0.96 per year, 95% CI 0.91-0.99, P=0.047) were independently 
associated with symptom recurrence.
Two post-FESD recurrences occurred in the treatment-naïve group (5.6%) and 
14 (48.3%) in the recurrent group. The median time to recurrence was 20.0 
months (95% CI 12.5 to 27.5 months) in the recurrent group (Figure 1). Kaplan-
Meier estimated symptom recurrence rates in the naïve ZD group at 12, 24, and 36 
months were 3.2%, 10.7%, 10.7%, 10.7%, respectively, which were lower than in the 
recurrent ZD group (26.7%, 59.3%, 69.4%, and 84.7%, respectively). In total, 5.6% of 
the treatment naïve group and 34.5% of the recurrent group underwent additional 
unplanned FESD during the follow-up period.
Figure 1: Kaplan-Meier plot of time to symptomatic recurrence post-FESD




Overall, 60 patients (92.3%) met the criteria for symptom improvement post-
FESD, 35/36 (97.2%) in the treatment-naïve group and 25/29 (86.2%) in the recurrent 
ZD group (P=0.098). At 12 months, patients demonstrated significant reductions 
(P <0.001) in the overall DRC score, as well as each of its subsets, of post-FESD, with 
median differences of -4.0 (95% CI -5.5 to -3.0) for DRC score, -2.0 (95% CI -3.0 to 
-1.0) for the dysphagia subset, and -4.0 (95% CI: -5.5 to -3.0) for the regurgitation 
subset and 0 (95% CI -1.0 to 0). On sensitivity analysis, improvements in DRC and 
its individual subsets remained significant for both treatment naïve (Figure 2) and 
recurrent ZD (Figure 2) cohorts.
Discussion
In this prospective single-centre study evaluating the long-term efficacy of SB 
knife FESD for the treatment of ZD, we demonstrate that a significant proportion 
of patients develop symptom recurrence over time, especially those with recurrent 
Figure 2: Kaplan-Meier estimated time to symptomatic recurrence post-FESD for treatment naïve and recurrent 
ZD cases 
FESD, flexible endoscopic septal division; ZD, Zenker’s diverticulum
138
disease following stapling therapy. The rates of symptom recurrence at 12 months 
approached 15.0%, increasing to 51.2% after 48 months. At 48 months, the 
therapeutic efficacy of FESD was superior in the treatment-naïve group compared 
to those with recurrent ZD (Kaplan-Meier estimated recurrence rates of 10.7% vs. 
84.7%). We attribute this to two possible mechanisms: first, fibrosis from previous 
procedures, which could hamper repeated attempts at septal division; and second, 
a blow out of residual sac leading to pseudodiverticulum may form following CP 
excision (13), which may cause regurgitation, even in patients without substantial 
remnant CP muscle. 
Our study also provides additional validity data in support of the DRC scale for 
measuring ZD-related severity. Although dysphagia and regurgitation are both 
recognised symptoms of ZD, we found the correlation between these two symptoms 
to be poor. Moreover, dysphagia severity did not correlate with complications 
(aspiration or weight loss), whereas this was true for regurgitation. As such, the 
use of dysphagia assessment scores (e.g. Dakkak) may not be sensitive enough 
for capturing symptoms in ZD, which could be better served using the DRC scale 
which measures regurgitation.
Several studies have studied the role of the SB knife for the purpose of FESD. The 
SB knife is a scissor-shaped cutting knife with both blades insulated externally. 
This has the potential advantage of enabling precise grasping and cutting of CP 
muscle fibers whilst allowing an upward pulling action to prevent deeper layer 
damage such as perforation (6,11). Our postprocedural complication rate of 
0% attests to the favorable safety profile of FESD with this device, which is low 
compared to other FESD studies and open surgical approaches. The device can 
also be fully rotated (360 degrees), which may benefit therapeutic precision and 
reduce procedure time (11). 
Although the role of FESD is now supported by an established body of literature, 
long term outcomes data remain limited. Only one study had assessed outcomes up 
to 48 months using a Kaplan-Meier approach (14). The authors reported a clinical 
success rate of 69% at 6 months and 46% at 48 months using a diverticuloscope-
assisted FESD method, which was similar to the 48.8% rate observed in our study. 
However, it should be noted that patients that had undergone previous treatment 
for ZD treatment were excluded from that study. When restricting analyses to 
the treatment-naïve subgroup, our 48-month clinical remission rate was 89.3%. 
Furthermore, our study included an unselected population, as evidence by the 
high percentage of ASA III/IV patients, who may otherwise have been unsuitable 
7
139
for FESD under general anesthesia. Most studies reported the use of the 
diverticuloscope, a specific overtube designed to straddle the CP muscle between 
two flaps to improve procedural safety. However, the diverticuloscope adds to the 
procedure’s cost and may cause endotracheal tube-related trauma.15 Studies on 
the outcomes of FESD using a distal cap attachment have reported comparable 
success and complication rates (14,16-18). 
Figure 3: Differences in symptom severity score as measured using the Dysphagia, Regurgitation and 
Complication (DRC) severity scale
FESD, flexible endoscopic septal division
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To our knowledge, our study is unique in providing long term post-FESD data in 
patients with post-stapling recurrence, which occurs in 0-20% of patients. These 
cases can be particularly challenging to manage and are associated with a high risk 
(HR of 8.7) of symptom recurrence. In a retrospective review of FESD outcomes 
in patients with recurrent ZD, Antonello et al reported a relapse rate of 24% (6/25 
patients) over a 6-month period (19). By comparison, our corresponding 6-month 
recurrence rate was 18.8% in this subgroup, although this proportion increased 
over time. This suggests that FESD may provide short term symptomatic relief, 
but raises doubts over whether it can achieve sufficiently durable remission 
in this group of patients. Given that both recurrent ZD and younger age were 
independently associated with earlier time to recurrence, longer term data are 
needed to confirm the efficacy of FESD versus alternative therapeutic modalities. 
There are several limitations that merit discussion. First, our definition of 
recurrence was clinical and based on symptomatology (DRC score of 1 or less) 
rather than endoscopic or Barium confirmation, with the exception of patients 
willing to undergo recurrent FESD. This limitation is shared by most of the existing 
literature on FESD. Second, this was a retrospective single-operator study without 
a comparison arm assigned to other cutting devices. Third, the use of the DRC 
scale was not blinded, i.e. recorded by an independent investigator. Correlation 
analyses involving symptoms were exploratory and did not assess other symptom 
scores, such as the MDADI (20), EAT-10 (21), and SWAL-QoL (22). Fourth, it was 
likely that our study was insufficiently powered for multivariable analysis of 
prognostic variables. In the study by Costamagna et al (14), septotomy length and 
post-FESD ZD dimensions were identified as predictors of recurrence, but these 
were not routinely measured in our study. Fifth, the Kaplan-Meier approach has 
the potential to overestimate recurrence rates, especially when such outcomes 
occur during more recently performed cases. Finally, it is conceivable that our 
tertiary centre status may attract refractory post-surgical recurrences which may 
have been declined for treatment elsewhere.
The time-dependent nature of post-FESD symptom recurrence in our study, 
particularly in the recurrent subgroup, points to the important role of long-term 
follow-up. It may be prudent to warn patients with recurrent ZD that more than 
one procedure may be required to achieve complete remission. We suggest that 





FESD using the SB knife is feasible and safe, with a complication rate of 6.2%. 
The majority (75.4%) of patients achieve symptom remission, although recurrent 
ZD and younger age were independently associated with post-FESD recurrence. 
Patients with recurrent ZD should be counseled pre-operatively regarding the risk 
of recurrence and should be provided open access follow-up arrangements post-
FESD to ensure symptom control.
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Abstract
Introduction: Although barium swallow imaging is established in the investigation 
of Zenker’s diverticulum (ZD), no agreed measurement protocol exists. We 
developed a protocol for measuring ZD dimensions and aimed to correlate 
measurements with symptoms and post-operative outcomes.
Methods: This prospective study included patients with confirmed ZD who 
underwent flexible endoscopic septal division (FESD) between 2014-2018. ZD was 
confirmed on barium radiology with measurements reviewed by two consultant 
radiologists. Symptom severity pre- and post-FESD was measured using the 
Dysphagia, Regurgitation, Complications (DRC) scale. Regression analyses were 
conducted to identify dimensions associated with therapeutic success, defined as 
remission (DRC score ≤1) 6-months after index-FESD.
Results:In total, 67 patients (mean age 74.3) were included. Interobserver 
reliability (intraclass correlation coefficients - ICCs) was greatest for pouch width 
(0.981) and pouch depth (0.934), but not oesophageal depth (0.018). Male gender 
(60.9%) was associated with larger pouch height (P=0.008) and width (P=0.004). 
A positive correlation was identified between baseline DRC score and pouch 
depth (rho 0.326, P=0.011), particularly the regurgitation subset score (rho 0.330, 
P=0.020). The index pouch depth was associated with FESD procedure time (rho 
0.358, P=0.041). Therapeutic success was achieved in 64.2% and was associated 
with shorter pouch height (median 14.5mm vs. 19.0mm, P=0.030), pouch width 
(median 19.9mm vs. 28.8mm, P=0.34) and cricopharyngeal length (median 
20.2mm vs. 26.3mm, P=0.036). 
Conclusions: ZD dimensions may be feasible evaluated using Barium radiology. 
Specific parameters appear to correlate with severity and post-FESD outcomes, 
which aid with pre-procedural planning.
Key Summary
The dimensions of a Zenker’s diverticulum may be reliably measured using a 
protocolised approach.





CP  Cricopharyngeus muscle
DRC Scale Dysphagia, Regurgitation, Complications Scale
FESD  Flexible endoscopic septal division
ICC  Intraclass correlation coefficients
IQR  Interquartile range
ZD  Zenker’s diverticulum 
Introduction
Zenker’s diverticulum (ZD) is the most common diverticulum of the upper 
gastrointestinal tract and is a treatable cause of dysphagia (1,2). Over the last two 
decades, the treatment paradigm for ZD has shifted away from surgical stapling 
towards less invasive endoscopic means (3). With its favourable efficacy and safety 
profile (4) flexible endoscopic septal division (FESD) has established itself as the 
primary therapeutic modality for both treatment naïve and recurrent ZD (3,5). 
Currently, barium swallow remains the mainstay imaging modality for patients 
with suspected ZD. Multi-frame fluoroscopic imaging is typically performed with 
at least lateral and anteroposterior projections of the hypopharynx and cervical 
oesophagus, although oblique views may also be helpful to adequately image the 
cricopharyngeus muscle (CP). In addition to the initial diagnosis, this technique 
differentiates ZD seen on the posterior wall, with the neck of the diverticulum 
seen above the level of the cricopharyngeus muscle, from the less common, 
smaller and less symptomatic Killian-Jamieson diverticulum that arises from the 
lateral wall below the level of the CP. Following on from the diagnosis, the typical 
radiological barium swallow assessment of ZD usually involves anatomical and 
functional elements with the lateral projection being most useful. The anatomical 
assessment traditionally consists of an estimate of pouch size and neck width. 
Functional assessment includes evaluating for pooling of contrast, regurgitation 
and aspiration, with exploration of the effects of the diverticulum on the adjacent 
oesophagus which may contribute to symptomatic dysphagia (6). Specific 
assessment and measurement of the cricopharyngeus muscle that is central to 
FESD is less commonly undertaken.
Despite its role in the diagnosis and functional assessment of ZD, there is no 
accepted protocol for the standardised reporting of ZD dimensions based on 
barium swallow. This is relevant as certain dimensions correlate with treatment 
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outcomes. The study by Costamagna et al found “ZD size” to be an independent 
factor associated with FESD treatment failure (7). It was assumed that the ZD size 
represented the width of the pouch, although the precise plane of measurement 
was not defined. There is therefore a need to establish a protocol to standardise 
the nomenclature of ZD dimensions, both for radiological and endoscopic usage, 
and to facilitate such measurements. Accordingly, this study aimed to develop 
a protocol for the fluoroscopic measurement of ZD dimensions, assess for 
interobserver reliability, and to correlate these measurements with pre-treatment 
symptoms and post-treatment outcomes.
Methods
Study design
This was a prospective single-centre observational study of patients with 
symptomatic ZD who underwent barium swallow and subsequent flexible 
endoscopic septal division (FESD) therapy. Patients were deemed symptomatic 
if they presented with dysphagia or regurgitation symptoms, with or without 
complications of aspiration or weight loss (DRC >1). Patients with treatment naïve 
and recurrent ZD (post-surgical stapling) were included. FESD procedures were 
performed by a single operator within a tertiary referral centre (Dudley Group 
Hospitals NHS Foundation Trust, Dudley) between 2014-2018. The procedure was 
performed using the standardised FESD technique as previously described.4,5 ZD 
dimensions were derived from barium swallow examinations using the protocol 
below, with consensus from two consultant radiologists. All patients received 
propofol sedation with anaesthesiologist assistance, with the a priori intention of 
achieving symptom remission after index therapy. All patients received follow-up 
at 6-months either via clinic or telephone consultation. Due to the tertiary nature 
of referrals, follow-up barium swallow was not routinely performed post-FESD.
Ethics approval
The study protocol conforms to the ethical guidelines of the 1975 Declaration 
of Helsinki and was approved by the local NHS Research and Development 
department. Written consent was obtained from all study participants.
Fluoroscopic measurement protocol for Zenker’s diverticulum
Fluoroscopic procedures were supervised by either accredited radiographers, 
radiology registrars or consultant radiologists in an upright position, and images 
were later reviewed by two specialist gastrointestinal radiologists (with 9 years and 
8
149
22 years’ experience in Barium studies respectively) to derive ZD measurements. 
The anteroposterior (AP) view showing the largest pouch dimensions was used to 
estimate the pouch width (Figure 1A). The lateral view demonstrating the widest 
oesophageal luminal opening (Figure 1B) was used as the image for maximum 
oesophageal depth and maximum pouch neck depth, both in a plane parallel to 
the vertebral endplates. Using the same image, the maximum craniocaudal pouch 
height was measured in a plane perpendicular to the vertebral end plates. The length 
of the cricopharyngeus muscle and maximum cricopharyngeus muscle thickness 
(inset) were also measured either on the lateral view or additional oblique views 
if these better demonstrated the relevant anatomy. The local examinations were 
performed on Siemen Luminous dRF, with a pulse rate of 7.5 frames per second 
and frame rate of 4 frames per second. Being a tertiary referral centre, externally 
acquired images were from a variety of sources with variable parameters. 
Figure 1: Protocol for the measurement of Zenker’s diverticulum on barium radiology. A 25mm ball bearing is 
used to calibrate distances. Figure 1A: Anteroposterior view, with measurement of pouch width; Figure 1B: Lateral 
view, with measurement of maximum oesophageal depth, pouch height, cricopharyngeus length, pouch neck 
and pouch depth; Figure 1C: zoomed in lateral view demonstrating maximum cricopharyngeal thickness.
A B
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To facilitate morphometric analysis for patients with ZD, a 25mm ball-bearing (BB) 
was taped around the level of the sternal notch to avoid obscuring the ZD on the 
lateral view. For the AP view the BB was moved taped in a more lateral position at 
a rough estimation of the position of any ZD. This enabled an estimate of the ZD 
parameters by calibrating a known dimension in a similar plane to the ZD, from 
which other measurements could be extrapolated, and to minimise radiographic 
parallax error.8 
For patients who did not have the 25mm BB for reference, e.g. examination 
performed externally, unexpected finding of ZD, or performed by a practitioner 
unfamiliar with the protocol of using a 25mm BB, a surrogate landmark was used 
to estimate the above ZD measurements. The C4 vertebra was chosen as it is likely 
to be constant, is usually more readily identifiable than higher or lower cervical 
levels which may be obscured by overlying anatomy, and lies in the midline. 
The craniocaudal height of the C4 vertebra (mid-sagittal vertebral body height) 
was approximated to 14mm,9 and the required measurements extrapolated 
accordingly. We have since abrogated use of the BB in favour of the simpler method 
of using the height of C4 to calibrate ZD measurements. 
Study outcomes and covariates
The primary outcome measured was therapeutic success, i.e. durable remission 
after single attempt at FESD. Symptom severity related to ZD was measured 
using two scoring systems: Dakkak score10 and the Dysphagia, Regurgitation, 
Complications (DRC) scale (Supplementary Table 1).5,11 Remission was defined as 
a Dakkak score of 0 and DRC score of ≤1. Patients met the primary outcome if they 
received only one attempt at FESD and achieved remission during their 6-month 
review. Data were collected on a standardised pro forma by a dedicated team 
member. Intraprocedural and post-procedural complications were recorded. 
Procedural times were calculated by subtracting the extubation time from the 
intubation time, which were recorded by the in-room anaesthetist. In addition 
to the protocolised ZD measurements, other covariates of interest included age, 
gender and previous surgical intervention.
Statistical analyses
All continuous variables were subjected to normality assessment using the Shapiro-
Wilk test. Non-parametric variables were presented as medians with interquartile 
range (IQR), with univariable comparisons made using Mann-Whitney (2 groups) 
and Kruskal-Wallis tests (>2 groups). 
8
151
The inter-rater reliability (reproducibility) of ZD dimensions was evaluated. 
Measurements were independently undertaken by two radiologists for the first 10 
cases as proof of concept. Intraclass correlation coefficients (ICCs) were calculated 
using average measures within a two-way mixed effects model, with consistency 
set as the model type. P-values were derived from corresponding F-tests. 
Reliability interpretation of ICC values were as follows: <0.5: poor reliability, 0.5-
0.75: moderate reliability, 0.75-0.9: good reliability, >0.90: excellent reliability.
Multivariable linear regression analyses were conducted to identify predictors 
of ZD dimensions according to age, sex, symptoms (DRC score) and Zenker’s 
status (recurrence vs treatment naïve). A binary logistic regression model was 
also performed to identify factors associated with therapeutic success. Statistical 




Over the study period, a total of 67 patients (mean age: 74.3; SD: 11.4) were included 
for analysis. 41 (61.2%) were male and 30 (44.8%) had undergone previous surgical 
stapling. This cohort had significant co-morbidity, with29 (43.3%) comprising 
American Society of Anaesthesiologist Grades III or IV. Baseline dysphagia severity 
scores, as measured using the DRC score, are presented in Supplementary Table 2. 
All but one patient reported dysphagic symptoms; this patient had a regurgitation 
score of 3 and complication score of 2.
Reliability
Reliability coefficients (ICCs) are presented in Table 1. ICCs for all measurements 
exceeded 0.8, with the exception of the oesophageal depth dimension (ICC 0.018). 
ICCs for pouch width (0.981) and pouch depth (0.934) exceeded 0.9, indicating 
excellent reliability. Overall, the ICC for pouch width was highest, with a lower 
bound 95% CI of 0.925. Due to the poor reliability of oesophageal depth as a ZD 
dimension, this was removed from subsequent analyses.
Fluoroscopic dimensions
Fluoroscopic ZD dimensions were stratified by age, sex and according to whether 
the patient had undergone previous surgical intervention (Table 2). This found 
that male patients had significantly larger dimensions with regard to pouch 
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height, pouch width and a trend towards significance for CP length and pouch 
depth. Patients with recurrent ZD who were selected for FESD had significantly 
larger pouch neck and pouch width dimensions compared to those without prior 
therapy. No significant differences in dimensions were found in patients aged >75 
vs. 75 or less.
Table 1: Interobserver reliability of Zenker’s diverticulum barium measurements as measured using intraclass 
correlation coefficients (ICCs).
Dimension ICC 95% CI of ICC P-value (F-test)
Oesophageal Depth 0.018 -2.95 to 0.756 0.489
CP length 0.891 0.562 to 0.973 0.001
CP thickness 0.822 0.284 to 0.956 0.008
Pouch neck 0.858 0.427 to 0.965 0.004
Pouch height 0.875 0.496 to 0.969 0.002
Pouch width 0.981 0.925 to 0.995 <0.001
Pouch depth 0.934 0.734 to 0.984 <0.001
Table 2: Baseline Zenker’s diverticulum measurements prior to flexible endoscopic septal division, with 
comparisons made according to gender, previous surgical intervention and age. CP: cricopharyngeus. *P<0.05
Dimension 
(mm)
Median dimension in mm (IQR)
















































































































On multivariable linear regression analysis (Table 3) after accounting for age, 
sex, DRC and ZD status (recurrence vs naïve), male gender remained significantly 
associated with pouch height (P=0.018), pouch width (P=0.003) and pouch depth 
(P=0.017), whereas previous intervention was associated with higher pouch height 
(P=0.034).
Table 3: Multivariable linear regression analysis of factors associated with Zenker’s diverticulum dimensions. 
The Beta coefficient (Beta) denotes increases in dimension size from the constant (B) for each categorical 
factor, or for each unit increase for continuous variables. M: male, F: Female, DRC: Dysphagia, Regurgitation, 
Complications scale. 




Age (per year)  -0.03 -0.32 to 0.26 0.833
Sex (M vs F) 4.53 -1.95 to 11.0 0.166
DRC (per score) 0.88 -0.87 to 2.63 0.316




Age (per year) -0.01 -0.04 to 0.03 0.645
Sex (M vs F) 0.60 -0.20 to 1.40 0.138
DRC (per score) -0.07 -0.30 to 0.17 0.564




Age (per year) -0.08 -2.1 to 0.06 0.248
Sex (M vs F) 1.17 -1.79 to 4.14 0.432
DRC (per score) 0.63 -0.17 to 1.43 0.119




Age (per year) 0.14 -0.19 to 0.47 0.392
Sex (M vs F) 9.44 1.66 to 17.21 0.018*
DRC (per score) 0.88 -1.13 to 2.89 0.384




Age (per year) -0.216 -0.52 to 0.09 0.161
Sex (M vs F) 10.9 3.91 to 17.81 0.003*
DRC (per score) 1.024 -0.79 to 2.83 0.261




Age (per year) -0.049 -0.23 to 0.13 0.595
Sex (M vs F) 5.03 0.92 to 9.13 0.017*
DRC (per score) 1.41 0.33 to 2.49 0.011*
Recurrence vs Naïve 2.851 -1.27 to 6.97 0.171
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Symptom severity
ZD dimensions were also subjected to Spearman rank analyses against each subset 
of the DRC score in addition to the total score (Table 4). No statistically significant 
correlations were found between ZD measurements and individual subset scores 
for dysphagia (D) and complications (C), but was positive for regurgitation (R), 
which correlated with pouch depth (rho=0.330, P=0.010) and pouch neck (rho 
0.267, P=0.045) measurements. The composite DRC score correlated with pouch 
depth size (rho 0.326, P=0.011). This remained significant after multivariable 
analysis for age, sex and previous intervention (Table 3).
Table 4: Comparisons of Zenker’s diverticulum dimensions according to the primary outcome. 
CP: cricopharyngeus. *P<0.05























































Table 5: Correlations between Zenker’s diverticulum dimensions. CP: cricopharyngeus








































The median procedure time was 20 minutes (IQR 20.0-25.0). There were no significant 
correlation between any ZD dimension and procedure duration or according to 
whether the patient had undergone previous surgical intervention (P=0.695). In the 
treatment naïve subgroup, pouch depth was the only dimension which showed a 
statistically significant correlation (rho 0.358, P=0.041) with procedure time.
Correlations with other ZD dimensions
Bivariate correlation analyses between individual ZD dimensions were performed 
(Table 5). This revealed strong positive correlations between CP length and the pouch 
height (rho 0.890, P<0.001), pouch width (rho 0.719, P<0.001) and pouch depth (rho 
0.719, P<0.001), and a moderately positive correlation with the pouch neck (P=0.546, 
P<0.001), but not with CP thickness (P=0.194). There were no significant correlations 
between CP thickness and other dimensions.
Therapeutic Success
The primary outcome of durable remission after first episode FESD was met in 
64.2%. On univariable analysis (Figure 2), therapeutic success was associated with 
shorter CP length (P=0.036), pouch height (P=0.030) and pouch width (P=0.034). No 
significant differences were found on multivariable analyses after accounting for 
age, previous surgical intervention or gender. 




Barium swallow is the primary radiological investigation for dysphagia (2). The 
technique is dependent upon practitioner experience and local protocols, with 
variation in terms of radiographic projections and fluoroscopic capture rates. In 
order to standardise the assessment and reporting of ZD dimensions on barium 
fluoroscopy, we have developed a novel and purpose-specific protocol for quantifying 
ZD morphometrics. In this prospective single-centre study, we show that, by using 
this protocol, ZD measurements can be reproducible amongst GI radiologists, as 
evidenced by inter-rater reliability analyses (ICCs). Importantly, we demonstrate 
that specific dimensions correlated with symptom severity, procedure time and the 
outcome of durable therapeutic success. These results provide validity evidence in 
support of our ZD measurement protocol.
Although endoscopy is often first-line in the evaluation of dysphagia, the hypopharynx 
represents a potential blind spot which may lead to a false negative diagnoses of ZD. It 
is also recognised that ZD can hinder endoscopic intubation of the oesophagus. Thus, 
there is a role for fluoroscopic assessment in patients with intubation failure (12) or 
in patients with oropharyngeal dysphagia for which a high index of suspicion for 
structural abnormality remains despite normal endoscopy. This may be particularly 
helpful in patients with regurgitation-predominant symptoms, as our analyses 
demonstrate a positive correlation between pouch dimensions and the regurgitation 
subset of the DRC symptom severity scale. Although designed to assess patients with 
endoscopically confirmed ZD for pre-FESD workup, our Barium protocol could also 
be adopted for use in the evaluation of oropharyngeal dysphagia.
In our experience, the anteroposterior and lateral views of the pharynx and upper 
oesophaguswere most helpful for determining ZD morphometrics. An image 
acquisition rate of 3 or 4 frames per second (dependent on equipment manufacturer) 
was felt to be a pragmatic balance between minimising radiation exposure to as 
low as reasonably achievable (ALARA) and providing adequate temporal resolution 
for functional assessment to evaluate for pooling of contrast, regurgitation and 
aspiration, and mass effect on the adjacent oesophagus. Routine oblique views 
and spot radiographs of the ZD were not felt to be as useful with problematic 
quantification of the ZD measurements and inherently lacked real-time functional 
information, although some radiologists prefer oblique views as the ZD projects 
posterolaterally (and usually to the left). The externally referred images had a variety 
of pulse rates and frame rates, some being spot films, with inherent limitations of 
non-standardised image acquisition. 
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The local operators comprised radiographers, radiology registrars an consultants 
and we presume a similar spread for external sites. Clearly given the radiation 
exposure we did not repeat examinations if the measurements could be derived 
from the referral source. We hope discussion of these factors will lead to an 
awareness of measurements used in ZD, particularly for patients who may 
be considered for FESD. Whilst we did use a ball-bearing for calibration, this 
was sometimes found to be cumbersome and could obscure assessment of the 
underlying anatomy, requiring repositioning during the examination. The utility 
of using a ball-bearing over calibrating from the ever-present posterior height of 
the C4 vertebral body was not separately investigated, however given the inherently 
dynamic nature of ZD filling and opacification, theoretical discrepancies between 
the two methods were felt to be small and unlikely to have a significant impact 
on the ultimate procedural outcome. For these reasons, we suggest an alternative 
method for extrapolating ZD dimensions by using 14mm as the height of the C4 
vertebral body (9). 
Correlations between ZD dimensions can provide insights on its pathophysiology. 
There was significant inter-correlation between the pouch height, width, depth 
and the CP length, but not CP thickness. Male patients were associated with 
significantly larger pouch height, depth and width, which complements the 
observation that ZD, is nearly twice as common in men (13). The observation that 
patients with recurrent ZD had larger dimensions may be due to selection bias. It 
is possible that, in patients who have failed previous therapy, clinicians may have 
a higher threshold to refer for further endoscopic therapy.
Several limitations should be discussed. First, our study size was small (N=67) 
which did not permit multivariable analyses of therapeutic efficacy. For the 
evaluation of reliability, only the first 10 cases were reviewed by two GI radiologists 
(blinded to the results) due to resource constraints, which may have influenced the 
precision of reliability estimates. Some cases were performed externally, which 
may affect the accuracy and consistency of ZD measurements. The success rate 
of 64.2% is lower than other series, and may be due to several factors. Our study 
outcome of therapeutic success was based on a stringent definition of durable 
remission at 6 months after index FESD. It should be noted that the definition of 
procedural success within the literature is heterogeneous. Some defined success 
as symptomatic improvement after three episodes of FESD, improvement of 
symptoms, or after 3-months of follow-up. 
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Procedures were mainly performed in elderly patients (mean age of 74) with co-
morbidity (43.4% had ASA grades of III or IV), of which a significant proportion 
(44.8%) of patients were patients with recurrent ZD who had previously failed 
endoscopic stapling. These factors may affect the generalisability of our data towards 
other patient populations. Finally, patients post-FESD may have a degree of bridging 
fibrosis, i.e. scarring, which may result in dysphagic symptoms but may not necessary 
have recurrent ZD. Due to the tertiary nature of referrals from throughout the UK, 
it was not feasible to repeat barium fluoroscopy in all patients post-FESD. This may 
have been useful to confirm recurrence and to study pairwise comparisons of pre and 
post-FESD dimensions. Indeed, there is little evidence that assessment of residual 
pouch size post-procedure predicts a successful outcome or future symptomatic 
recurrence (14,15). 
In summary, a measurement protocol for the assessment of ZD on barium radiology 
has been developed. These measurements are reproducible and correlate with 
symptom severity, procedure time and post-FESD outcomes, and may inform 
FESD planning and patient counselling of post-FESD outcomes. Further studies 
are required to inform whether volumetric analyses can be used in conjunction 
with Barium dimensions to benefit patient selection, procedural selection (e.g. 
FESD vs. submucosal tunnelling techniques) and ultimately, on patient outcomes. 
Further studies are required to inform whether volumetric analyses can be used 
in conjunction with Barium dimensions to benefit patient selection, procedural 
selection (e.g. FESD vs. submucosal tunnelling techniques) and ultimately, on patient 
outcomes.
Clinical applicability of study findings—what gap in evidence does 
the study fill? 
Despite its role in the diagnosis and functional assessment of ZD, there is no 
accepted protocol for the standardised reporting of ZD dimensions based on barium 
swallow. Accordingly, this study aimed to develop a protocol for the fluoroscopic 
measurement of ZD dimensions, assess for interobserver reliability, and to correlate 
these measurements with pre-treatment symptoms and post-treatment outcomes. 
This is the first study to describe measurement protocol for the assessment of ZD 
on barium radiology. These measurements are reproducible and correlate with 
symptom severity, procedure time and post-FESD outcomes, and may inform FESD 
planning and patient counselling of post-FESD outcomes. We hope this protocol 
can be tested in further studies before adoption for routine practice. 
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Supplementary Files
Score Dysphagia (D) Regurgitation (R) Complication (C)
0 No dysphagia No regurgitation No complications
1 Dysphagia with normal/solid diet More than once a week, less than 
once a day
Recurrent chest infections OR 
unintentional weight loss >5kg over 
last 3 months
2 Dysphagia with soft diet (semi solid) At least once per day Recurrent chest infections and 
unintentional weight loss
3 Dysphagia with fluids Immediately following all meals/
drinks
4 Difficulty swallowing saliva Regurgitation resulting in choking or 
coughing
Supplementary Table 1: Distribution of Zenker’s diverticulum symptom severity scores.
Score Dysphagia (D) Regurgitation (R) Complication (C) DRC Total
0 1 (1.5%) 14 (20.9%) 36 (53.7%) 2-3 15 (22.4%)
1 16 (23.9%) 10 (14.9%) 24 (35.8%) 4-5 28 (41.8%)
2 22 (32.8%) 7 (10.4%) 7 (10.4%) 6-7 18 (26.8%)
3 23 (34.3%) 16 (23.9%) - 8-9 4 (6.0%)
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Abstract
Introduction: Cricopharyngeal hypertrophy (CPH) also known as “cricopharyngeal 
bar”. Common presentation is with dysphagia. Gastroscopy can be difficult and 
may result in failed intubation. CPH is functional disorder of pharynx in which 
CPH muscle excitability leads to spasm and moderate periodical swallowing 
difficulty. Management of cricopharyngeal dysphagia poses a real challenge. 
Aim of this current animal model study is to determine whether similar treatment 
and approach can be used to dissect CP muscle using same SB knife junior as is 
used to treat Zenker diverticulum. Result: Unfortunately, based on this we couldn’t 
get the orientation of oesophageal wall properly and as a result we did not dissect 
the posterior wall as intended, but more towards anteromedial aspect. From gross 
cross examination the length of the CP muscle from left to right was 6.8 cm and its 
width from top to bottom was 2.7cm and depth from inside to outside be 0.7cm. 
Conclusion: Important lesson learnt was to use a Pigs head and neck model and 




The pharyngeal circular muscles that facilitate swallowing comprises of superior, 
middle and inferior pharyngeal constrictors. CP muscle lays Inferior to the 
inferior pharyngeal constrictor. The CP is a striated skeletal muscle, is tonically 
closed but opens to facilitated passage of food into oesophagus, forming an upper 
oesophageal sphincter.
The CP muscle sphincter remains tonically contracted at rest and opens only 
during passing of a food bolus, belching and vomiting. This basal pressure is 
believed to be actively maintained by vagal input but the opening of the sphincter 
(i.e. relaxation of the CP muscle) is controlled vagal and glossopharyngeal (cranial 
nerve IX) nerve endings in the oropharynx by a food bolus. 
UES function depends on pharyngeal contraction from above and relaxation 
of CPM. Failure of any of these two mechanisms usually results in CP muscle 
dysfunction.
Key component of the true upper oesophageal sphincter (UES) is the 
cricopharyngeus muscle (CPM). In cricopharyngeus muscle dysfunction (CPD) 
muscle fail to, appropriately, relax or contract during swallowing. This over the 
period of time leads to CPH. The clinical manifestation is dysphagia to solid and 
or liquid food and aspiration. These symptoms adversely affect quality of life of 
patients.
Barium video-fluoroscopy, oesophageal monomeric studies can help clinicians to 
distinguish CPD from other causes of UES dysfunction. CPD on radiographically 
appears as a cricopharyngeus muscle bar (CPB) with varying degrees of obstruction 
For CPH, accurate diagnosis is paramount to choose the appropriate treatment. In 
appropriately selected patients, intervention at the CPM may yield improvement 
in dysphagia. Management of cricopharyngeal dysphagia poses a real challenge. 
Endoscopic dilatation, botulinum toxin (BoT) injection in the muscle has been used 
with short term benefit. The traditional surgical treatment for upper oesophageal 
sphincter dysfunction involves cricopharyngeal myotomy via a transcervical 
approach (1, 2, 3). 
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An open approach, while effective, carries surgical morbidity, including possible 
pharyngocutanous fistula, recurrent laryngeal nerve paralysis, hematoma, 
seroma, and wound infection (4). 
In 1994, endoscopic cricopharyngeal myotomy (ECPM) was developed using direct 
laryngoscopy with laser incision of the cricopharyngeus (CP) using a potassium-
titanyl phosphate laser. Soon after, CO2 laser was employed and has become the 
laser of choice because of its ability to coagulate small vessels and minimize 
unintended spread of thermal damage (6). 
Adapted from Michael J. Pitman (Operative Techniques in Otolaryngology (2011) 22, 135-141) – requested for 
permission
Endoscopic cricopharyngeal myotomy technique required GA and does carry 
anaesthetic related risk as many patients are frail. Serious risk of complications 
such as oesophageal perforation and mediastinitis has been reported (5).
There is great deal of need to develop safely and minimally invasive flexible 
endoscopic treatment for CPH. Flexible endoscopic septum division (FESD) is a 
rapidly evolving technique for the treatment of Zenker’s diverticulum (ZD). FESD 
is a feasible, safe, and effective treatment for symptomatic ZD, with low adverse 
event and recurrence rates. Newer devices have been used with promising results 
with scissor shaped SB knife junior (6). 
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Aim of this current animal model study is to determine whether similar treatment 
and approach can be used to dissect CP muscle using same SB knife junior as is 
used to treat Zenker diverticulum. 
Objective of the study
Feasibility of dissecting CP muscle in the absence of Zenker diverticulum with 
flexible endoscope using SB-knife junior. Safety of full CP muscle dissection using 
blue dye (detect leak/perforation). Pathological assessment and confirmation of 
CP-muscle myotomy (length and depth in reference to control, normal side) and 
related complication such as micro perforation. 
Ethical approval
This study-model does not include sacrificing live animals, hence exemption 
from animal protocol review. Organs, including pharynx and upper oesophagus 
sample, could be obtained from a slaughter house. The study was approved by the 
National Hospital Organization Kure Medical Centre and Chugoku Cancer Centre, 
Japan, Institutional Review Board Ethics Committee as well as from the Hospital 
ethical committee Beijing Shijitan Hospital, China.
Funding
Experiment was supported by Beijing Shijitan Hospital and carried out in the 
Endoscopy Lab in the Hospital in Beijing. Six SB knifes were donated by Sumimoto 
Company (Sumimoto, Japan). 
Methods and materials 
Swine Pharynx and oesophagus models were used Figure 1. Per oral endoscopy 
could be performed and CP identified as start of upper oesophageal sphincter. 
Two skilled endoscopists (experienced in EMR and ESD) carried out in all the 
6 cases.
Mucosal bleb was being raised at the start of the CP muscle on posteriorly with 
hyaluronic acid and indigo carmine solution (blue dye). SP-knife was used to 
create midline-longitudinal mucosal incision over the mucosal bleb to expose 
cricopharyngeal muscle using ERBE setting of 1, 1, and 1. Once muscle was 
exposed, SB-knife will be used to grasp & lifted inner CP muscle fibres toward 
the oesophageal lumen then dissect. In this stepwise manner, all of CP-muscle 
was dissected to expose buccopharyngeal fascia (BPF). Where BPF could not be 
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identified, we aimed to carry out full myotomy of all layers of CP muscle. Figure 
2- A-G, Figure 3. Photographs were taken at every stage and are recorded. After the 
procedure, the specimens were analysed by a local pathologist with histological 
assessment Figure 4-6.
Figure 1: Swine pharynx and oesophagus
Figure- 2: A- Upper oesophageal sphincter, B submucosal injection, and 
C submucosal lift, D start of incision, E longitudinal incision, F submucosal 










Figure 3: after dissection
Figure 4: CP muscle Figure 5: MP layer




Unfortunately, we could not orientate of oesophageal organ properly and as a result 
we did not dissect the posterior wall as intended, but more towards anteromedial 
aspect. From gross cross examination the length of the CP muscle from left to 
right was 6.8 cm (Figure 4), and its width from top to bottom was 2.7cm and depth 
from inside to outside be 0.7cm. We also learnt that MP (muscularis propria is 
different from human and its skeletal muscle and not smooth muscle (Figure 5). 
Another interesting observation as that there is no MM (muscularis mucosa in the 
oesophagus in the swine model (Figure 6a- submucosa, 6b- mucosa)
Conclusions
We have learnt a great deal about CP muscle in swine and that it is feasible to access 
and dissect this muscle in a Pig model. We used SB scissor knife to dissect CPM. 
We believe such an animal model might open up new avenues for developing, 
improving or modifying treatment. We in this experiment used Pigs oesophagus 
but leant that using an oesophagus model might be too challenging to orientate in 
to the anatomical structures. CPM muscle is like sling with bulk to form posterior 
wall of upper oesophageal sphincter, hence it is important to orientate so posterior 
wall is identified. Unfortunately, this is very challenging in our oesophagus animal 
model. We concluded that we should repeat this experiment with full head and 
neck of swine model not just the oesophagus to facilitate a better identification of 
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Flexible endoscopic septum division (FESD) is considered the preferred treatment 
of a Zenker’s diverticulum. Post procedure recurrences pose a new challenge to 
treat. Complete myotomy of CPM is considered the key to prevent recurrence. 
The recently described Z-POEM offers complete myotomy, but requires general 
anaesthesia and seems associated with high percentage of complications such as 
perforations and median procedure time of 52 minutes. We in this animal model 
studied the feasibility of minimally invasive complete myotomy with anterior 
oesophageal tunnel approach in living pig model. Complete myotomy achieved 
with a modified conventional technique with the need to make sub-mucosal tunnel 
hence might reduce the procedure time without the need of general anaesthetic. 
(This work would have been presented along with chapter 9 in European ESGE 




Flexible endoscopic septum division (FESD) is now considered the preferred 
treatment of a Zenker’s diverticulum. Conventional endoscopic technique of 
septotomy has been ascribed to high recurrence rate of 10-25% (1). Most plausible 
explanation for this high recurrence is incomplete myotomy with conventional 
technique in which although the septum (CPM with its anterior and posterior 
mucosal layers) is dissected but lower 1 cm of septum (CPM with its anterior and 
posterior mucosal layers) is left behind as safety cushion to prevent procedure 
related perforation. This residual septum with passage of time leads to recurrence 
of Zenker pouch and related symptoms. Recurrent ZD poses another additional 
challenge. Access may be poor and re-treatment cause scar on scar. Hence new ways 
to expose and completely dissect cricopharyngeus muscle (CPM) are warranted. 
Inspired by POEM technique (Per oral endoscopic myotomy used to treat 
Achalasia), Li et al reported Z-POEM, a novel endoscopic technique to treat ZD, 
using a so called 3rd space approach (2). 
In an international study Yang et al also used of peroral endoscopic myotomy 
(POEM) in the management of Zenker’s diverticulum (ZD). (2) The authors describe 
the Z-POEM technique, i.e. submucosal tunnelling of the septum extending below 
the anterior and posterior aspects of the cricopharyngeus muscle (CPM) prior 
to septotomy. The Authors report a clinical success rate of 92% but a perforation 
rate of 5.5% which required endoscopic closure. All cases done under GA and 5 
days antibiotics were prescribed (3). Although inspired by POEM technique for 
achalasia: Z-Poem was different as exposure of CP muscle required dissection on 
both side of the muscle that are quite different from POEM in which submucosal 
dissection carried out in front of muscle. It was considered by many as more 
invasive requiring GA (4), hence still desirable to look for new less invasive way to 
carry out complete myotomy.
Objective of the study
Aim of this current animal model study is to determine feasibility of complete 




Experiment was supported by Universitatsmedizin, University Centyrum, Mainz, 
Germany. The study was be approved by the local Hospital ethical committee. The 
experiment was carried out in University Hospital Mainz animal Lab in June 2019.
Methods and materials 
One Anaesthetised live Swine model was used. A diagnostic endoscope (Fuji- 
Japan) with transparent hood was carefully introduced until the diverticulum 
was visualized, emptied of any food residue and septum (cricopharyngeus muscle 
[CPM]) identified. A nasojejunal tube placed through the endoscopy. This helped 
mark the CP muscle and protect the anterior oesophageal wall. Midline anterior-
posterior incision was made on septum to expose cricopharyngeus muscle (CPM) 
that was then carefully dissected downward along with overlying mucosa as in 
conventional myotomy. Once most of the septum dissected then dissection only 
Figure 1: Pharyngeal muscle and CP muscle 
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focused on the CPM and oesophageal mucosa in front, without touching anterior 
mucosal lining of pouch. Once muscle was exposed, scissor knife used to grasp 
& lift inner cricopharyngeus muscle (CPM) fibres toward the oesophageal lumen 
then dissect. This cutting towards oesophageal lumen created tunnel anteriorly 
into oesophageal lumen. In this stepwise manner, all of the cricopharyngeus 






Figure 2: A- midline dissection of mucosa over CP 
muscle to expose muscle, B dissection of muscle 
toward anteriorly, C anterior open tunnel, D- CP muscle 
dissected exposing areas of buccopharyngeal fascia 
(BPF), E. CP muscle completely dissected exposing BPF
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the time that allowed safe dissection of the cricopharyngeus muscle (CPM). The 
pouch disappeared at the end of the procedure. All steps highlighted in Fig 2.
Photographs were taken at every stage and were recorded and available when 
applicable. The pig was then euthanized using potassium chloride (KCL) on closed 
monitoring using unit protocol.
Conclusions
The anterior open tunnel complete myotomy was feasible and looked safe in 
this pilot experiment. Important learning lesson was that complete myotomy 
of cricopharyngeus muscle (CPM) can be carried out without the need of 
dissection posterior to the cricopharyngeus muscle (CPM) to prevent breach of 
buccopharyngeal fascia (BPF). This has very important implications in human: 
as cutting of cricopharyngeus muscle (CPM) is possible without breaching 
buccopharyngeal fascia (BPF) to prevent secondary infection or an air leakage into 
the superior mediastinum during dissection of cricopharyngeus muscle (CPM). 
Z-ATM is a combination of conventional septotomy to cut 90% of the septum 
(cricopharyngeus muscle with its surrounding mucosal layers both anterior and 
posterior), then followed by dissection of remaining cricopharyngeus muscle 
(CPM) along with only anterior mucosal lining (oesophageal side). Dissection 
of mucosal layer anteriorly creates a tunnel into oesophageal lumen, that gives 
a good overview and access to the distal lower fibres of cricopharyngeus muscle 
(CPM) for a safe complete myotomy.
Such technique of an anterior tunnel into oesophagus might facilitate good 
operating space and access to lower fibres of cricopharyngeus muscle (CPM) when 
compared with the reported 3rd space tunnel myotomy, hence this may have 
advantages over the Z-Poem technique recently described. Another advantage in 
Z-ATM is cutting of mucosal layer covering the cricopharyngeus muscle (CPM), 
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Abstract 
Zenker’s diverticulum (ZD), or pharyngeal pouch, is an anatomical defect 
characterised by herniation of the posterior pharyngeal wall through Killian’s 
dehiscence, and may result in dysphagia and regurgitation. Multiple therapeutic 
modalities including surgery, rigid and flexible endoscopy have been developed 
to manage ZD. Although surgical management with open and endoscopically-
assisted techniques have historically been the mainstay of ZD treatment, minimally 
invasive flexible endoscopic techniques emerged as first line treatment option. 
Various flexible endoscopic techniques have been reported to treat ZD in the last 
25 years. Incomplete myotomy has been ascribed to high recurrence rate of 10-
25% that led to concept of completely CP myotomy in the treatment of ZD, but 
not without increasing the risk of perforation. We report a modification of the 
conventional reported technique, which is minimally invasive and might offer 




Zenker’s diverticulum (ZD), also known as pharyngeal pouch, is a condition 
characterised by herniation of the posterior pharyngeal wall. Specifically, this 
occurs in an area located between the thyropharyngeus and the cricopharyngeal 
muscle fibres of the inferior constrictor, known as Killian’s triangle. [Fig 1]. 
Anatomical landmark of ZD are described in Figure 2. It is imperative for treating 
endoscopist to be aware of landmark structure around the pouch.
Flexible endoscopic septum division (FESD) has evolved as the preferred treatment 
in daily practice and involves the use of a flexible endoscope to perform septal 
myotomy. The cricopharyngeus muscle (CPM) with its anterior and posterior 
mucosal covering layers constitutes this septum. The goal of treatment is to 
reduce the size of the diverticulum and improve pharyngeal motor function, thus 
improving the symptoms of dysphagia and regurgitation.
The frequently used single incision technique involves a midline incision to the 
septum (cricopharyngeus muscle (CPM) with its anterior and posterior mucosal 
covering layers) with the option of clipping the base using various devices (1). 
[Figure 3]. This technique involves dissecting the septum wall between the 
pouch and the oesophagus. Figure 3 illustration is to understand the concept of 
conventional septotomy. [Figure 4]
In a recent meta-analysis recurrence with conventional FESD has been reported 
at 11% (10-25%) (2). The most plausible explanation for this high recurrence is 
incomplete myotomy with conventional technique in which although the septum 
Figure 1: this illustrate that CPM is circular 
muscle and not supported posteriorly by 
ELM as is the case in the oesophagus. CPM- 
Cricipharyngeus muscle, KT- Killian triangle, 
ECM- esophageal circular muscle, ELM- 
esophageal longitudinal muscle. ICM: Inferior 
constrictor muscle and after cricopharyngeal 
myotomy. Head Neck. 2017 Sep; 39(9):1869-
1875.
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(cricopharyngeus muscle with its anterior and posterior mucosal layers) is dissected 
but lower 1 cm of septum is left behind as safety cushion to prevent procedure 
related perforation. This residual septum with passage of time leads to recurrence 
of Zenker pouch and related symptoms. [Figure 3] To overcome recurrence new 
techniques are proposed and developed to allow complete myotomy. Inspired by 
POEM technique, per oral endoscopic myotomy used to treat Achalasia, Li et al 
reported Z-POEM, a novel endoscopic technique to treat ZD, using the so called 
3rd space approach (3).
Figure 2: anatomical landmark of ZD. CPM 
is covered in front by esophageal mucosa 
and at the back by mucosal layer that makes 
anterior wall of pouch (both shaded as blue). 
Buccopharyngeal facia is shaded green 
and is also important protective layer, not to 
be breached to prevent entry into superior 
mediastinum.




In an international study Yang et al also used of peroral endoscopic myotomy 
(POEM) in the management of Zenker’s diverticulum (ZD) (4). In another study 
Repici et al reported POES suing this technique for short ZD (5). The authors describe 
the Z-POEM technique, i.e. submucosal tunnelling of the septum extending below 
the anterior and posterior aspects of the cricopharyngeus muscle (CPM) prior to 
cricopharyngeus muscle dissection. They reported a clinical success rate of 92% 
but a perforation rate of 5.5%, which required endoscopic closure. All cases done 
under GA and 5 days antibiotics prescribed. Although inspired by POEM technique 
for achalasia: Z-Poem was different as exposure of CP muscle required dissection 
on both side of the cricopharyngeus muscle that are quite different from POEM in 
which submucosal dissection carried out in front of oesophageal muscle. 
Dissection on both sides of the cricopharyngeus muscle was considered by many 
as more invasive requiring GA (6). In Z-Poem the cricopharyngeus muscle (CPM) 
is cut but not the covering anterior and posterior mucosal layers. These mucosal 
layers potentially can form mucosal partition between pouch sac and oesophagus. 
Advantage of Z-poem is to dissect the cricopharyngeus muscle completely but not 
the covering mucosal layers. But in the conventional technique the whole septum 
is cut (albeit incomplete) including the cricopharyngeus muscle along with its 
anterior and posterior mucosal covering. Illustration of Z-Poem is in Figure 5. 
We developed a new technique that allows complete myotomy (cricopharyngeus 
muscle and anterior mucosal layer). We used anterior Tunnel complete 
cricopharyngeus Myotomy (Z-ATM) technique in one patient referred to us in 2019 
with a recurrent symptomatic pouch (4cm). As complete myotomy was needed 
in this patient hence patient was counselled and informed about this modified 
technique. The procedure was carried out after informed consent.
Figure 4: Conventional septotomy, CPM is cut almost to 90% leaving 1cm at the base to prevent perforation.
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Endoscopic procedure (figure 5, 6, 7)
Procedures were performed with deep sedation using propofol. A diagnostic 
endoscope (Pentax- Japan) with transparent hood was introduced to identify 
diverticulum and a nasojejunal tube placed through the endoscopy to mark the 
cricopharyngeus muscle and protect the anterior oesophageal wall. Mucosa over 
cricopharyngeus muscle was cut to expose the cricopharyngeus muscle that was 
then carefully dissected downward along with the overlying oesophageal mucosa 
(like conventional septotomy). Once lower part of cricopharyngeus muscle 
reached then mucosal layer anterior to cricopharyngeus muscle cut to create an 
anterior tunnel towards the oesophageal lumen. 
This not only exposed the lower fibres of cricopharyngeus muscle probably better, 
but also provided the much needed operating space. All of the lower fibres of 
cricopharyngeus muscle then were exposed and cut and the pouch disappeared as 
we not only cut the cricopharyngeus muscle (CPM) but also anterior mucosal layer 
covering it leading to complete disappearance of the wall between pouch and 
oesophagus. Cutting of anterior mucosal layer created an open anterior tunnel 
towards oesophageal lumen that was then closed with zipper clipping method to 
allow fast healing and to prevent delayed perforation. We used the SB SB-Knife 
(Sumitomo Bakelite®, Tokyo, Japan) with ERBE VIO with a diathermy setting of 
Endocut Q effect 2, interval3 and cut duration 3. One shot of co-amoxiclav (1.2 gm) 
was given prior to the procedure.
Figure 5: Z-POEM- CPM muscle is completely dissected, this may collapse the pouch size to some extent, but 
significant pouch potential can exist.
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Figure 5 and 6 are the endoscopic photos of the steps and Figure 7 is the illustration 
of the procedure to understand the treatment concept.
There was no complication recognized. Post procedure observation, X-Ray of neck 
were satisfactory; hence the patient was allowed to go home to stay nil by mouth 
for 24 hours. Patient was allowed soft food following telephone review day after the 
procedure. After a follow up at 12 month, patient remains free of any symptoms.
Figure 6: Z-ATM procedure: video still) - A- identify ZD and placement of NJ tube, B- mucosal incision to expose CP 
muscle, C-, CP muscle dissection with SB knife, D-dissection by creating anterior tunnel also cutting oesophageal 
mucosa, E- after complete myotomy and complete disappearance of pouch, F- clipping using zipper technique, 
G-tunnel defect closure, H after complete closure of mucosal defect.





We used the anterior Tunnel complete cricopharyngeus Myotomy (Z-ATM_ 
approach to allow complete myotomy. As we expect scarring from previous 
procedure we felt dissection behind the cricopharyngeus muscle (as proposed in 
Z-POEM) to be too risky and may breach the buccopharyngeal fascia layer that is 
very close to posterior wall of cricopharyngeus muscle. Hence we created anterior 
tunnel towards oesophageal lumen to expose the cricopharyngeus muscle (CPM). 
With our anterior Tunnel complete cricopharyngeus Myotomy approach complete 
exposure and dissection of the CP was possible. Our approach has multiple 
advantages over Z-Poem technique which has recently been reported (4). 
First, more space seems available in hypopharynx as no general anaesthetic and 
intubation was necessary, that allowed clear views and easy movement of scope tip 
being in the oesophagus in contrast to the limited operating space in the so called 
sub-mucosal tunnel approach. Secondly no dissection or injection was needed 
posterior to the CP muscle, which may lead to a higher perforation rate in the 
recently described Z-POEM technique by possible disruption of buccopharyngeal 
fascia into retropharyngeal space and into superior mediastinum (4). 
Thirdly in Z-POEM pouch the mucosal sac remains unchanged ( as it offer dissection 
of cricopharyngeus muscle not covering mucosal layers) in comparison to our 
suggested approach of cutting the cricopharyngeus muscle and mucosa (septotomy 
with complete cricopharyngeus muscle dissection) to prevent a remnant mucosal 
sac, that can result in mucosal blow out giving symptoms of regurtiation (5). In 
Z-Poem paper, the authors only used dysphagia as symptom scoring tool and not 
the regurgitation, that created a symptoms score bias resulting in under scoring. 
Our Z-ATM technique might offer a more complete myotomy with additional 
benefits during follow up. 
This proposed Z-ATM approach allows complete exposure and dissection of the 
CP was possible with minimal invasive approach. As general anaesthetic and 
intubation are not required more working more space in hypopharynx is available 
with the endoscope. In Z-ATM we used the transparent cap only, this provided 
better space allowing clear views and movement of scope tip. 
In conclusion anterior Tunnel complete cricopharyngeus Myotomy (Z-ATM) is a 
different approach to Zenker. We only have this pilot experience. In this patient 
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anterior Tunnel complete cricopharyngeus myotomy offered a minimally invasive 
complete myotomy. This might provide a true endoscopic solution of ZD to reduce 
the recurrence rate. Before it is recommended in routine practice further well 
designed prospective studies required assess and compare this technique with 
Z-POEM and conventional myotomy in multicenter expert centers for Zenker.
Figure 8: Z-ATM- first two photo is conventional 
septotomy. This result is stub of septum that is then 
dissected downward and mucosa in front. This 
creates tunnelling in oesophageal lumen that is 
later closed with clipping.
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Summary 
The first use of minimally invasive flexible endoscopic therapy in Zenker’s 
diverticulum (ZD) was reported in 1995 by Mulder and Ishioka. Ever since endoscopic 
techniques have been adapted over the last two decades with increasing operative 
success and safety profile. Unfortunately, the technique of this procedure is not 
standardised. In the last two decades many variations of the techniques have been 
reported and a wide array of cutting and coagulation devices has been used. Most 
of the published literature is consistent of limited sample sized studies mostly 
retrospective series with variable definitions of success used in these studies. 
Chapter 1 – Meta-analysis – endoscopic treatment of ZD
To make sense of what little has been published on management of Zenker’s 
diverticulum we aimed our meta-analysis to pool the results of endoscopic 
treatment of ZD in terms of efficacy and safety as well as recurrence. 
In this meta-analysis, we carried out a comprehensive literature search to identify 
any peer reviewed articles that examined the efficacy and safety of flexible 
endoscopic treatment of ZD. Pub-Med and Embase database were systematically 
searched. Once the duplicates were removed and exclusion criteria applied, 20 
studies were included in our meta-analysis. We looked at the techniques, the 
devices and sedation used. We looked at the midline single incision and double 
parallel incisions on the septum and using a polypectomy snare to remove 
the middle of the septum. We also looked at the use of diverticuloscope verses 
transparent cap as well as the use of clips and prophylactic antibiotics. 
Twenty studies with a total of 813 patients were selected. The pooled success rate 
was 91% (95% confidence interval, 86% - 95% colon I2 = 69.5%). The pool adverse 
event rate was 11.3% (95% confidence interval, 8% - 16% colon I2 = 64%). The 
recurrence rate was 11% (95% confidence interval, 8% - 15% I2 = 38.4%). Substantial 
heterogeneity across studies was found, but this was crucially observed in one 
article which revealed the lowest rate of success (approximately 56%). 
We found no direct association between device, technique and FESD (Flexible 
Endoscopic Septum Division) safety, although evidence from one study published 
in 2007 by Costamagna has linked a soft diverticular scope to a higher success rate. 
Bleeding and perforations (diagnosed either directly or indirectly through the 
presence of subcutaneous emphysema) are the potentially life threatening adverse 
event that could develop during or after FESD. When these adverse events occurred, 
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they were successfully managed conservatively. The bleeding was stopped with 
endoscopic therapies and adverse events were treated conservatively by keeping 
the patient nil by mouth, positioning of a nasogastric tube and IV antibiotics. In all 
but two instances when due to the presence of an abscess drainage was required. 
It was reassuring that patients who developed adverse events after FESD in these 
studies included in this review did not require surgery. 
We were surprised with the finding of regression analysis that revealed that both 
the rate of success and rate of recurrence were influenced by the time of the 
publication. The success rate was found to be negatively associated with the time 
of the publication with lower pooled estimates for studies published after 2005, 
whereas the opposite pattern was found for the recurrence rate estimate. Although 
this was an unexpected finding (increased experience over time should lead to 
improved outcome), it should be interpreted with caution because of the small 
number of studies in each subgroup (2005 or before versus after 2005), and other 
factors may be responsible. Indeed, characteristics of the practice settings such 
as endoscopic expertise and skills and characteristics of the patient population 
may have significantly influenced the outcome of FESD use. We propose that such 
findings underpin the need for comprehensive large prospective and multicentre 
studies to validate new technologies applied to ZD to identify potential predictors 
of recurrence and complications. We also concluded with meta-regression analysis 
for success and safety show that cutting device, diverticular size and sample size of 
the trial or sedation had no influence on the outcomes. 
This was the first meta-analysis on ZD that shows promising success and 
comparable recurrence and complications when compared with surgical stapling. 
Although this review reported flexible endoscopic treatment of septum division 
(FESD) safe but also indicated a high degree of heterogeneity amongst studies; 
hence, proposed the need for improved standardisation in terms of symptom 
evaluation and objective scorings as well as a clear definition of success, relapse 
and adverse events. 
Chapter 2- New and Emerging Techniques for Endoscopic 
Treatment of Zenker’s Diverticulum – a State-of-the-Art Review
In this state of the art review we described a synopsis of the established and 
emerging therapeutic methods of ZD with particular focus on the latest evidence. 
We have reported the evolution of the devices and the impact on the outcome 
and looked at the emerging devices. We also reported various incision techniques 
including single versus double incision and described the endoscopic management 
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of recurrent ZD. Last but not least, we highlighted the limitation since the inception 
of FESD. 
We recognised a lack of clinical guidelines or auditable performance matrix in 
endoscopic management of ZD. Incorporating quality assurance into the ZD arena 
may be the upcoming strategy to improve operators’ proficiency and the patient’s 
outcome in the future.
Finally, there has been no consensus on training and technical aspects as how the 
therapy should be carried out. Optimal technique to date remains controversial. 
As ZD is a rare disorder, training and therapeutic endoscopy can be challenging 
with an unknown learning curve. We recognised a need to develop animal 
training models and to develop clinical guidelines and standardise treatment. 
Incorporating quality assurance may be an up and coming strategy to improve 
operating proficiency and the patient outcome in the future.
Chapter 3 - Intubation Failure (IF) during Gastroscopy – Incidence, 
Predictors and follow-up Findings
Although this is a relatively common problem during endoscopy training, the 
incidence of IF is relatively unknown. Despite this, neither the incidence nor the 
aetiologies of IF have been reported in large cohort studies. Limited data arise from 
randomised trials which have compared conventional gastroscopy with trans-
nasal routes, with rates of IF ranging from 0% to 1.8%. Moreover, the Mallampati 
classification is routinely used to assess variations in oropharyngeal anatomy to 
gauge the difficulty of airway intubation. However, for gastroscopy, little emphasis 
is placed on variations in oropharyngeal anatomy. In clinical practice, patients 
are often deemed to not tolerate intubation due to factors such as anxiety, when 
these may be due to variations in oropharyngeal anatomy. So far, no studies have 
explored whether patients fail intubation due to anxiety, or anatomical causes.
We looked to assess incidence and aetiology of Intubation failure (IF) and predictors 
of structural pharyngeal abnormalities in patients with IF in a single centre and 
demonstrated that incidence of IF is 0.95%. We concluded that patients with IF 
should be investigated owing to high risk of underlying pathology, particularly 
if associated with age ≥65, dysphagia, and failure of endoscopic progression. 




Chapter 4 - Feasibility of High Flow Nasal Oxygen Therapy (HFNOT) 
and two-stage sedation during endoscopic hypopharyngeal 
therapy
Deep sedation with or without intubation poses challenge in patient with ZD 
who do have significant co-morbidities and have a particular risk of aspiration 
gastric or pouch content during procedure. We conducted the first prospective 
observational study, designed to assess the efficacy and safety of High Flow 
Nasal Oxygen Therapy (HFNOT) in patients undergoing pharyngeal and upper 
oesophageal procedures using a flexible endoscope. In this study we reported use 
of transnasal HFNOT that has enabled the procedure requiring deep sedation to 
be performed without endotracheal intubation. We also proposed new concept 
of two stage sedation. In this cohort, the majority of patients were ASA 2 or 3 and 
no procedure was abandoned. In view of low rates of adverse events we proposed 
that HFNOT is a useful adjunct to two-stage sedation, which can enable high- risk 
patients to safely undergo deep sedation.
Chapter 5: Flexible endoscopic treatment for Zenker’s diverticulum 
with the SB Knife. Preliminary results from a single centre 
experience
Despite Flexible endoscopic septum division was emerging as an effective treatment 
option for Zenker’s diverticulum (ZD), the main hazard of this procedure was the 
risk of perforation, which was reported in up to 27% of patients. There was a need 
and desire to improve the safety of this procedure using newer devices. Sumitomo 
Bakelite Ltd. Just commercialized the SB Knife: a scissor shaped, rotating device 
with two insulated monopolar blades designed for ESD. This device was associated 
with an improved safety profile for ESD in comparison to other devices. The aim 
of this study was to assess the efficacy, safety and outcome of flexible endoscopic 
treatment of ZD with the SB Knife.
Thirty-one consecutive patients with ZD treated with the SB knife. The procedure 
was carried out successfully in all patients with the median procedure time of 14 
minutes. No perforations were observed and there was a substantial reduction 
of symptoms after the treatment. One case of late-onset bleeding developed one 
week after the procedure, and was managed endoscopically. Endoscopic treatment 
of ZD using this new device was safe and efficient.
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Chapter 6: The role of flexible endotherapy for the treatment of 
recurrent Zenker’s diverticula after surgery and endoscopic stapling
Since the inception of flexible endoscopic treatment in 1995 of ZD, the pharyngeal 
pouch management has evolved over the last two decades despite the exact 
pathogenesis still remaining ambiguous. The mainstay of flexible endoscopic 
treatment is either a single midline incision to cut the septum or a double incision 
with an ability to excise the septum in between the two incisions. 
One of the earlier devices used in 1995 was a needle knife papillotome which 
has a major disadvantage of lacking precision in knife tip control; hence, led to 
increased perforation and mediastinitis. One of the major shifts in using newer 
devices is the precision in which the CP muscle fibres are grasped and the ability 
to pull them upward before cutting. 
The Stag Beetle (SB) knife was recently introduced. In the first study (Chapter 5), 
31 patients with ZD were consecutively treated and a double incision technique 
was used with SB knife and a monopolar snare was used to remove the portion 
of septum in between. Two to three clips were used at the site of the incision to 
prevent mucosal dissection and perforation. One of the great advantages of the SB 
knife was the reduction in the procedure time. A significant improvement in the 
dysphagia score was achieved. Only two patients had mildly relapsing symptoms 
after 4 and 9 months but declined further treatment. 
Recurrence of Zenker after surgery or endotherapy can be high at 20%. Treatment 
of recurrence of ZD after surgery or endoscopic stapling can be challenging. 
Endoscopic stapling of residual small pouches pose some issues, an adequate bite 
of the common wall between the diverticulum and oesophagus cannot be achieved 
in some patients and high risk of perforation is encountered when small pouches 
are stapled. Moreover, the staple over staple may lead to unpredictable scarring 
that can lead to persisting dysphagia. In this chapter 6 we evaluated patients that 
underwent a flexible endoscopic septum division for symptomatic ZD. Patients 
were subsequently divided into those who underwent previous treatment (either 
surgery or endoscopic stapling) and those who did not. 
The treatment was carried out successfully. Interestingly, there was no difference 
found in the technique used or the device employed between the naïve patient 
and the patient with recurrent ZD. This was the first study to evaluate the flexible 
endoscopic treatment of ZD with recurrence after surgery and endoscopic stapling 
that also compared the outcome with de novo patients .Our results clearly suggest 
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that flexible endotherapy is a safe, feasible and efficient treatment in patients with 
recurrent ZD. We proposed flexible endotherapy should be first line treatment in 
patients with ZD who relapse. 
Chapter 7 - Long-term Success of flexible endoscopic septal division 
with stag beetle knife for Zenker’s Diverticulum: a tertiary centre study 
In this original study we looked at Long-term success of Flexible Endoscopic 
Septal Division for ZD with the SB Knife in treatment naïve and recurrent ZD. 
We demonstrated that a significant proportion of patients develop symptom 
recurrence overtime. The rates of symptom recurrence at 12 months approached 
15.0%, increasing to 51.2% after 48 months. At 48 months, the therapeutic efficacy of 
FESD was superior in the treatment-naïve group compared to those with recurrent 
ZD (Kaplan– Meier estimated recurrence rates of 10.7% vs. 84.7%). We also reported 
superiority of our proposed Dysphagia, Regurgitation and Complications (DRC) 
score over the frequently used Dakkak score (which measures dysphagia) for 
measuring ZD symptoms. 
Our results suggested that FESD using the SB knife is feasible and safe, with a 
complication rate of 6.2%. The majority (75.4%) of patients achieve symptom 
remission, although recurrent ZD and younger age were independently associated 
with post-FESD recurrence. Complete myotomy at the index FESD has better 
outcome Long-term. Patients with recurrent ZD should be counselled regarding 
the risk of further recurrence and recurrent treatment. Our study also supports 
the role of the DRC scale over the Dakkak dysphagia scale in the monitoring of ZD 
symptoms. 
Chapter 8- Zenker’s diverticulum- can protocolised measurements 
with barium Radiology predict severity and treatment outcomes? – 
A “Zen-Rad” study 
In this Zen-Rad study we looked at role of barium radiology. Currently, barium 
swallow remains the mainstay imaging modality for patients with suspected 
ZD. Despite its role in the diagnosis and functional assessment of ZD, there is 
no accepted protocol for the standardised reporting of ZD dimensions based 
on barium radiology. In this study we establish a protocol to standardise the 
nomenclature of ZD dimensions. 
We concluded that ZD dimensions may be feasible evaluated using Barium radiology. 
Specific parameters appear to correlate with severity and post-FESD outcomes.
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Chapter 9
Chapter 9.1 Experimental treatment of Per-Oral Endoscopic 
myotomy of CricoPharyngeus Muscle with using SB knife junior- 
Swine model – CP-POEM
Chapter 9.2 Experimental treatment of Zenker diverticulum with 
per oral endoscopic complete myotomy of CricoPharyngeus Muscle 
with clutch cutter knife – live Swine model -open tunnel approach
In chapter 9.1 and 9.2 describe we describe 2 experiments and demonstrated 
minimally invasive flexible endoscopic treatment for CPH: “Experimental 
treatment of Per-Oral Endoscopic myotomy of CricoPharyngeus Muscle with 
using SB knife junior- Swine model – CP-POEM” and anterior tunnel approach in 
treating ZD in swine model
In the first experiment (chapter 9.1) Very little was known role of flexible endoscopic 
myotomy of Cricopharyngeus Muscle in the absence of ZD. This swine model 
experiment gave us insight into this concept. We believe such an animal model 
might open up new avenues for developing, improving or modifying treatment. We 
in this experiment used Pigs oesophagus but leant that using an oesophagus model 
might be too challenging to orientate in to the anatomical structures. CPM muscle 
is like sling with bulk to form posterior wall of upper oesophageal sphincter, hence 
it is important to orientate so posterior wall is identified. Unfortunately, this is 
very challenging in our oesophagus animal model. 
We concluded that should repeat this experiment with full head and neck of 
swine model not just the oesophagus to facilitate a better identification of CPM 
posteriorly to permit experimental treatment.
In the second experiment (chapter 9.2) we looked into feasibility of complete 
myotomy modifying conventional septomtotoy technique, with an additional 
anterior myotomy. The anterior open tunnel complete myotomy was feasible 
and safe in this pilot experiment. Important learning lesson was that complete 
myotomy of cricopharyngeus muscle (CPM) can be carried out without the need 
of dissection posterior to the cricopharyngeus muscle (CPM) to prevent breach 
of buccopharyngeal fascia (BPF). This has very important implications in human: 
as cutting of cricopharyngeus muscle (CPM) is possible without breaching 
buccopharyngeal fascia (BPF) to prevent secondary infection or air leak into 
superior mediastinum during dissection of cricopharyngeus muscle (CPM). 
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Such technique of an anterior tunnel into oesophagus facilitate good operating 
space and access to lower fibres of cricopharyngeus muscle (CPM) when compared 
with the reported 3rd space tunnel myotomy, hence may have advantages over the 
Z-Poem technique recently described. Another advantage in Z-ATM is cutting of 
mucosal layer covering the cricopharyngeus muscle (CPM), resulting in reduction 
in pouch size.
Chapter 10 Zenker diverticulum (ZD): Anterior Tunnel complete 
cricopharyngeus (CP) Myotomy: Z-ATM
In this novel concept we introduced a complete myotomy by anterior tunnel 
approach with deep sedation without the need of general anaesthesia. This 
allowed complete myotomy using Z-ATM in one patient referred to us in 2019 with 
recurrent symptomatic pouch (4cm). As complete myotomy was needed in this 
patient hence patient counselled and informed about this modified technique.. 
This technique should be validated and compared with other treatment in future 
studies. This we hope sets the scene for complete solution of endoscopic treatment 
of ZD.
PhD 2013-2020
We defined our goals about this PhD project in the introduction, then described 
our work in the last 7 years trying to answer the research questions on ZD that 
were not known. 
Our Meta-analysis (MA) systematic review indicated unfortunately a high degree 
of heterogeneity among the reported studies and highlighted the lack of large 
prospective RCT studies to recognize any advances in flexible endoscopic treatment 
of ZD. Our MA emphasized the need for improved standardization in terms of 
symptom evaluation and objective scoring, as well as clears definitions of success, 
relapse and adverse events. However, based on the findings of this meta-analysis 
suggest that flexible endoscopic cricopharyngeal myotomy is a feasible, safe and 
effective treatment of symptomatic ZD, with low recurrence rates. Success and 
adverse event rates are comparable to surgical treatment and the rigid endoscopic 
approach. 
The strengths of this review include: A rigorous literature search with well-defined 
inclusion and exclusion criteria and careful exclusion of redundant studies. 
Success, complication and recurrence in our MA were different to that reported 
by Verdonck et al in 2015. In a systematic review Verdonck et al compared rates of 
failure, revision and morbidity from endoscopic and open approach as treatment 
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for ZD. He reported failure of open and endoscopic approaches as 42% and 18.6% 
respectively, and corresponding complication rate of 11% and 7%. He concluded 
that failure rate with rigid endoscopic technique was up to 21.8%. Unfortunately, 
most studies on flexible endoscopic treatment of ZD until 2015 were not captured 
in this review.
Our Meta-analysis was comprehensive and included 831 patients and twenty 
studies and we reported pooled success, adverse events and recurrence rates were 
92% [95% CI: 86-95%, I2=72%], 13% [95% CI: 9-19%, I2=61.4%], and 14% (95% CI: 9-21%, 
I2=69.6%) respectively. 
Long-term outcomes of Flexible Endoscopic Septum Division (FESD) and ENT led 
approaches were poorly reported in literature, which poses a dilemma in real life. 
In our prospective study of Long-term outcome of Stag Beetle Knife treatment in 
ZD, we looked at Long-term success of Flexible Endoscopic Septal Division for ZD 
(de novo and recurrent ZD) with the SB Knife. 
The majority (75.4%) of patients achieve symptom remission, although recurrent 
ZD and younger age were independently associated with post-FESD recurrence. 
Complete myotomy at the index FESD has better outcome Long-term. Our study 
supports the role of the DRC scale over the Dakkak dysphagia scale. 
Assessment of Symptoms in ZD was poorly defined and historically. In the absence 
of any specific ZD score, researchers started to use the Dakkak and Bennett score 
for ZD. We know that 80% of the patients with Zenker have significant frustrating 
symptoms of regurgitation and some will have weight loss and recurrent aspiration 
and chest infections. Our new DRC scoring tool now has been validated. We hope 
this will be used and evaluated by gastroenterologists and ENT colleagues. This 
score measures all symptoms of ZD and not just dysphagia.
Prevalence of intubation failure in pharyngeal disorder was not well known. In 
a recent original study, we explored the incidence and aetiology of intubation 
failure in endoscopy to assess the predictors of intubation failure and predictors 
of pathology in patients with intubation failure. This is the first report in literature 
that gives insight those pharyngeal abnormalities such as Zenker’s could be a 
significant predictor of intubation failure. 
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Sedation in patients with Zenker’s diverticulum poses another challenge as most of 
these patients are elderly with high ASA 2-3 score with multiple cardiorespiratory 
comorbidities. Our Zenker results might have impact on practice and approach of 
endoscopists whilst treating patients with ASA 2-3 or higher without the need of 
GA. We suggest that this HFNOT might be used adjunct with Propofol for complex 
endoscopic procedures on high risk patients. 
In the last 10 years there has been a change and shift using devices that allows the 
Zenker septum to be pulled upwards and cut. We introduced a device such as SB 
knife that allowed the precise and safe cutting of the cricopharyngeus muscle.
Despite the evolution of new techniques and devices, data on the long-term efficacy 
of Flexible Endoscopic Septum Division (FESD), particularly in recurrent ZD, are 
lacking. Recurrence of Zenker’s diverticulum after surgery or endoscopic stapling 
can be technically challenging as treating endoscopic stapling of small residual 
pouches poses technical challenges. We reported the first study with patients to 
evaluate flexible endoscopic treatment of ZD with recurrence after surgery and 
endoscopic stapling. We also compared the outcome with de novo patients. We 
suggest that Flexible Endoscopic Septum Division (FESD) in recurrence ZD is 
feasible, safe with good outcome. 
In another prospective study we aimed to evaluate the durability of symptom 
improvement after Flexible Endoscopic Septum Division (FESD) and identify 
predictors of post-FESD recurrence. Post-stapling recurrence is high and time-
dependent, longer post open surgery follow up is mandatory.
We are satisfied that our work was helpful for many of the recommendations of 
upcoming ESGE Guideline on flexible endoscopic treatment of ZD, published in 
June 2020. Based on the literature Flexible Endoscopic Septum Division (FESD) 
is recommended as first line treatment in this ESGE Zenker Guideline. These 
Guideline need to be shared and discussed with ENT Societies to make a choice 
which treatment for symptomatic ZD is indicated. 
To address issues of safe and minimally invasive complete myotomy we carried 
out animal experiment on modifying the tunnel approach in such a way to 
prevent need of dissection posterior to cricopharyngeal muscle (Zenker- anterior 
tunnel myotomy- (Z-ATM), We modified conventional myotomy to make anterior 
tunnelling towards oesophageal lumen. This approach helped to completely 
dissect the cricopharyngeal muscle (CPM) without the need to dissect posterior 
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to cricopharyngeal muscle (CPM) to prevent avoidable breach to buccopharyngeal 
fascia and leak into superior mediastinum. This approach should be tested in 
prospective studies. 
Implications for future research
We recognized 8-9 main questions as we started our work. Despite what we have 
studied, there is much more work needed to be done. Our symptoms score (DRC) 
needs to be validated by other groups. Due to the relative infrequency of the 
condition, studies for treatment of ZD are at best, limited to small prospective 
studies, without randomised-controlled trial data. There is a clear need for larger, 
well-designed, comparative prospective studies to assess the optimum method, 
treatment device and techniques (External/Stapling vs flexible endoscopy). There 
is also a need for standardization of training and practice. Less is known on very 
small or very large ZD and best way to deal with it. Probably in the very large ZD’s 
in (younger) patients an open approach by the ENT specialist might be indicated 
and gives better results in FU.
Additionally, universal definitions of outcomes, such as treatment success, relapse 
and complication rates need to be agreed to allow better comparisons between 
studies, and to quality assure practice.
Since the inception of Flexible Endoscopic Septum Division (FESD), there has been 
no consensus on the training. Due to ZD being a rare disorder, training in therapeutic 
endoscopy can be challenging, with an unknown learning curve. There is a clear 
need to ensure that training for such a high-risk procedure is required, supported 
by mentorship and competence assessments. As most pigs possess pharyngeal 
diverticula resembling human ZD, beginners in Flexible Endoscopic Septum Division 
(FESD) may benefit from animal model training. Perhaps endoscopy societies need 
to come together with joint resources to lead on training using an animal model. 
Training centres across Europe need to be identified, recognised and established to 
train and mentor endoscopists to conduct teaching and training. With prevalence of 
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